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ABSTRACT
The purpose of the current study was to assess the performance of depressed
young adults on tests of executive function, while addressing the variables of age and
medication status, which have been inconsistently measured in previous research. It was
hypothesized that statistically significant group differences would occur on tests of
executive functions in three distinct groups: medicated depressed, non-medicated
depressed, and non-medicated non-depressed individuals.
Participants included 53 adults who were medicated depressed (n = 15), nonmedicated depressed (n = 16), and non-medicated non-depressed (n = 22) and were
between the ages of 19 and 40 years. Participants completed measures assessing
depression, psychological well-being (including anxiety), intelligence, and executive
functions.
Between group comparisons revealed several statistically significant differences
on executive function measures including the Wisconsin Card Sorting Test (WCST)
Trials Administered, WCST Failure to Maintain Set, Trail Making Test (TMT) B, Stroop
Color, and Stroop Color-Word. The non-medicated non-depressed group performed
better overall than those in the medicated depressed and non-medicated depressed groups.
Post hoc stepwise regression analyses indicated that anxiety predicted performance on a
number of executive function measures to a greater degree than did depression.

xi

Findings suggest that executive functions of young adults are affected by
depression, medication status, and anxiety. Results of the present study contradict the
assumption that psychotropic medications do not affect cognitive abilities. These findings
also suggest that future research investigating the interaction between anxiety and
executive functions are necessary.
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CHAPTER I
INTRODUCTION
Depression has been documented as far back as the ancient Greeks (Caroll, 2006).
Between the 17th and 18lh centuries many Europeans used the term melancholia to
describe, not only depression, but a vast array of mental illnesses. At that time many
physicians believed that mental illnesses, including depression, were disorders of the
brain. However, soon after, other theories of mental illness and depression began to
flourish. Most of this began with Freud and his psychoanalytic theory.
In the late 19th and early 20th centuries, psychoanalytic explanations gained favor
of most in the fields associated with mental illness (see Freud, 1917). Although
psychoanalytic and many other purely psychological explanations have been widely
accepted and utilized regarding the understanding of depression, discussions of a brainbased illness were never too far off. Geneticists and biologists believed that there were
factors to depression that scientists simply had not yet found. Some have argued that
complex hormonal feedback loops have gone awry or that the overstimulation of certain
hormones results in depression (see Pepper & Kreiger, 1984). Others have argued that
there are specific genes that are passed down from one generation to the next often
resulting in depression (see Numbereger & Gershon, 1984). While all of the
aforementioned explanations have gained much respect and credibility within each one’s
respective field, the World Health Organization (WHO; 2001) asserted that they all likely
share some responsibility in the cause of depression.
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More recently, scientists have begun to focus again on the brain’s role in
depression. Neuropsychologists have begun to examine the behavioral aspects of
depression that are mediated by the brain. The executive functions, one’s skill and ability
at performing novel problem-solving tasks from there beginning to there end, have found
mixed results regarding the effects of depression on neurocognitive functions (Grant,
Thase, & Sweeney, 2001; Landro, Stiles, & Sletvold, 2001; Paradiso, Lamberty, Garvey,
& Robinson, 1997; Purcell, Maruff, Kyrios, & Pantelis, 1997). Scientists have argued that
the executive function deficits that occur in depressed individuals in some studies and not
in others have resulted from numerous confounds. Specifically, age and medication status
(medicated or non-medicated) have been implicated as two major inconsistencies. The
purpose of the current study was to add to the burgeoning literature regarding executive
function deficits in depressed individuals while accounting for age and medication status.
Depression
According to Webster’s II: New College Dictionary (Berube et al., 1995),
depression is “a neurotic or psychotic condition marked by an inability to concentrate,
insomnia, and feelings of dejection and guilt” (p. 304). To many, depression is a source
of terrible pain and unrelenting despair about themselves and their future. Of depression,
Kay Redfield Jamison (1995) wrote:
Depression is awful beyond words or sounds or images; I would not go
through an extended [depression] again. It bleeds relationships through
suspicion, lack of confidence and self-respect, the inability to enjoy life, to
walk or talk or think normally, the exhaustion, the night terrors, the day
terrors. There is nothing good to be said for it except that it gives you the
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experience of how it must be to be old, to be old and sick, to be dying; to
be slow of mind; to be lacking in grace, polish, and coordination; to be
ugly; to have no belief in the possibilities of life, the pleasures of sex, the
exquisiteness of music, or the ability to make yourself and others laugh.
(p. 217)
According to WHO (2001), approximately 121 million individuals worldwide
presently experience the deleterious effects of depression. The magnitude of this number
leads some to believe that in the near future it will be the leading cause of disability in the
world. Currently, it is reported to be the leading cause of lost work days for both men and
women (Quinn, 2000). Quinn noted that there have been reports that found depression
costs employers approximately $33 billion a year due to the increased absenteeism and
decreased productivity of employees.
According to the Diagnostic and Statistical Manual o f Mental Disorders, Fourth
Edition, Text Revision (DSM-IV-TR; 2000), depression is the combination of several
symptoms simultaneously occurring over the course of a 2-week period that represents a
change from previous levels of functioning. Specifically, an individual must experience
either a depressed mood or a loss of interest or pleasure in daily activities. Furthermore,
an individual must experience other symptoms such as feeling depressed (e.g., feelings of
sadness or emptiness), a noticeable decrease of interest or pleasure in activities, weight
fluctuations, sleep difficulties, observable difficulties with motoric movements, fatigue,
feelings of worthlessness, cognitive processing difficulties, and/or recurrent thoughts of
death and/or suicide.
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Comer (2001) has described depression as a decreased mood that is highlighted
by pronounced sadness, significant reduction of energy, feelings of low self-worth and
guilt. He elaborated by noting, depression “has no redeeming characteristics. It brings
severe and long lasting psychological pain that may intensify as time goes by. Those who
suffer from it may lose their will to carry out the simplest of life’s activities” (p. 193),
while others lose their will to live outright.
WHO (n.d.) noted that fewer than 25% of those experiencing the negative effects
of depression actually have access to effective treatment. The DSM-IV-TR (2000)
reported that as many as 15% of those with Major Depressive Disorder (MDD) die by
suicide. Furthermore, we now know that depression is not usually experienced in one
episode (Barlow & Durand, 1999). According to Barlow and Durand (1999), reports have
found that as many as 80% of individuals who experience a single episode of depression
will have another, more severe, episode at a later time.
As previously noted, numerous explanations of depression have been set forth
from the fields of biology, genetics, and psychology. Recently, neuropsychologists have
begun to investigate neurocognitive functioning and its relationship with depression, and
more specifically, what executive function deficits are present in individuals with
depression.
Executive Functions
Zillmer, Speirs, and Culbertson (2001) asserted that executive functions are
“higher-order regulatory and supervisory functions th at... [are believed to be] subserved,
in part, by the frontal lobes. Cognitive operations such as planning, mental flexibility,
attentional allocation, working memory, and inhibitory control are considered executive
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functions” (p. 552). Johnson-Greene and Adams (1998) elaborate on the previous
description by including organization and regulation of affective state to their list of
executive functions. Much of what is known about the executive functions of the brain
has come from studies of brain damaged individuals.
Sbordone (2000) noted that reports have found associations between damage to
the orbitofrontal cortex and certain behavioral manifestations (e.g., decreased social tact,
use of crude language, inability to regulate one’s emotions, emotional lability, &
insensitivity toward others). Furthermore, neuroimaging studies have shown decreased
regional blood flow and metabolism in depressed individuals in the anterior regions of
the brain. More specifically, depressed individuals showed decreases in the prefrontal
cortex, left dorsolateral prefrontal cortex, Supplementary Motor Area (SMA), anterior
cingulate cortex, and premotor areas of the frontal lobes as well as the posterior cingulate
cortex and angular gyrus of parietal lobes (Baker, Frith, Dolan, 1997; Bench et al., 1992).
Additionally, Positron Emission Tomography (PET) studies have implicated frontal lobe
inactivity in depressed individuals (Paradiso et al., 1997).
Age and medication status appear to be common confounds in the literature
regarding the executive functions and depression. Operational definitions of young adult,
middle age, and late life/elderly individuals have been erratic. For example, while
executive function deficits in older individuals have been fairly well documented (Grant
et al., 2001), attempts to investigate younger adults have resulted in research participants
that range in age from as young as 18 (Merriam et al., 1999) to those as old as 61 years
(Porter et al., 2003).
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Additionally, medication status has been investigated half-heartedly by most.
Although studies such as Porter et al.’s (2003) have focused on depressed medication free
individuals, their sample included individuals in their 60’s. Furthermore, studies such as
Paradiso et al. (1997) clustered their experimental sample together under one variable
(depressed) whether they were medicated or not. According to Paradiso and his
colleagues, post-hoc analyses showed that there were no differences between their
medicated depressed and non-medicated depressed groups. However, comparing only 12
medicated individuals to 8 non-medicated individuals hardly accounts for the confounds
inherent to such small sample sizes and loose methodology.
Purpose
Depression has been a recorded part of the human experience since the days of
antiquity. To date, various hypotheses and theories have been set forth to explain how
depression develops as well as how one can ameliorate the effects of depression in one’s
life. With a recent emphasis on depression’s effects on the brain, researchers have
attempted to identify sequelae of depression on a brain-behavior continuum. However,
the research to date has overlooked various methodological aspects that have hindered
health care providers from utilizing the information to help younger adult’s diagnosed
with depression. For example, too wide of an age range has been utilized in various
studies (e.g. Porter, Gallagher, Thompson, & Young, 2003) and medication status
appears to have been studied as an afterthought rather than as the major variable it is.
While some studies have attempted to mitigate these confounds, no research has managed
both age and medication status adequately. It is well known that the brain continues to
develop well into one’s early twenties (Zillmer et al., 2001) and that different areas of the
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brain are used for the same task at different stages of development (Riccio, 2006). Thus,
any comparison of differently aged individuals must address these differences
methodologically. Moreover, medication status (e.g., antidepressants) directly affects
one’s neurochemistry and is thus of key importance in any discussion of cognitive
functioning.
The purpose of the current study was to assess the level of executive functioning
in a depressed and non-depressed sample. Furthermore, medication status was managed
by separating the depressed group into medicated and non-medicated individuals.
Additionally, participants consisted of individuals between the ages of 19 and 40. This
age group allows for a purer understanding of the effects of depression on the executive
functions in a younger adult population.
It is the hypothesis of the current study that differences in performance will be
found between medicated depressed, non-medicated depressed, and non-medicated nondepressed participant groups on measures of executive functioning. More specifically, it
is hypothesized that all three of the aforementioned groups will obtain statistically
significant differences from one another regarding their performance on five well
established tests of executive functions (i.e., Wisconsin Card Sorting Test [Heaton,
Chelune, Talley, Kay, & Curtiss, 1993], Trail Making Test [Reitan, 1993], Tower of
London: Drexel Edition [Culbertson & Zillmer, 2005], Stroop Color and Word Test
[Golden & Freshwater, 2002], & Controlled Oral Word Association [Spreen & Straus,
1998]).
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CHAPTER II
REVIEW OF LITERATURE
In the following sections a discussion occurs regarding the various aspects of
depression that include a definition of depression, prevalence rates, and theories.
Psychological, genetic, and biological theories of depression are reviewed. Within the
psychological domain, the focus is on Psychoanalytic, Interpersonal, and (particularly)
Cognitive conceptualizations. Twin studies are emphasized in a discussion focused on
genetic implications related to depression, while the serotonin, norepinephrine, and
corticotropin-releasing factor hyperactivity models are discussed in terms of biological
explanations of depression. These are in no way meant to be exhaustive lists of all
conceptualizations of depression in each field. However, these explanations are presented
in an effort to provide an overview of some of the most popular psychological, genetic,
and biological explanations of depression. Furthermore, descriptions of depression at
different developmental points in time (i.e., childhood, adolescence, young adulthood, &
later-life) serve to provide context to the varied paths depression takes across the lifespan.
The second half of the literature review overviews the executive functions, with
emphasis on the most popular theories of executive functions (including the most
common symptoms of executive dysfunction), the development of the executive
functions, and different measures that assess aspects of the executive functions.
Furthermore, the scientific literature regarding executive functioning and depression are
discussed in order to provide context related to what has been accomplished in the
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research literature and highlight what further research is necessary in order to further the
scientific communities understanding of the complex interaction that results between the
executive functions and depression.
Depression
DSM-IV-TR definition o f Depression
According to Barlow and Durand (1999), the Major Depressive Episode is the
most often diagnosed and most severe type of depression. An extension of this is the
DSM-IV-TR (2000) mood disorder, Major Depressive Disorder (MDD), Single Episode.
The DSM-IV-TR indicates that individuals diagnosed with a MDD, Single Episode must
be in the process of experiencing a Major Depressive Episode that is not better accounted
for by a Schizoaffective Disorder nor simply covering over Schizophrenia,
Schizophreniform Disorder, Delusional Disorder, or Psychotic Disorder Not Otherwise
Specified. Furthermore, the individual must have never experienced a Manic, Mixed, or
Hypomanic Episode.
If the full criteria just described are met, the clinician then has several labels at
her/his disposal to make the diagnosis more specific. For example, one can further
specify the clinical condition by attaching the statement, In Partial Remission, In Full
Remission, Chronic, With Catatonic Features, With Melancholic Features, With Atypical
Features, or With Postpartum Onset (DSM-IV-TR, 2000). These various labels clearly
show how complex and multifaceted depression truly is.
The DSM-IV-TR (2000) criteria for a Major Depressive Episode requires that an
individual possess at least five of the following symptoms: depressed mood most of
nearly every day, either by self-report or observations of others; strikingly diminished
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interest or pleasure in most or all activities every-or nearly every-day, either by selfreport or observations of others; significant weight loss, not due to the effects of dieting,
or gain; insufficient or too much sleep nearly every day; agitated, delayed, or impeded
movement or muscular action due to mental processes nearly every day; fatigue or loss of
energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt,
which can be delusional, nearly every day; diminished ability to think and/or concentrate
or indecisiveness; and/or recurrent thoughts of death or suicidal ideation (DSM-IV-TR).
These symptoms must have been present for at least two weeks and represent a
change from one’s previous level of activity. Furthermore, at least one of the symptoms
an individual possesses must be a depressed mood or loss of interest or pleasure.
Additionally, the symptoms cannot meet criteria for a Mixed Episode, they must cause
clinically significant distress or impairment in social, occupational, or other important
areas of the individual’s functioning, they must not be symptoms related to the
physiological effects of drugs or medication or a medical condition, and the symptoms
must not be better explained by Bereavement (DSM-IV-TR). While the DSM-IV-TR has
attempted to provide a clear list of descriptive symptoms that manifest themselves during
a Major Depressive Episode, others have theorized the underlying causes of this disorder.
Prevalence o f Major Depressive Disorder
Depression has been reported to be one of the most common and severe
psychological disorders (Weissman, Bruce, Leaf, Florio, & Holzer, 1991) with typical
onset occurring in one's mid-twenties (DSM-IV-TR; 2000; Ebmeier, Donaghey, & Steele,
2006; McMahon & DePaulo, 1996). However, Clayton (1983) has asserted that the true
prevalence of MDD is unknown as the numerous studies in this area have varied in their
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methodology and case criteria. Although an exact prevalence rate will never be known,
studies have consistently reported rates of MDD that concur with the DSM-IV-TR (2000)
and WHO (2001) rates previously reported (see Weissman & Myers, 1978; Boyd &
Weissman, 1981).
Weissman et al. (1991) reported lifetime prevalence rates for individuals living in
the United States. They reported that 4.9% of individuals will experience a MDD in
her/his lifetime with the subgroups of 30-44 year-olds, females, and Caucasians showing
the greatest lifetime prevalence percentages (7.5, 7.0, & 5.1, respectively). The research
literature generally agrees that women experience this disorder much more than men
(Clayton, 1983; DSM-IV-TR, 2000). Furthermore, while the DSM-IV-TR (2000) reports
that the disorder appears to be unrelated to one’s “ethnicity, education, income, or marital
status” (p. 372), Weissman et al. (1991) found somewhat contradictory evidence
regarding differences related to race. Weissman et al. reported prevalence percentages for
European Americans, African Americans, and Hispanic Americans of 5.1, 3.1, and 4.4,
respectively.
More recently, of the approximately 121 million individuals who currently deal
with depression on a daily basis (WHO, 2001), estimates show that between 5% and 10%
of adults in the United States will experience a unipolar (i.e., non bi-polar) depressive
episode during any given year. The DSM-IV-TR (2000) reports the prevalence rates of
MDD in community samples at between 10% and 25% for women and between 5% and
12% for men.
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Theories o f Depression
Psychological Theories o f Depression. Affective disorder is a commonly used
term that refers to a disorder in one’s mood (Thomas, 1993). Taber’s Cyclopedic Medical
Dictionary (17th Ed.; Thomas, 1993) defines affective disorders as “a group of disorders
characterized by a disturbance of mood accompanied by a full or partial manic or
depressive syndrome that is not caused by any other physical or mental disorder” (p. 50).
It further describes depression as being characterized by an altered mood (Thomas).
Mood is defined as “a pervasive and sustained emotion that may have a major influence
on a person’s perception of the world” (Thomas; p. 1236; e.g., elation, joy, anger,
depression, & anxiety). Additionally, Taber’s (Thomas) suggests that mood and affect are
somewhat interchangeable and describes affect as “the emotional reactions associated
with an experience” (p. 50)
Comer (2001) has defined depression as “a low, sad state marked by significant
levels of sadness, lack of energy, low self-worth, guilt, or related symptoms” (p. 191).
WHO (2001) describes depression as a common mental disorder that is typically
“characterized by sadness, loss of interest in activities and by decreased energy” (]j 2,
retrieved March 29, 2005). WHO further states that depression can be distinguished from
a normal decrease in one’s mood by the severity, symptoms, and duration of the low
mood state and acknowledged that psychosocial, genetic, and biological factors are
implicated in causing the onset of a depressive episode.
Past psychological explanations have been put forth by numerous theorists. For
example, in 1917 Freud published Mourning and Melancholia which has been heralded
as the most influential work on depression to come from psychodynamic theory. Freud’s
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seminal work grew from a belief that depressed individuals were much like grief stricken
individuals following a loss (Becker, 1977; Comer, 2001). Therefore, as Freud believed
that depressed individuals were likely the result of severe, uncontrollable stress
associated with a loss, they would regress back to the Oral phase of psychosocial
development (Comer, 2001) and appear to others as an individual who’s world and self
appeared empty, self-regard severely impaired, and external relations minimal (Becker,
1977). Furthermore, Freud believed that depressed individuals were predisposed to
pathological reactions to loss and that regression to earlier psychosexual stages of
development (e.g., the Oral phase) were the result (Becker).
Another theory of depression came in the form of Interpersonal theory (Schwartz
& Schwartz, 1993; Weissman & Klerman, 1990). The Interpersonal Psychotherapy (IPT)
approach to depression was the first of its kind to look at a variety of factors that led to
and maintained depression. IPT is based on the theory that although one’s environment,
genetics, symptom patterns or severity, childhood experiences, and biological factors all
interact and result in depression, these all occur in the context of interpersonal
relationships (Schwartz & Schwartz, 1993; Weissman & Klerman, 1990).
Harry Stack Sullivan was another notable theorist whose work influenced the
development of IPT. For example, he emphasized that most psychiatric illnesses are
related to flawed interpersonal relationships (Schwartz & Schwartz, 1993). Additionally,
Meyer viewed psychiatric illnesses “as an expression of the patient’s attempt to adapt to
the environment” (Weissman & Klerman, 1990, p. 380). IPT began to focus its work on
individual’s interpersonal functioning and the various problems that co-occur with
depression (Weissman & Klerman). Thus, relationships between family members,
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friends, and significant others, as well as the role that each plays in one another’s lives,
proved to be the foundation for the development o f IPT.

IPT theorists created a frame of depression from which three main components
have been set forth that are seen as being involved in depression. The first of these three
components is believed to be symptom formation (Weissman & Klerman, 1990).
Symptom formation includes the depressive affect and vegetative signs of depression
such as fluctuations in sleep and appetite, loss of interest in pleasurable activities,
psychomotor agitation, and fatigue (Weissman & Klerman). The second component is
related to social and interpersonal relations. This component reflects social roles, past
learning, and current problems in social relationships (Schwartz & Schwartz, 1993;
Weissman & Klerman, 1990). The third component is that of personality. This includes
one’s enduring traits and behaviors, communication deficits, low self-esteem, and
inadequate management of anger and guilt (Weissman & Klerman, 1990). Weissman and
Klerman asserted that this component is “... the person’s unique reactions and patterns of
functioning and may contribute to a predisposition to depression...” (p. 381).
According to Schwartz and Schwartz (1993) and Weissman and Klerman (1990),
IPT only focuses its energies on intervening at the first two levels due to the lack of
research indicating that personality change is fruitful. Klerman, Weissman, Rounsaville,
and Chevron (1984) asserted that IPT works to decrease depressive symptoms and help
the individual develop healthier ways of dealing with interpersonal relationships that are
linked to the depressive episode. Another psychological view of depression has
implicated one’s own thoughts rather than social interactions. Cognitive theorists,
beginning with the work of Aaron Beck in the early 1970’s, has attempted to explain
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depression through three interacting aspects of one’s cognitions (i.e., the self, one’s
environment, and one’s future).
The cognitive theory of depression hypothesizes that the negative and pessimistic
beliefs that are typically associated with depression are not a result of the depression, but
are actually a cause of it (Schwartz & Schwartz, 1993). According to Barlow and Durand
(1999), these continuous negative and pessimistic beliefs are cognitive errors. A common
example of a cognitive error is arbitrary inferences (Barlow & Durand). For instance, an
individual may say hello to another person as they pass one another on the street and, for
some reason, the person may not say hello back. For the individual who makes inferences
arbitrarily, he/she may believe that the person did not say hello because of something
he/she said or did. The individual will likely come up with many negative reasons for the
person to have not said hello, potentially asking her/himself, “what did I do to make that
person upset with me?”
Although many hypotheses are typically made by the individual, it is likely that
none of them will include a neutral response, such as the person did not hear the remark.
All of the cognitive errors are hypothesized to revolve around three main areas, self,
environment, and future; together these are referred to as the cognitive triad of depression
(Barlow & Durand; Schwartz & Schwartz, 1993; Young, Weinberger, & Beck, 2001).
The cognitive triad model of depression posits that a depressed individual will
typically view her/himself as worthless and/or unable to be loved. A typical view of a
depressed person’s environment is that it is unmanageable, overwhelming, and harsh. The
future is often believed to be the source of only more pain as many feel what they are
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going through will never be assuaged. Young et al. (2001) asserted that the hopeless
belief regarding one’s future often leads to suicidal attempts and many lost lives.

Cognitive theorists hypothesize that childhood and development are integrally
related to depression. They have asserted that while growing up people do the best they
can to deal with and understand their environment (Schwartz & Schwartz, 1993; Young
et al., 2001). In so doing, they unintentionally create negative patterns of dealing with
situations resulting in schemas. According to Beck, Shaw, Rush, and Emory (1979),
individuals screen, code, and evaluate information, and a schema is the structure one
gives to this information. Based on this information and subsequent structure, “the
individual is able to orient himself in relation to time, and space and to categorize and
interpret experiences in a meaningful way” (Beck et al., p. 283). While schemas can be
positive, most schemas in depressed individuals are negative (Schwartz & Schwartz,
1993). Recent work by Jeffrey Young and his colleagues (2001) has extended the concept
of schemas.
Young has identified a total of 18 negative schemas that are compiled into five
categories (disconnection and rejection, impaired autonomy and performance, impaired
limits, other-directedness, and overvigilance and inhibition; Young et al., 2001).
Cognitive theorists have not only set forth an explanation of depression, they have also
set forth a treatment regimen to ameliorate the negative thinking that is believed to occur
in depressed individuals. According to Young et al. the center of attention in cognitive
therapy is to change the negative thinking that is so prevalent in depressed individuals. A
great deal of research has supported the concepts set forth by cognitive theorists (see
Gloaguen, Cottraux, Cucherat, & Black, 1998). Thus, it appears that psychological
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theories of depression have made a considerable impact on the diagnosis and treatment of
depression and will likely continue to do so well into the future.

The cognitive theory of depression has received a great deal of attention in the
scientific literature as it relates to treatment outcomes (see Dobson, 1989; Robins &
Hayes, 1993). Furthermore, Hollon, Shelton, and Davis (1993) discussed the debate
regarding cognitive therapy’s efficacy. Overall, they identified several studies that have
shown how cognitive therapy has fared well against other forms of psychotherapy. For
example, dynamic (see Covi & Lipman, 1987), non-directive (see Shaw, 1977), and
interpersonal therapies (Shaffer, Shapiro, Sank, & Coghlan, 1981; see also Dobson, 1989
for an excellent review of a large number of psychotherapies as compared to cognitive
therapy). Robins and Hayes (1993) also noted that several studies have shown that
cognitive therapy resulted in better treatment outcomes than pharmacotherapy.
Dobson (1989) reviewed the efficacy of several forms of psychotherapies and
pharmacotherapy as compared to cognitive therapy through meta-analysis. Dobson
reported, “cognitive therapy is more effective than nothing at all, behavior therapy, or
pharmacotherapy in the treatment of clinical depression. It also appears that cognitive
therapy is superior to other forms of psychotherapy in the treatment of depression” (p.
417).
Genetic Theories o f Depression. Genetic models of depression have also been put
forth by various researchers. Past research has shed some light on the heritability debate
of whether or not genetics play a factor in one’s susceptibility to depression. Numbereger
and Gershon (1984) reported more than 20 years ago that the differences in correlations
evidenced in research studies of monozygotic/identical (one fertilized egg splits into two)
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and dizygotic/fratemal (two different eggs are fertilized by two different sperm) twins
have provided a strong argument for heritability. Research conducted approximately ten
years (Kendler et al., 1994) and 20 years (McGue & Christensen, 2003) later emphasized
the consistent finding that shared environment (i.e., reared together) accounts for very
little, to none, of the variance in depression in twins.
Lyons et al. (1998) asserted that twin studies generally reflect the importance that
genetics play in the etiology of depression and thus utilized a proband concordance rate
approach in their study. According to Thomas (1993), proband is the initial individual
presenting with a condition (generally genetic) “who causes a study of his or her heredity
in order to determine if other members of the family have had the same disease or carry
it” (p. 1599). Furthermore, concordance “in twins, [is] the equal representation of a
genetic trait in each” (Thomas, p. 432).
In their article, Lyons et al. (1998) reported concordance rates from 3,372 pairs of
male twins with unipolar depression. Statistical analyses were used to remove the effects
of shared and non-shared environments revealing proband concordance rates for
monozygotic and dizygotic twins of 22.5% and 14.0%, respectively. Lyons et al. further
asserted that their analyses showed strong effects of genetics on major depression while
at the same time excluding various environmental factors (e.g., parenting behaviors, peer
relationships, and experiences outside of the family) through structural equation
modeling.
Additionally, McGue and Christensen (2003) recently completed a longitudinal
study of 2100 elderly Danish twins. Over the course of four years the researchers
assessed depression in the twins at yearly intervals resulting in pooled (average of the
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four trials) concordance rates. They found concordance rates of 33% for male and female
monozygotic twins (range = 25% to 39%, 95% confidence interval) while dizygotic twins
had a concordance rate of 14% (range = 7% to 21%, 95% confidence interval). McGue
and Christensen further noted that their study was consistent with others (e.g., Kendler et
al., 1994) that have failed to produce evidence that a shared environment by mono- or
dizygotic twins influences the prevalence of depression therefore encouraging further
evidence of genetic involvement in depression.
Biological Theories o f Depression. Biological conceptualizations have been
posited by researchers looking at body chemistry imbalances as a primary underlying
component of depression. Klein (2000) asserted that Positron Emission Tomography
(PET), a device which measures the “metabolic activity of a specific structure of the
nervous system in order to determine neuronal functioning” (p. 492), has confirmed that
there is decreased cortical brain activity during depressive episodes and increased activity
during manic episodes. More specifically, Davidson (1992) has reported decreased
activity in the left frontal cortex during depressive episodes. Klein (2000) asserted that
the correlation between metabolic activity in the brain and one’s mood is key evidence
that invites a biological explanation of depression.
Nemeroff (1997) reported that of the numerous biological theories of depression
that have been set forth in recent years, three major theories have progressed to the
forefront: (a) the serotonin theory (the hypothesis that there is a deficiency of serotonin at
specific synaptic sites, (b) the norepinephrine theory of depression (the hypothesis that
there is decreased norepinephrine at specific synaptic sites within the central nervous
system), and (c) the corticotropin-releasing factor hyperactivity model (the hypothesis
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that there is a hypersecretion of corticotropin-releasing factor in the central nervous
system). Furthermore, Nemeroff asserted that the serotonergic and corticotropin-releasing
factor hyperactivity models have received the most empirical attention.
In 1984, von Praag asserted that the link between serotonin and depression had
been studied for over 20 years. With serotonin affecting one’s mood, behavior, and
thought processes (Barlow & Durand, 1999), it seems quite appropriate to put efforts into
studying the relationship between serotonin and depression.
Siever, Guttmacher, and Murphy (1984) presented a discussion and review of the
literature implicating serotonin’s role in mood disorders. They asserted that “the
serotonergic system has known contributions to a variety of affect-related behaviors” (p.
587). For example, they noted that the link between aggression, psychomotor activity,
and irritability and the serotonergic system have led many researchers to investigate their
relationship.
Studies have investigated serotonin levels and found lower levels of serotonin in
blood, blood cells, and cerebrospinal fluid of depressed individuals (Siever et al., 1984).
von Praag (1984) acknowledged that various studies of serotonin arose from the fact that
certain antidepressant medications decreased the amount of serotonin in the presynaptic
neuron by blocking its reuptake into the synapse (Vasko & Gutierrez, 2003), which
decreased depressive symptoms. Furthermore, assertions maintaining that medications
that increase the uptake of serotonin can induce a depressive state (e.g., reserpine,
methyldopa, & propanolol; Vasko & Gutierrez; van Praag, 1984) have also provided a
great deal of insight into the serotonergic aspects of depression.
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More recently, Nelson, Mazure, Jatlow, Bowers, and Price (2004) showed that a
sample of 38 hospital psychiatric inpatients that met criteria for MDD had lower
depressive rating scale scores after taking a combination of serotonin and norepinephrine
reuptake inhibiting medications than when taking one medication without the other.
While the differences in scores were not statistically significant, the authors asserted that
the combination of drugs still produced a greater change than either drug acting alone.
This may be true, however, the fact that the difference is only semantically different and
not statistically different casts definite doubt on the necessity to prescribe or ingest two
medications when one will apparently do. Although this study failed to gather statistical
backing for its hypothesis, the results appear to back the serotonergic hypothesis of
depression in that there were noteworthy decreases in the depressive rating scales of the
participants.
The corticotropin-releasing factor hyperactivity model is another popular
biological theory of depression (Nemeroff, 1997). According to this theory of depression
an oversecretion of Corticotropin-releasing factor is secreted into the central nervous
system which triggers a cascade effect within various other parts of the body that, in turn,
ultimately result in depression. The hypothesis is that a hypothalamic-pituitary-adrenal
axis is activated when the brain is stimulated by stress, or other glucocorticoid hormones
(Pepper & Kreiger, 1984). In this type of situation, the brain is stimulated, which then
activates the hypothalamus to release corticotropin-releasing factor; this stimulates the
anterior pituitary gland which then releases adrenocorticotropic hormone (ACTH). The
ACTH is carried via the blood stream to the adrenal cortex where it activates the release
of glucocorticoids, especially cortisol (Huether & Zekauskus, 1996).
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According to Huether and Zekauskus (1996), one of the major roles of the adrenal
system is to maintain an optimal internal body environment throughout one’s life.
Clearly, if there is a hypersecretion along the way, it offsets the homeostatic balance that
is achieved through the hormonal regulation system resulting in untoward effects. As
ACTH stimulates secretion in the adrenal gland, cortisol, the main glucosteroid, is
produced and can cause major problems in the feedback loop. For example, if there is a
problem of oversecretion at the point of corticotropin-releasing factor, there will
ultimately be an oversecretion of ACTH, thus resulting in an overproduction of cortisol.
Therefore it would logically make sense that stress and worry associated with depression
would trigger such adverse biological hypersecretions.
Muller and Wurst (2004) suggest that brief situations of stress, either experienced
with excitement or fear, result in the adaptive hypothalamic-pituitary-adrenal axis
response. However, an uncontrolled and unrelenting activation of this feedback loop can
leave one in a chronic state of distress that results in a surplus of stress hormones which
is believed to enhance one’s vulnerability to problems such as affective disorders (Muller
& Wurst). The corticotropin-releasing factor hyperactivity model has been supported by
investigations that found increased secretory impulses of ACTH and cortisol as well as
elevated urinary levels of cortisol (Rubin et al., 1987), elevated levels of corticotropin
releasing hormone in cerebrospinal fluid (Nemeroff et al., 1984), increased secretion of
corticotropin-releasing hormone from neurons in the limbic area of the brain (Raadsheer
et al., 1994), and elevated levels of corticotropin-releasing hormone as compared to the
number of available binding sites in the prefrontal cortex of the research sample
(Nemeroff et al., 1988).
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Of the three views of depression that have been discussed (psychological, genetic,
& biological), it is the biological view that addresses the issue of medication. A common
sense approach related to the biological view is that if there is a chemical imbalance, then
a medication could help to reestablish equilibrium. This assertion is key to the present
study in that the body chemistry being discussed in these biological models is actually
brain chemistry. Furthermore, medication that is designed to affect brain chemistry may
result in untoward effects on brain functioning.
Depression Across the Lifespan
School Aged Children. School aged children (6-12 years) are a group that is not
often discussed in MDD literature, likely due in part to the typical onset occurring in
one’s mid-twenties (DSM-IV-TR, 2000). While MDD is much less common in school
aged children, prevalence rates have been reported as being between 0.04% and 2.5%
(Birmaher & Rozel, 2003). A noteworthy difference between adolescent and adult onset
MDD and school aged child MDD is that the disorder occurs at approximately the same
rate in boys as it does in girls (Birmaher & Rozel). Another noteworthy detail regarding
childhood MDD is that the prevalence has been increasing in this population (Birmaher
& Rozel). Although there is an age of onset difference between children and adults, the
underlying etiological factors are similar (i.e., psychological, genetic, & biological
factors; Watts & Markham, 1997)
The clinical characteristics of school aged MDD are also fairly similar to that of
the DSM-IV-TR (2000) MDD previously described. However, Birmaher and Rozel
(2003) reported that children with MDD often are irritable or report feeling bored rather
than sad, and they typically experience “more symptoms of separation anxiety, phobias,
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somatic complaints, and behavioral problems” (p. 48) than do adolescents with MDD.
Another stark difference in this population is that there is rarely melancholic school aged
MDD children, however, many (40%-70%) have at least one comorbid psychiatric
disorder, while between 20% and 50% have two or more (Costello et al., 1999). With
such high comorbidity rates, Birmaher and Rozel (2003) asserted that “...the presence of
comorbid psychiatric disorders is more the rule than the exception” (p. 48).
As noted earlier, psychological, biological, and genetic factors are believed to
play vital roles in the etiology of MDD in school aged children (Birmaher & Rozel,
2003). The course of MDD in children has been reported to last between 8 and 13 months
with high relapse rates ranging between 30% and 70% within 2-7 years (Goodyer et al.,
1997). Outcomes in school aged MDD children appear to be hampered by the
psychosocial dysfunction experienced during the disorder (Puig-Antich et al., 1985).
Puig-Antich et al. asserted that most children’s interpersonal relations improve as the
MDD remits although some impairment has been found to remain. While there appears to
be a base of research attempting to elucidate the connection between MDD and school
aged child, more understanding is needed in order to make more declarative statements
regarding how to treat this group of individuals.
Adolescents. Adolescents experiencing depression may have had difficulties in the
past receiving appropriate treatment due to a commonly held professional belief that
adolescent turmoil is normal (Harrington, 2003). However, there has been research
indicating that adolescent depressive symptoms resemble that of the adult criteria for
depression (see Pearce, 1978; Puig-Antich, 1982; Weinberg et al., 1973). While
depressive symptoms appear to manifest themselves in adolescents, the effects are
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somewhat different than those in adult populations. For example, Harrington and Clark
(1998) discussed a study in which no participants were found to have the full five or more
depressive symptoms necessary to receive the diagnosis of Major Depressive Episode.
However, parental reports suggested that students with as little as one or two symptoms
were experiencing significant problems in school as a result of the symptoms. Harrington
and Clark asserted that such information indicates that “[i]t is better for adolescents to
have no depression at all than to be averagely depressed” (p. 34) by having only one or
two symptoms.
As with school aged children, the etiological factors of depression are similar in
adolescents (i.e., psychological, genetic, & biological factors), as are the increased
comorbid difficulties that commonly occur. Costello, Federman, Erkanli, and Angold
(1999) presented meta-analytic research indicating that depression is highly comorbid
with other psychiatric disorders; specifically with anxiety, conduct disorder, and attention
deficit hyperactivity disorder (ADHD; with median odds ratios of 8.2, 6.6, & 5.5,
respectively at 95% confidence intervals). These comorbidity estimates match the results
reported by van Dulmen et al. (2002) in which they found the comorbidity of depression
and conduct disorder/oppositional defiant disorder to be at 5.9%, which they report is
consistent with those of the DSM-IV. Furthermore, van Dulman et al. reported adolescent
prevalence rates for MDD at 1%. However, Lewinsohn, Rohde, and Seeley (1998)
forecasted that 28% of all adolescents will experience a MDD by their 19th birthday.
An interesting detail emerges in regard to gender and adolescent depression.
Harrington (2003) reported that there are greater numbers of girls who experience MDD
than boys of similar age. Furthermore, Angold, Costello, and Worthman (1998) reported
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that in the adolescent population the question of onset may not be so much of how old the
adolescent is, but more of whether or not he/she has started puberty. This is apparently
due to rates of depression increasing with advancing cycles of puberty (Angold et al.).
While there appears to be more adolescents who experience MDD than school
aged children, research suggests that adolescents have good prognoses of remittance. For
example, Harrington suggested that “... most young people with major depression will
recover to a significant extent...” (p. 72). However, not all is positive as Kovacs et al.
(1984) reported that approximately 40% of their sample of adolescents with MDD had a
MDD relapse. It appears that many gains have been made in regards to adolescent MDD;
however, Harrington (2003) warned that more research must be done in order to validate
the concept of adolescent depression.
Young Adulthood. Depressed younger adults (approximately 19-40 years for the
current study) have also been somewhat overlooked in the research literature regarding
MDD. However, while onset of MDD can occur at any age, the most common age at
onset is in one’s mid-twenties (Ebmeier et al., 2006; McMahon & DePaulo, 1996).
McMahon and DePaulo (1996) asserted that there is, however, some debate as to what
exactly constitutes onset. Some argue that it is age at first treatment while others define
onset as the age at identification of first depressive symptoms. However, McMahon and
DePaulo acknowledged that most investigators typically use age at first hospitalization,
age at first diagnosis of MDD, or age at first identified impairment. Regardless of the
definition used, as noted earlier, young adulthood is the most common onset period for
depression.
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Numerous prevalence rates have been published regarding MDD. The
Epidemiologic Catchment Area (ECA) and the National Comorbid Survey (NCS) data
have suggested that depression occurs in considerably higher numbers than does bipolar
disorder (Zarate & Tohen, 1996). Weissman et al. (1988) reported the lifetime prevalence
rate of at least one episode of MDD at 4.4%. However, their range was between 2.9% at a
site in Baltimore, MD and 5.8% at a site in New Haven, CT. More specifically, Zarate
and Tohen (1996) reported the NCS prevalence rates by age and sex. For 15 to 24 yearold males and females, rates were 11% and 20.8% respectively (total of 15.7%), 13.1%
and 19.4% for 25 to 34 year-old males and females respectively (total of 16.5%), and
14.7% and 23.8% for 35 to 44 year-old males and females respectively (total of 19.2%).
Although etiology remains similar to that as has been discussed in the previous
age groups (i.e., psychological, genetic, & biological), there are different factors that
affect younger adult individuals. For example, it appears that a staple of young adult
depression is that it is often invoked as a result of stressful life events (Friis, Wittchen,
Pfister & Lieb, 2002).
Friis, et al. (2002) reported that while stressful life events appear to be an
antecedent to depression, stressors do not necessarily need to be negative. In their
research they found that negative life stressors showed a significantly elevated odds ratio
of resulting in a depressive condition (e.g., school, family, work. & living situations).
However, positive life stressors (e.g., graduating college, marriage, beginning a family,
purchasing a home) also showed a significantly elevated odds ratio as an antecedent of
depression (Friis et al.; Horwitz & White, 1991). Lewinsohn and Seeley (2003) have
recently been investigating what effects previous episodes of MDD in adolescence may
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have on MDD episodes of younger adults. Having found that the symptoms of MDD are
somewhat similar between the closely aged groups, researchers are now beginning to
look at other areas where the two may be similar regarding their depressive disorder in an
attempt to better understand the younger adult depressive phenomena.
One area that appears to be more isolated to the younger adult depressed
population is the fact that depression in young adulthood appears to lead to role
impairment in more than 50% of depressed individuals (Ebmeier et al., 2006).
Furthermore, use of professional health care services in order to assuage depressive
symptomatology is low in the younger adult population. Ebmeier et al. reported that
approximately half of those needing treatment for depression in the United States were
not receiving such treatment. Druss, Hoff, and Rosenheck (2000) reported that less than 1
in 13 young adults were receiving antidepressant therapy. They suggested that patient,
clinician, and systemic issues combined to contribute to overall poor treatment situations.
Moreover, only 1 in 9 individuals experiencing symptoms consistent with MDD and with
suicidal ideation were receiving antidepressant therapy (Druss et al., 2000).
Ebmeier et al. (2006) have speculated that there has been an increased worry
among the general population regarding the untoward side effects of antidepressant
medication (e.g., increased suicide among antidepressant users). Organizations such as
the National Institute for Clinical Excellence have recommended that antidepressant
therapy for mild cases of depression in adults be contraindicated due to the poor riskbenefit ratio (Ebmeier et al.). However, this is in sharp contrast to the recommended
guidelines made by the American Psychiatric Association (2000) regarding
pharmacotherapy for depression, which asserts that “if preferred by the patient,
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antidepressant medications may be provided as an initial primary treatment modality for
mild major depressive disorder” (p. 2). While some things are similar as far as depression
in younger adults as compared to children and adolescents, this review suggests that there
are age specific factors that play into younger adult depression. This is important in the
context of the current study in order to obtain a better understanding of this population in
order to facilitate better overall treatment.
Later Life. Depression has historically been a common condition in later life
individuals and continues to remain so (O’Brien & Thomas, 2003). Lobo, Saz, Marcos,
Dia, and De la Camara (1995) reported prevalence rates of 4.8% for depressive disorders
in their sample. Similarly, Steffens et al. (2000) reported prevalence rates of 4.4% in
women and 2.7% in men. Overall, however, prevalence rates from various other research
studies have ranged from as low as 1% to as high as 20% (see Ernst & Angst, 1995;
Katona, 1994; Palsson & Skoog, 1997). Additionally, a noteworthy gender difference is
found in later life depression. While women with depression still outnumber men, the
difference becomes much less as age increases (O’Brien & Thomas, 2003). Bebbington
(1998) observed that this decline in female cases of depression coincided with female
menopause. However, he elaborated by stating that the decrease in depression is likely a
result of psychological and social change rather than a hormonal change from
menopause.
The clinical presentation of depression in later life individuals has been reported
to be quite similar to younger adults (O’Brien & Thomas, 2003). Along with this is the
evidence suggesting that cognitive impairments, while common in all adults with
depression, (Austin, Mitchell, & Goodwin, 2001) are likely more severe in later life
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persons with depression (O’Brien & Thomas, 2003). Much like that of younger adults,
the etiologic factors believed to be at work in later life depression are genetics, biology,
and life events. However, these take on quite different presentations in the later life
individuals. For example, in later life individuals life stressors revolve more around
bereavement, illness, and financial issues (O’Brien & Thomas, 2003), whereas in
younger adults they are school, work, or living situation related (Friis et al., 2002).
Biological factors appear to affect depression in later life individuals more than any other
grouping of people. Coronary artery disease (CAD), myocardial infarction (MI), and
cerebrovascular disease (e.g., stroke and hypertension) have all been implicated in
increased cases of depression as well as poorer outcomes (O’Brien & Thomas, 2003).
While the underlying factors related to the etiology of depression (e.g.,
psychology, genetics, & biology) are fairly similar throughout the lifespan, it appears that
specific factors are more relevant or less relevant depending on the developmental group
an individual is in. Therefore, just as it is important to study depression in the context of
the overall human experience, it is just as important to study each group separately in
order to identify group specific issues that are related to depression in order to adjust
treatment to best help individuals.
As was noted earlier, more research is looking into how the brain is affected by
depression. Regardless of age, recent research has begun to use neuroimaging techniques
to investigate brain structure and function in an attempt to gain an increased
understanding of how these two aspects may affect or be affected by depression.
Neuroimaging studies have suggested various links between frontal lobe structure and/or
function and depression (O’Brien & Thomas, 2003).
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Parashos, Tupler, Blitchington, and Krishnan (1998) used a type of magnetic
resonance imaging (MRI) that measured brain volume of numerous anatomical areas.
They found various subcortical areas (e.g., caudate and putamen) that were significantly
decreased in size in a group of 72 depressed inpatients with a mean age of 55.4 years (SD
= 16.8). Furthermore, the frontal lobes of their sample were found to be smaller with
increased age (Parashos et al.). Additionally, Kumar, Bilker, Lavretsky, and Gottlieb
(2000) found normal asymmetry of the frontal lobes in their control group using MRI
technology. However, the minor and major depressed groups had less asymmetry with
the highest degree of symmetry being in the major depressed group.
The frontal lobes have been described as the executive of the brain, helping one to
self regulate, plan, and execute behaviors (Malloy, Cohen, & Jenkins, 1998). O’Brien and
Thomas (2003) asserted that research has highlighted the importance of the frontal and
subcortical areas of the brain in regards to later life depression and conclude that
structural differences in the brain may account for the cognitive deficits that remain after
the clinical symptoms of depression have been assuaged. Executive functioning
(regardless of life stage) is considered more fully in the following section.
Executive Functions
Executive function is a term used in neuropsychology that refers to a varied group
of skills that are goal directed and future oriented (Bennetto & Pennington, 2003).
Burgess (2003) asserted that the study of the executive functions is likely the newest area
of investigation within the field of neuropsychology and are “probably the most
technically and theoretically complex aspect of neuropsychological assessment” (p. 313).
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Yet, a generally accepted definition of the executive functions has eluded scientists to
date.
Alexander and Stuss (2006) have gone so far as to state that the “frontal functions,
or impairment, have achieved the status of pornography: everyone knows them when
they see them, but there is little agreement on their exact defining properties” (p. 192).
Riccio (2006) stressed that there has been difficulty in operationally defining the
executive functions as a frontal lobe problem due to the possibility that there may be
other brain areas involved (e.g., one cannot do a number of tasks that utilize the executive
functions without using a part of the brain that is considered non-executive). Burgess
(2003) asserted that test "performance can be affected by dysfunction in other cognitive
systems (e.g., memory, etc.)" (p. 313). Therefore, one is not necessarily purely
investigating frontal lobe dysfunction. Rather, researchers have had to theorize what
cognitive abilities are affected by damage to specific brain areas.
Most of the previous literature regarding the executive functions has come from
correlational work (i.e., frontal lobe damage resulting in poorer performance on a given
measure). However, a large majority of the measures used to assess the executive
functions were not created to be used as such (Burgess, 2003). Alexander and Stuss
(2006) have noted that planning, monitoring, sequencing, and inhibiting responses are
typical impairments in individuals with frontal lobe lesions. They further describe frontal
lobe lesioned individuals as “simultaneously unaware and distractible, irritable and
apathetic, violent and passive, impulsive and perseverative” (Alexander & Stuss, p. 192).
These individuals tend to have difficulties related to feelings of empathy, lack selfawareness, and are unable to emotionally regulate themselves (Alexander & Stuss).
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Riccio (2006) asserted that planning, attention, abstract reasoning, self-regulation,
sequencing, temporal orientation, organization, and-even-motor control are considered
executive functions, depending on who is identifying them. Different definitions of
executive functions results from each particular researcher. However, most acknowledge
that these separate entities can be compartmentalized into approximately four main
categories.
Lezak, Howieson, and Loring (2004) described the executive functions as
consisting of volition, planning, purposive action, and effective performance. Malloy et
al. (1998) added that self-monitoring the adequacy and correctness of one’s behavior,
correcting and modifying one’s behaviors when situations change, and persisting in the
face of distraction are also key components of the executive functions. Alexander and
Stuss (2000) identified cognitive flexibility, goal setting, information processing, and
attentional control as four inter-related, yet distinct, components of executive functions.
Lezak et al.’s (2004) and Alexander and Stuss’ (2000) conceptualizations overlap
considerably in their subcomponent parts (e.g., both discuss planning of tasks, initiation
of tasks, etc.). The following section describes the components set forth by Lezak and her
colleagues (2004). Additionally, when overlap is present, Alexander and Stuss’ (2000)
categorical system is discussed within the context of Lezak et al. (2004). For the purpose
of the current study, executive functions will follow an integrated view of executive
functions that utilizes aspects of both Lezak et al.'s and Alexander and Stuss’ (2000)
conceptions of executive functions. Additionally, as not all identified areas of executive
functioning are directly measured in isolation by tests of executive functioning, symptom
identification (Burgess, 2003), by way of established measures, will be utilized.
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Lezak et al. (2004) identified volition as one component of the executive
functions. This “refers to the complex process of determining what one needs or wants
and conceptualizing some kind of future realization of that need or want” (Lezak et al.).
Additionally, an ability to form intentions, create goals, and initiate activities are also
elements that fall into the volition component of executive functions (Lezak et al.).
Alexander and Stuss (2000) describe several of these activities in their goal
setting component (i.e., the ability to initiate, plan, and carry out a task). According to
Lezak and her colleagues (2004), “persons who lack volitional capacity simply do not
think of anything to do” (p. 612). Alexander and Stuss (2000) report that there is specific
frontal lobe brain structures relevant to self-awareness, for example, the right frontal lobe
consisting of the hypothalamic limbic, posterior cortical, and cingulate associations.
Problems associated with this area include feelings of apathy or indifference,
deterioration of personal hygiene, loss of curiosity and/or self-awareness, decreased
awareness of cognitive problems, loss if interest in previously enjoyed activities, and
decreased social awareness (Sbordone, 2000).
It should be noted that there are no formal tests of volitional capacity and Lezak et
al. (2004) suggest that assessment of volition be done by observation and self-report of
day-to-day living by collateral interview. However, one can assess volition by way of
neuropsychological measures via qualitative data such as whether or not an individual
makes spontaneous speech, engages in conversation, asks questions, actively participates
in testing by turning cards, moving beads, or exerts effort that is noticeable to the
examiner (Lezak et al., 2004); claims of validity are common practice in
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neuropsychological evaluations based on examinee effort. With this information, it could
be argued that all neuropsychological instruments are tests of volition.
Planning is the second of Lezak et al.’s (2004) components of executive
functioning. She and her colleagues note that while one must identify and organize steps
and materials needed to carry out a task, one must also think of alternatives, make
choices, and entertain different ways in which a plan might be carried out. Alexander and
Stuss (2000) also describe many subcomponents of this area in their goal setting
component. They stress the ability to initiate, plan, and carry out a task. Sbordone (2000)
notes that those who exhibit “planning deficits are unable to formulate a set of plans to
achieve a desired goal, evaluate the effectiveness of such plans, or select a particular plan
to be executed” (p. 445).
Deficits in the area of planning exhibit themselves as a loss of abstract or
conceptual thinking, disorganized behaviors and thoughts, inflexible thinking, poor
planning and organization, decrease in goals or planning for the future, and social
inappropriateness (Sbordone, 2000). Several instruments have been recommended as
tests of planning. For example, mazes, visual search tests, and tower tests (Lezak et al.,
2004; Sbordone, 2000).
Purposive action is the third component of Lezak et al.’s (2004) main executive
function components. According to Sbordone (2000), “purposive action involves the
patient’s ability to initiate a particular plan while simultaneously ignoring irrelevant or
competing needs, wants, or other plans” (p. 446). Lezak et al. (2004) elaborate by noting
“the translation of an intention or plan into productive, self-serving activity requires the
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actor to initiate, maintain, switch, and stop sequences of complex behavior in an orderly
and integrated manner” (p. 621).
Alexander and Stuss (2000) discuss such concepts in their information processing
area. This area includes the subcomponents of efficiency, fluency, and speed of
processing. Efficiency and speed of processing can be thought of in terms of how fast one
is able to maximally achieve a task (mental or physical) while expending the least amount
of effort possible. Those who have difficulties in this area will exhibit distractibility, loss
of initiative, problems processing external activities simultaneously, an inability to
maintain ongoing cognitive and/or motor response sets, disorganization in thinking,
emotional lability and impatience, discrepancies between expressed intentions and
actions, difficulties in maintaining train of thought, circumstantial or tangential thinking,
decreased ability to perform novel activities, and/or poor work habits/frequent
terminations (Sbordone, 2000).
Several instruments (e.g., TOLl)X [Culbertson & Zillmer, 2005]; Tinkertoy Test
[Lezak, 1982]) that assess purposive action and its subcomponents have been identified
(Lezak et al., 2004). However, all require the “ability to initiate, maintain, switch, and
stop sequences of complex behavior in an orderly and integrated manner” (Sbordone,
2000, p. 447).
The last area conceived by Lezak and her colleagues (2004) was that of effective
performance. Effective performance refers to one’s ability to “monitor, self-correct, and
regulate goal-directed behavior” (Sbordone, 2000, p. 447). Individuals with impairment
in this area often exhibit erratic performances (a hallmark of executive dysfunction) as
they are unable to self-correct mistakes or self-monitor their actions
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(Lezak, 1982; Lezak et al„ 2004). Impairments related to poor effective performance
include perseveration (persistence of a same response even though its inappropriateness
has been established), cognitive rigidity, decreased ability to complete or follow through
on tasks, inability to recognize or rectify errors, poor work habits or employment history,
clear problem solving difficulties, and an inability to utilize plans or strategies that were
previously effective (Sbordone, 2000).
Any instrument that requires self-monitoring of behavior can be considered a test
of effective performance. For example, fluency tests do not allow repetition and thus
require an individual to self-monitor for success while an inhibition task would require
one to refrain from some action in order to accomplish another. Lezak (1982) asserted
that “constructional or drawing tasks in which more of the solution process is overt...
can be particularly instructive in bringing to light how the patient errs, self-corrects or
not, and monitors his performance” (p. 294) and are thus helpful in assessing
effectiveness of performance.
Lezak et al. (2004) left out certain areas of executive functioning that have been
incorporated by several scholars. For example, Alexander and Stuss' (2000) area of
attentional control has also been utilized by several others in their definitions of executive
functioning (see Dagenbach & Carr, 1994; Denckla, 1996). According to Loring (1999),
attention is a “process that enables an individual to engage in certain cognitive operations
while ignoring others. Thus, attention involves a selective awareness or responsiveness.
Attention also refers to the ability to focus and maintain interest for a given task or
activity” (p. 24). Thus, attentional control refers to one’s ability to monitor and regulate
one’s attention and is an important aspect of the executive functions.
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There are various areas of attention that are utilized, for example, selective
attention (“the capacity to highlight the one or two important stimuli or ideas being dealt
with while suppressing awareness of competing distractions” Lezak et al., 2004, p. 34,
also known as concentration) and sustained attention (“the capacity to maintain an
attentional activity over a period of time,” Lezak et al., 2004, p. 34). Alexander and Stuss
(2000) also include self-monitoring and self-regulation under the attentional control
heading in their conceptualization whereas Lezak et al. (2004) holds it as its own
peripheral component of executive functioning. Self-regulation is characterized by
decreased productivity and dissociation between an intention and an action (Lezak et al.).
Lezak et al. (2004) also fully described self-regulation as a “peripheral but equally
important executive capacity]” (p. 612). Lezak et al. divided self-regulation into two
main areas that coincide with Alexander and Stuss’ (2000) main component of cognitive
flexibility, productivity and flexibility and the capacity to shift. Riccio (2006) described
several aspects of cognitive flexibility. She asserted that components such as
perseveration (i.e., “persistence of the same response, even when it is shown to be
inappropriate” [Loring, 1999, p. 125]), the ability to shift between sets (i.e., ability to
adapt to a change in rules such as identifying items by color and then changing to shape),
learn from mistakes, and working memory function (i.e., the ability to take in
information, hold it briefly, process it, and then formulate a response [Groth-Mamat,
2003]) are all subcomponents of cognitive flexibility. With an emphasis on aspects such
as set shifting and cognitive flexibility, the WCST (Heaton et al., 1993) is a common and
often used measure to assess this area of executive functioning.
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When these components are disturbed, one is inflexible in his/her thought
patterns, often times attempting to solve a problem in the same manner repeatedly (i.e.,
perseveration). Such difficulties may be seen as an inability to shift one’s train of thought
or a certain behavior in order to meet the demands of a given situation (Lezak et al.,
2004). Problem solving is also impaired as one will not be able to organize adequately.
This is problematic as one will not be able to inhibit one action in order to carry out
another. It is interesting to note that Lezak et al. conceptualize the former as a self
regulation difficulty and consider the area a peripheral part of the executive functions.
Instruments that assess productivity and flexibility and the capacity to shift have been
reported as any test that reveals slowing in completion time and any “tests of abstraction
that emphasize shifts in concept formation touch upon mental flexibility” (Lezak et al., p.
628).
Throughout Lezak et al.’s (2004) four components of executive functioning, the
various subcomponents can, and do, overlap significantly. This highlights the difficulty in
defining what pure executive functions are and what they are not. Riccio (2006)
emphasized this difficulty by noting that although there are several overlapping
subcomponents, they are all unique in some ways and related in others; and sometimes
dependent on one another.
Therefore, overall, it is generally accepted that the executive functions serve to
“facilitate adaptation to novel situations” (Burgess, 1997, p. 83) and maintain self
regulation (locus of control is transferred from external to internal control). They also
consist of the abilities one needs in order to solve novel problems from beginning to end
by way of identifying a problem, evaluating the problem, formulating a plan or goals in
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order to solve the problem (e.g., establishing new behaviors and patterns of thinking and
critically analyzing the appropriateness of each) and modifying them as necessary,
terminating all actions when plan is complete, and finally storing information in order to
access it later when the same or similar situations arise (Burgess, 2003; Sbordone, 2000).
Due to several difficulties in theoretically defining the executive functions,
Burgess (2003) highlighted the most commonly reported symptoms of executive
dysfunction. The top five symptoms reported by caregivers were planning (48%),
Distractibility (42%), Lack of Insight (39%), Poor Decision-Making (38%), and
Unconcern for Social Rules (38%). Following closely behind these were Apathy (27%),
Perseveration (26%), Lack of Concern (26%), Poor Temporal Sequencing (25%),
Aggression (25%), Impulsivity (22%), Know-Do Dissociations (21%), Poor Abstract
Thinking (21%), and Inability to Inhibit Responses (21%).
Instruments used to assess executive functions and/or component parts are
discussed in greater detail later in this chapter. However, it should be noted that there are
not one-to-one relationships with any current conceptualization of executive functions
and any neuropsychological measures. As noted previously, the major instruments used
to assess executive functioning were not developed to specifically assess particular
executive function symptoms. Rather, they came from research investigating individuals
with frontal lobe damage who performed poorly on certain neuropsychological measures.
While the executive functions have been described (i.e., theoretically defined), they have
not been operationally defined.
Burgess (1997) points out that this is a major obstacle for researchers in this area.
He adds that this is commonly due to the well-established link between executive
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dysfunction and frontal lobe lesions. Heppner, Kivlighan, & Wampold (1999) noted that
to operationally define a construct, one must specify “the activities or operations
necessary to measure it in this particular experiment” (p. 39). However, without a one-toone relationship between an instrument and a component of the executive functions, an
operational definition is impossible.
Burgess (2003) stated that the ideal assessment of executive functions would
address all symptoms. However, he goes onto note that such an effort is impractical and
that formal measures do not yet exist for many executive dysfunction symptoms.
Moreover, "little is known about what many of the tests shown to be sensitive to frontal
lobe lesions are actually measuring...(... a theoretical problem that is far more complex
than it seems at first)" (Burgess, p. 306). Burgess (1997) warns that until executive
functions are clearly operationally and theoretically defined, allowing for identification
by way of psychological grounds alone, the topic will not receive equivalence with other
well established areas of neuropsychology.
Although not all measures associated with decreased executive functioning fit
nicely into Lezak et al.’s (2004) or Alexander and Stuss’ (2000) component systems,
several instruments have been identified as primary measures associated with frontal lobe
damage, and thus, executive dysfunction. These instruments will be discussed later in this
chapter.
Brain and Executive Function Development
At birth the human brain weighs approximately 368.5 grams (Dawson & Guare,
2004), which equates to just about one-fourth its adult weight of 1,300 to 1,500 grams
(Majovski, 1997). This difference in weight from birth to adulthood shows that as a child
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grows and develops so does his/her brain. Various processes occur during brain
development in the human being. Approximately 18 days after conception the neural tube
is created. This event gives rise to the process of brain development that does not reach
its culmination until many years later in late adolescence to early adulthood (Zillmer et
al., 2001). Key points within brain development include cell migration/arborization,
synaptogenesis, and pruning.
Cell migration is the act of neuronal travel along glial fiber tracks throughout the
brain that function to aid the neurons travel to various destinations within the brain. Thus,
at approximately the 18th week of gestation, most, if not all, cortical neurons have
reached the location to which they will ultimately serve (Zillmer et al., 2001). At this
point, dendrites begin to sprout, creating various spines throughout the brain enabling
ultimate communication throughout the brain system. Although this action begins
prenatally, a majority of the arborization and spine growth occurs postnatally from birth
up to 18 months of age (Zillmer et al.).
As axons and dendrites develop, synaptogenesis also takes place. This is the act of
synaptic development, where connections between the various axons and dendrites begin
to appear. Zillmer et al. (2001) reported that increases in synaptic connections are
responsible for the behaviors displayed in children. For example, increases in synaptic
density within the frontal lobes during the first 12 months of life parallels the emergence
of basic executive functions (e.g., delayed response performance; Zillmer et al.). It is
interesting that the brain actually overproduces the number of neurons people need to
function in our world. Through the pruning process, our own natural development
actually eliminates unneeded neurons.
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In the pruning process, large numbers of neurons are eliminated in order to
facilitate structural and functional economy within the brain. Estimates have reported that
as much as 40% of the brains total cortical neurons can be pruned (Zillmer et al.). An
interesting fact of pruning is that it is not random. Zillmer et al. (2001) asserted that it is a
calculated shaping of the neural network that functions to eliminate weak and/or
redundant neural connections and promote neural efficiency. Pfefferbaum et al. (1994)
noted that prefrontal cortex pruning takes place from approximately age 5 through 16
years.
As these various processes take place, so too does the development of functional
areas of the brain. For example, speech, language, vision, and executive functions just to
name a few. Developmentally, it is generally believed that the executive functions
develop early in life (i.e., infancy) and follow a protracted course through late
adolescence (Dawson & Guare, 2004; Gioia et al., 2000; Zillmer et al., 2001). Gioia et al.
(2000) further expanded upon this concept by noting that infants and toddlers display
intentional self-control capacities that aid them in goal-directed problem solving. They
warn, however, that while these skills become apparent at an early point in the
developmental scheme, self-control is variable, fragile, and highly dependent upon the
external environment in which the child lives before becoming more stable around the
18th through 30th month of life (Gioia et al.).
In a study of Finnish children aged 3-12 years, Klenberg, Korkman, and LahtiNuuttila (2001) used various tests of executive functioning to sequence the
developmental course of executive function skills. According to their findings, they
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began seeing developmental changes in executive functioning in their lowest age group
(3-5 years).
In an inhibition task (e.g., ability to stop or modulate an ongoing task, particularly
when there is a strong association involved), children as young as 6 and 7 years-old were
showing relative proficiency. In a test of planning (ability to identify and organize steps
and materials in order to carry out a task), monitoring (i.e., assessing progress), self
regulation (ability to maintain productivity), and problem solving (cognitive process
requiring modulation and control of routine skills in order to complete a task) children
were showing relative mastery of the task by 8 years of age. The last area of executive
functioning assessed was that of fluency (aspects of verbalized speech related to ease of
articulation, production of words, and use of sentence structure; Loring, 1999). Children
in the sample were able to reach a relative mastery of Semantic Fluency (generating
words from specific semantic categories [e.g., animal names or foods], which likely
involves strategy and self-regulation skills) by age 10 and Phonemic Fluency (similar to
Semantic, although here the child must generate words that begin with a specific letter)
and Design Fluency (this is a visualmotor task that requires an individual to generate
novel designs and likely assesses systematic production and use of strategy) by age 11,
respectively (Klenberg et al., 2001).
There are caveats to the interpretation of findings such as this. While studies, such
as Klenberg et al. (2001) have found rapid development in some areas at certain times,
stages of executive function development are likely not clearly differentiated and various
skills probably emerge before, during, and after peak developmental periods (Gioia et ah.
2000; Klenberg et ah, 2001).

44

Various studies have attempted to chart the development of the executive
functions in childhood and have, to varying degrees, been successful. Although clear and
more distinguishable changes in children have been reported, less research has tracked
the development into and throughout adolescence (Anderson, Anderson, Northam,
Jacobs, and Catroppa, 2001; Dawson & Guare, 2004; Gioia et al., 2000; Zillmer et al.,
2001). Anderson et al. (2001) completed a study looking at children aged 11 years to 17
years and 11 months and primarily found flat trajectories of the executive functions
throughout adolescence. They concluded that while development of executive functions
is quite rapid through early and middle childhood they slow considerably during late
childhood and adolescence (Anderson et al.).
Symptomatic Measures of Executive Function
As noted in the previous section, there can be great difficulty when choosing
which neuropsychological test to use for a given situation. Many have been found to be
highly correlated with brain impairment and serve to distinguish between brain impaired
and non-impaired individuals. In regards to tests of executive functioning, the majority of
measures were not specifically created to assess executive dysfunction (Burgess, 2003).
Moreover, when choosing an approach to assessment, one must also consider many
issues. For example, does one pick tests according to time, instrument psychometrics, or
theory (Burgess)? None of the previous examples are without merit and none are devoid
of fault.
Theoretically driven instrument identification will assess the domains that have
been identified as being within a certain area of dysfunction. However, as is the case with
the executive functions, there are myriad theories with no real consensus. Time is
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questionable as to its justifiability. One can simply give as many tests as possible given a
certain amount of time, but a shotgun approach is haphazard and may result in false
positive data (Burgess, 2003).
Psychometrics allows us to understand a measures merits and selection can be
made upon such information. However, Burgess asserts that this is more difficult when
assessing executive functions as measurement of something like strategy formation can
be difficult. He elaborated by stating that this "can subvert [a] theory behind traditional
psychometrics, and render the values a poor guide to a test's actual clinical utility"
(Burgess, p. 307). Moreover, as one's level of performance alters, so does the construct
validity of a test (Burgess), therefore making it difficult to simply use a test with the best
psychometrics regardless of other factors. Instead, Burgess encourages one to use a test
with sound psychometrics with all things being equal, "however, all things are unlikely to
often be equal" (p. 307).
There are many instruments available for an individual to use to assess the various
facets of the executive functions. Following is a description of some of the most popular
tests of executive functioning. This list is in no way meant to be exhaustive; however, it
is comprised of those most often utilized in research studies investigating the executive
functions.
Controlled Oral Word Association Test (COWA; Spreen & Strauss, 1998) - The
purpose of this measure is to assess an individuals spontaneous production of words that
begin with a certain letter, most commonly F, A, and S (Golden, Espe-Pfeifer, &
Wachsler-Felder, 2000; Johnstone, Holland, & Larimore, 2000). This measure is known

46

differentiate individuals with left frontal or bilateral frontal lesions from non-lesioned
individuals (Anderson, 1994; Lezak et al., 2004).
To administer the COWA, the examiner instructs the examinee to generate as
many words as possible in 1 minute. The rules of the test are that the examinee cannot
state proper nouns (e.g., peoples names) or create variations of the same word (e.g., fog
and foggy; Johnstone et al., 2000). Other variations of the measure have been used, for
example one can use different letters, such as C, F, L or P, R, W. Children’s versions
have been put forth where examinees are asked to generate words that belong in a certain
category (e.g., fruits, vegetables, or animals). However, Johnstone et al. warn to be
cautious when using varied letters in the COWA as letters have differing frequencies in
how they are used in words. Interpretation of this measure is based on normative data.
The COWA is believed to assess areas of the dorsolateral prefrontal cortex, inhibition,
perseveration, and may be more left frontal lobe sensitive (Malloy et al., 1998)
The Tower of London - Drexel University (TOLl)X): 2nd Edition (Culbertson &
Zillmer, 2005) - The TOLDXis based on the original Tower of London test described by
Shallice (1982) that was designed to assess adult patients with frontal lobe injuries and is
widely recognized as a test of planning ability. The actual test is comprised of two boards
(one for the examiner and one for the examinee) with three pegs on each board arranged
from shortest to longest. Three colored beads (red, blue, & green) are arranged on the
pegs in a specific manner.
The object of the test is for the examiner to set up his/her board with the beads in
a certain configuration and then ask the examinee to “[n]ow make one on your board in
as few moves as you can” (Culbertson & Zillmer, p. 11). The examiner is responsible for
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keeping time of how long it takes the examinee to complete the task (i.e., making the
examinee board look just like the examiner’s board), counting number of moves, and
ensuring that the examinee does not violate either of two rules. The first rule is that the
examinee may not place more beads on a peg than the peg will hold (the longest peg can
hold three beads, the middle peg can hold two, and the shortest bead can hold one bead;
Culbertson & Zillmer). The second rule is that the examinee is forbidden to move more
than one bead off a peg at a time (Culbertson & Zillmer).
Culbertson and Zillmer (2005) noted that they made several modifications in the
administration and scoring in order to improve “clinical utility, applicability, and
standardization” (p. 1) of the instrument. In order to maintain novelty of the task, the
authors removed the previous administrative technique of repeating trials of failed
attempts. Alterations were also made in order to make the test useful across the lifespan.
The authors note that the TOLDX is meant to assess the frontal lobes’ executive ability of
planning. Culbertson and Zillmer elaborated by stating that “systematic interaction with
other cortical and subcortical regions are centrally involved in executive planning...” (p.
1). Insult to these areas of the brain often result in decreased executive planning abilities.
Culbertson and Zillmer asserted “the value of the TOLDXassessment as a measure of
executive planning relates to its novel and anticipatory problem-solving demands” (p. 2).
Successful completion of the tasks is reportedly indicative of expected abilities to plan
sequentially, execution of repetitive moves, and monitoring (Culbertson & Zillmer).
Wisconsin Card Sorting Test (WCST; Heaton, Chelune, Talley, Kay, & Curtiss,
1993) - “The WCST is often referred to as a measure o f ‘frontal’ or ‘prefrontal’
functioning” (Heaton, Chelune et al., p. 1) as it is believed to assess areas of the brain
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related to the dorsolateral prefrontal cortex (Malloy et al., 1998). The main function of
this test is to evaluate ones ability to form abstract concepts, shift and maintain a set (i.e.
a particular sequence), and make use of feedback (Lezak et al., 2004; Spreen & Straus,
1998). Malloy et al. (1998) assert that the WCST “has been considered the premier test of
executive functions for many years. It taps a variety of executive abilities, including
maintenance of task set, flexibility in response to feedback or changing circumstances,
and perseverative tendencies” (Spreen & Straus, 1998, p. 584).
The WCST requires an individual to sort cards that consist of varying forms
(crosses, circles, triangles, or stars), colors, (red, yellow, blue, or green), and numbers of
the figures (one, two, three, or four; Heaton et al., 1993) onto one of four stimulus cards.
The stimulus cards are set in front of the examinee who then must match her/his cards to
the stimulus cards according to color, form, or number. The examinee is never told how
exactly to complete the test, only whether their choice was correct or incorrect according
to the sorting principle in effect.
The first sorting principle is color (Spreen & Straus, 1998). Thus, after the
examinee has placed 10 cards down matching the color to the stimulus card (10 correct
responses), the examiner then changes the rule, without warning, to form (i.e., shape;
Spreen & Straus). The examinee must again utilize the feedback in order to figure out the
new sorting principle (Heaton et al., 1993). According to Spreen and Straus (1998), this
procedure continues on until the examinee has completed the principles of color, form,
number, color, form, number, or until all 128 cards have been used. Scoring dimensions
of the WCST are: Trials Administered, Correct-Incorrect, PerseverativeNonperseverative, Number of Categories Completed, Trials to Complete First Category,
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Percent Perseverative Errors, Failure to Maintain Set, Percent Conceptual Level
Responses, Learning to Learn, and Percent Errors (Heaton et al., 1993).
Trail Making Test (TMT; Reitan & Wolfson, 1993) - This measure has proven to
be quite useful in assessing “visual conceptual abilities, cognitive flexibility, set shifting
[changing concept of a task], sequencing ability, visual-motor tracking, and visual-spatial
functioning” (Golden et al., 2000) in the dorsolateral prefrontal cortex and the frontal eye
fields (Malloy et al., 1998). It consists of two parts, A and B, with the former measuring
cognitive processing speed and the latter assessing complex cognitive processing speed
and mental flexibility (Malloy et al.). Malloy et al. also noted that the Trail Making Test
(Reitan & Wolfson, 1993) is a test of abstraction, set maintenance, and cognitive
flexibility.
Part A consists of numbers from 1 to 25 with circles around the numbers. The
examinee is instructed to draw a line from 1 to 2, 2 to 3, and so on to the end as fast as
possible. If the examinee makes a mistake, the examiner is to point out the error and
redirect the examinee to begin at the number/circle previous to the error. Time is
recorded in seconds. Similar to Part A, there are circled numbers on Part B. However,
there are also circled letters as well. Thus, the examinee is instructed to draw a
continuous line from circle to circle, but this time the sequence must be number to letter
(e.g., 1-A, A-2, 2-B, B-3, 3-C, etc.).
Errors are noted on the TMT; however, no penalty is assessed, as increased errors
will result in increased time to complete the task, thus affecting one's score. Broshek and
Barth (2000) point out that slower times on the trails tests can indicate cerebral
dysfunction, potential problems related to the anterior frontal lobes, slow cognitive
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processing speed, visual scanning deficits, decreased motivation/effort, and depression
with psychomotor deficits (especially on Part B), and memory (Golden et al., 2000).
Stroop Color and Word Test (Stroop; Golden & Freshwater, 2002) - The Stroop
is a fairly quick and easily administered measure that assesses one’s ability to shift
perceptual set (a mental readiness to see one thing based on expectations, experiences,
emotions, or assumptions) to conform to changing stimuli and resist habitual responding
in favor of more unconventional responding (inhibition; Spreen & Straus, 1998) in the
orbital prefrontal cortex (Malloy et al., 1998).
One part of the Stroop requires an examinee to read words (i.e., the words RED,
BLUE, & GREEN) from a list. Another has the words printed in different colors (e.g., the
word RED is printed in blue colored ink). In all, there are three pages of required
activities, a word page, color page, and a color-word page. On the word page, the
examinee is informed that he/she must read the words as fast as possible. On the color
page, four X’s are set in columns in one of the three colors previously noted. The
examinee is required to name the color of the four X’s as fast as possible. For the colorword page, examinees are told to “... name the color of the ink the words are printed in,
ignoring the word that is printed for each item” (Golden & Freshwater, 2002 p. 4). One
needs to work as fast as possible while still attempting to make correct responses.
The use of these and other assessments to measure executive function deficits has
grown tremendously in recent years. The next section explores that line of scholarly
inquiry, especially as it relates to the association between the executive functions and
depression. The primary focus is on research that has both shown executive deficits in
those with depression as well as studies that have provided conflicting information
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Research Literature Regarding Executive Functioning and Depression
One group of researchers that have investigated the relationship between
executive functions and depression is Paradiso, Lamberty, Garvey, and Robinson (1997).
They noted that although much research has been done investigating neurocognitive
impairment in depressed individuals, it has been confounded by inconsistent applications
of the term depressed. Paradiso et al. asserted that much of the previous research has
combined both unipolar and bipolar type depressed individuals into one experimental
group and simply labeled them all as depressed. Furthermore, according to Paradiso et
al.. the previous literature has looked at individuals while they were experiencing a
depressive episode.
In an attempt to distinguish any potential differences between unipolar and
bipolar type individuals, as well as explore whether or not remission of depressed state
affects neurocognitive impairment, Paradiso et al. examined the neurocognitive
impairments in euthymic phase unipolar (age M = 55.9, SD 11.3), bipolar (age M= 57.0,
SD 11.3), and healthy comparison groups (age M= 49.8, SD 11.5). The number of years
of education was comparable across groups (unipolar M - 12.2, SD 3.0; bipolar M = 13.5,
SD 2.7; and healthy comparison A/=13.5, SD 1.9). Furthermore, citing previous literature
that there are gender differences in “brain organization of cognition and emotion”
(Paradiso et al., p.748), only males were investigated. A total of 65 individuals were
enrolled in the study, of which 20 participants had a history of unipolar depression and 11
participants had a history of bipolar disorder. All participants with a history of neurologic
and/or active substance abuse issues were excluded from their study (Paradiso et al.).
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All participants completed the Trail Making Test (TMT) Parts A and B, CERAD
word list memory test, Stroop Color and Word Test, and the Digit Symbol subtest of the
Wechsler Adult Intelligence Scale-Revised (Paradiso et al., 1997). Analyses of the data
indicated that the neuropsychological measures revealed group effects where unipolar
depressed individuals performed more slowly than the healthy comparison group on the
TMT Part A, Stroop Color and Word Test, Digit Symbol subtest, and the CERAD word
list memory test at a statistically significant level {p < .05). However, the only measure in
which the unipolar depressed individuals performed worse than the bipolar group at a
statistically significant level (p < .05) was on the TMT Part B. Paradiso et al.
acknowledged that the healthy comparison group typically performed better on all
measures in their study, however, no differences reached statistical significance between
the healthy comparison group and the bipolar disorder group.
Various conclusions reached by Paradiso et al. (1997) are of importance. For
example, they concluded that the cognitive deficits that have been associated with
depression continue on after symptom remittance. Furthermore, it also appears that
bipolar and unipolar types of depression are not unitary disorders and should be
investigated separately. However, a major caveat should be noted with regard to Paradiso
et al.’s work. All but three individuals in the experimental sample were taking
medications (Lithium; n= 12, Antiepileptics; n = 8, Tricyclic Antidepressants; n = 4,
Selective Serotonin Reuptake Inhibiters; n = 7, Buproprion or trazodone; n= 11, or
benzodiazepines or buspirone; n = 6) at the time of testing.
According to DiMicco and Gutierrez (2003) and Vasko and Gutierrez (2003),
several of these medications have sedative/hypnotic or confusional effects upon cognitive
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functioning. Paradiso et al. (1997) attempted to analyze and explain the effects of these
medications with post-hoc analyses and found that there were no statistically significant
differences between the medicated and non-medicated groups. However, this goes against
conventional wisdom (e.g., DiMicco & Gutierrez, 2003; Vasko & Gutierrez, 2003) and
research (Elliot, 1998) that says otherwise. Additionally, such results would need to be
replicated before investigators could accept that tricyclic antidepressants,
benzodiazepines, and trazodone have no neurocognitive effects.
Another example of work that has investigated the connection between depression
and neuropsychological functioning is that by Landro, Stiles, and Sletvold (2001). Landro
et al. recently examined a sample of depressed individuals who were identified via a
structured clinical interview and a depression inventory.
All individuals were screened and participants were excluded if they were taking
an antidepressant, lithium, or neuroleptic medications, or were actively abusing alcohol
or drugs (Landro et al., 2001). A total experimental sample of 22 individuals (82%
women) and thirty healthy comparisons (73% women) were enrolled based on their
report of no psychiatric illnesses and a score of at least 9 or below on the Beck
Depression Inventory (Landro et al.). All participants completed a test of motor function
(two finger tapping task), selective attention (choice reaction time test), mental flexibility
(Trail Making Test [TMT], Parts A and B), visuomotor tracking (Kimura Recurring
Recognition Figures Test), verbal fluency (Controlled Oral Word Association test),
visuospatial function (Block Design subtest from the original WAIS), and the Similarities
subtest from the original WAIS.
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Statistical analyses, including MANCOVA’s, ANOVA’s, t-tests, and Chi squares,
produced a variety of interesting results. Most notable was the significant overall group
differences between the depressed and non-depressed groups in neuropsychological test
performance (Landro et al., 2001). More specifically, there were statistically significant
group differences in selective attention, working memory, verbal long-term memory, and
verbal fluency (Landro et ah). Quite interesting was the lack of findings regarding mental
flexibility (TMT). Inconsistent with much of the young adult literature regarding
executive functioning, Landro et ah showed no differences between the depressed and
non-depressed groups on the TMT. While some studies have shown robust differences
(Paradiso et ah, 1997), others (Grant et ah, 2001)-including Landro et ah, (2001 )-have
shown no differences, thus adding to the debate of whether or not the executive skill of
mental flexibility is affected by depression.
While Landro et ah, (2001) matched participants well in regards to age, education,
and estimated intelligence, there are important pieces missing from their report. For
instance, although the mean age of 40.6 (SD = 10.7) was reported for the depressed
group, this suggests that over 95% of the sample was approximately between the ages of
30 and 50 years-old. Some have argued that this age group is considered middle-aged
(Paykel & Kennedy, 2003) and may possess different neurocognitive profiles than young
adults. According to Landro et ah, (2001), the results of their study match the literature
investigating neurocognitive differences in depressed and non-depressed individuals.
Although there were limitations and inconsistencies in the Landra et ah study, the overall
results were consistent with the literature and provide support for the hypothesis that
there are neurocognitive deficits associated with depression.
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In another study looking at the neurobehavioral effects of depression, Merriam,
Thase, Haas, Keshaven, and Sweeney (1999) used previous neuroimaging research that
showed decreased prefrontal cortical blood flow and metabolism in depressed individuals
to hypothesize that such an event would lead to neurocognitive decreases. The
participants ranged in age from 18 to 50, were not medicated, and were excluded if they
had a history of electroconvulsive therapy, neurological disorder, head injury, or
substance dependence (Merriam et al.). Unipolar major depressed individuals (five with
psychotic features), individuals with schizophrenia, and a healthy comparison group
made up the participant pool.
An ANCOVA (with age and IQ serving as covariates) showed that age did not
impact WCST performance (the depressed group was appreciably older than both the
schizophrenia and healthy comparison groups), while IQ impacted all groups (Merriam et
ah). It is noteworthy that the depressed group performed significantly poorer than both
the healthy comparison and schizophrenia groups on all aspects of the WCST {p < .001)
except the failure to maintain set task (i.e., participants were able to maintain a task once
it was figured out; Merriam et ah). Golden et ah (2000) noted that deficits in this area are
typical of frontal dysfunction (i.e., memory difficulties or increased distractibility).
Merriam et ah (1999) warn that their findings should be viewed with some
caution as their depressed group consisted mainly of ambulatory outpatients and the
schizophrenia group was primarily acutely psychotic inpatients. However, the significant
deficits found on the WCST in the depressed group definitely warrants further
investigation as the depressed group’s performance was so poor across the WCST
subtests which are a typical mainstay of any test of executive functions.
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In another study utilizing the WCST, Channon (1996) tested Dehaene and
Changeux’s (1991) theory of the WCST. Dehaene and Changeux’s hypothesized that
evaluating too many sources of failure on the WCST and neglecting the reward signal
(being informed one is correct), or failing to alter behavior in response to feedback (not
changing a strategy when informed a response was incorrect) are the reasons for errors on
the WCST.
A total of 56 college students participated by completing the Beck Depression
Inventory, and based on the score, were asked to participate in a study looking at
reasoning (Channon, 1996). This resulted in 28 individuals assigned to two groups, a
dysphoric group (male = 6, female = 22, age; M= 22.3, SD = 4.2) and a healthy control
group (male = 7, female = 21, age; M - 21.0, SD = 2.8). Both groups were administered
the BDI twice; once during a classroom lecture, which resulted in an invitation to
participate in the study, and another just before testing (dysphoric group; M= 20.0 &
17.8; control group; M= 2.3 & 1.6; Channon). No mention was made regarding
antidepressant medication use by the authors. Other inclusion criteria included average or
above vocabulary scores on the Wechsler Adult Intelligence Scale-Revised (WAIS-R)
and no significant physical or psychiatric illness (other than depression or dyslexia).
Statistical analyses (t-tests) indicated that the groups did not differ significantly in
vocabulary or age (Channon).
The results from Channon’s (1996) study revealed that dysphoric participants
took more trials to carry out a task and made significantly more perseverative and nonperseverative errors than the comparison group. Previous data has typically looked at
MDD instead of a subthreshold depression (i.e., dysphoria).

57

Overall, Channon’s (1996) work contributed to the body of literature suggesting
that depressed individuals suffer deficits on the WCST. More importantly, the finding
that dysphoric individuals performed worse than healthy comparisons suggests that even
lower levels of depression may impact frontal lobe function and the executive functions.
Additionally, Channon (1996) has also provided evidence supporting Dehaene and
Changeux’s (1991) theory of the WCST that failing to alter behavior in response to
feedback are the reasons for error on the WCST. Adding to the executive function belief
that individuals with decreased executive functions cannot self-regulate. Channon (1996)
further proposed that while fatigue has been suggested to affect depressed individuals
performance on tests, his study found no significant differences between the two groups
over the duration of the testing (Channon).
While Channon (1996) asserted that many aspects of his study support and further
the connection between depression and executive dysfunction, there are some limitations
that went unmentioned by the author. For example, the gender discrepancy should have
been addressed by Channon. As noted earlier in this paper, there are many more women
who are diagnosed with depression than men. However, without limiting the results of his
study to women he may have erred in regards to the generalizability of the results.
Additionally, Channon chose to use a sample of dysphoric individuals instead of a
clinically depressed sample. It was noted that previous research has found similar deficits
in those with clinical depression as in those with dysphoria (see Hartlage, Alloy,
Vazquez, & Dykman, 1993; Vredenburg, Flett, & Krames, 1993), although the clinical
samples with more severe levels of depression tended to have more severe executive
deficits (Channon, 1996). Instead of viewing this as a limitation, Channon asserted that
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his results support the hypothesis that depression, even mild depression, impairs
executive functions.
Based on literature that there are executive function deficits in depressed
individuals (Paradiso et al., 1997), Channon and Green (1999) recently investigated
whether or not providing individuals with a strategy aid would affect their performance
on tasks related to executive functioning. It was hypothesized that strategy aids (i.e.,
hints) would help depressed individuals make up for the reported deficits on many
traditional neuropsychological tests (Channon & Green).
Two groups of participants (depressed and healthy comparisons) were assigned to
strategy aid and no strategy aid groups and administered three measures related to
executive functioning (memory for categorized words task, response suppression task, &
multiple scheduling task; Channon & Green, 1999). The depressed participants were
identified via a structured clinical interview and two measures of depression (one
clinician rated form and the other self-report). Participants who scored more than one
standard deviation below normal on the spot the word test, had a relevant history of
physical or neurological illness, mania, hypomania, other psychiatric illness,
alcohol/substance abuse dependence issues, or had electroconvulsive therapy within the
previous 12 months were excluded (Channon & Green).
Regarding the testing procedures, all participants received the same introductory
instructions for all three of the executive function measures. However, the strategy aid
group was given further instructions that served as hints as to how to manage the test in a
more efficient and productive manner (Channon & Green, 1999). For example, on the
response suppression task, individuals were required to finish a sentence stem with a one-
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word non-contextual response as quickly as possible. Additionally, the word had to be
unrelated to the sentence as much as possible. The strategy aid group was further “... told
to imagine that they were on a [vacation] and to think of words relating to this to
complete the sentence” (Channon & Green, p. 164).
Channon and Green's (1999) analyses of their data revealed no statistically
significant differences in regards to participant age, years of education, or spot the word
test performance. Using analyses of variance, statistically significant differences were
found regarding group performance on all three of the measures utilized in this study,
with non-depressed individuals performing better than depressed individuals (both
strategy aid and non-strategy aid,p = .006; Channon & Green). Furthermore, Channon
and Green asserted that a qualitative (i.e., subjective) examination of participant
performance suggested that depressed individuals failed to spontaneously utilize the
performance strategies and when they did, it did not necessarily equate to improved
performance.
Although support was not found for strategy aids assisting depressed individuals
erase the performance deficits on neurocognitive tasks, Channon and Green (1999)
asserted that strategy aids in the form of hints might still prove beneficial in the everyday
treatment of depression. However, their study suggested that information alone does not
appear to eradicate deficits. Instead, the authors suggested that hints, along with practice
and training, may be helpful (Channon & Green). Furthermore research into this
hypothesis will have to be completed in order to gain a fuller understanding of what may
and may not be beneficial to depressed individuals performance on measures of
neurocognitive functioning.
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Remaining consistent with the previously described research. Grant, Thase, and
Sweeney (2001) investigated a large group of individuals throughout the young adult to
midlife age range. According to Grant et al., their goal was to comprehensively assess a
younger adult group of outpatient non-medicated individuals with major depression
utilizing various neuropsychological measures of attention, memory, abstract problem
solving, and motor skills as well as with a computerized battery of cognitive tests.
Without a direct hypothesis stated, these authors ultimately provide an exploratory look
at the relationship between the previously mentioned neuropsychological constructs and
participants with major depression.
A total of 123 outpatient individuals (age; M= 39.0, SD = 10.4) who met DSMIV criteria for MDD without psychotic features were compared to a group of healthy
comparison participants (n = 36; age; M= 40.2, SD = 9.7). Interestingly, only 36
participants were involved in the comparison group, equating to almost 3.5 times less
individuals than were used in the experimental group. However, there was no explanation
provided by the authors for this.
The overall sample was established by use of a structured clinical interview, a
clinician rated and a self-report depression scale, and each participant was assigned a
Global Assessment of Functioning (GAF) score (Grant et al., 2001). Of the outpatient
depressed participant group, two were also diagnosed with social phobia, one was
concurrently diagnosed with anorexia, and one with substance abuse issues (Grant et al.).
While the number of persons with these disorders were small (2, 1, & 1, respectively), the
fact that the comparison group was so small to begin with presents these individuals as
potential confounds to the Grant et al. study as any one of these diagnoses can
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deleteriously affect the ultimate results and any potential identification of depressions
affects upon the executive functions. Additionally, depressed participants were required
to be medication free for at least 28 days prior to the testing while the healthy comparison
participants were expected to be completely medication free.
Results of t and chi square tests indicated group differences between the
depressed group and the non-depressed group in the domain of executive functions but
not on tests of attention, motor, or memory (Grant et al., 2001). In the executive function
domain, the depressed group showed particular impairment on the WCST. Specifically,
deficits were found in areas of number of categories completed, perseverative responses,
perseverative errors, and failures to maintain set (Grant et al.). It is important to note that
all other tests of executive function (Trail Making Test B, Halstead-Reitan Categories
Test, & the COWA [FAS version]) revealed no group differences (Grant et al.). Grant et
al. further reported that the computerized assessments, the Cambridge
Neuropsychological Test Automated Battery (CANTAB), also revealed no group
differences on tests of executive function or memory (Grant et al.).
Overall, the Grant et al. (2001) study contrasts with some previous research
studies that have reported deficits in depressed younger individuals. It is important to
note that the mean age of individuals participating was 39 years. However, Grant et al.
defined their sample as young adults, thus attempting to show deficits in executive
functioning in depressed individuals other than mid-life and elderly individuals. Some
scholars have operationally defined young adulthood as those between the ages of 19-23,
not 39 (Lewinsohn & Seeley, 2003). Additionally, Grant et al.’s (2001) sample appears to
be looking at milder cases of depression, which may ultimately account for some of the
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discrepant (non-significant) findings regarding executive functioning in their sample.
Moreover, the results of this study have to be generalized with caution. The presence of
other mental health diagnoses among the depressed group is problematic and should have
been addressed theoretically by the authors. However, as such information was not
addressed, further research may need to be done in these other areas of mental health
functioning in order to fully understand their impact on the executive functions.
Purcell, Maruff, Kyrios, and Pantelis (1997) also investigated the
neuropsychological deficits in depressed young adults. In their study, 20 individuals (19
outpatients and 1 inpatient at time of testing) who met Anxiety Disorders Interview
Schedule for DSM-1V criteria for unipolar depression were assessed. Twenty depressed
individuals (male = 8; female = 12; age; M= 37.5, range = 18-52 [standard deviations not
reported by authors]; Purcell et al.) and all participants completed the National Adult
Reading Test (NART; a vocabulary test that correlates with IQ scores) in order to
estimate intelligence level. Seven of the 20 participants reported previous hospitalizations
due to their depression and 12 were taking antidepressant medication (medications not
named by authors) at the time of testing. It is noteworthy that the participants’ scores
assessing depression revealed a moderate level of depressive symptoms. Participants
were excused from the study if they endorsed a history of hypomania, neurological and/or
medical illness, or major alcohol/drug abuse (Purcell et al.). A healthy comparison group
(n = 20) was matched to the depressed group on sex, age, years of education, and NART
score (Purcell et al.).
All participants completed tests of executive functioning (spatial span, spatial
working memory, Tower of London planning task, & intradimensional/extradimensional
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[ID/ED] set shift task; shifting from a reinforced condition to a previously irrelevant
condition) and visual memory tasks (delayed matching to sample, spatial recognition,
pattern recognition; Purcell et al., 1997). Statistical analyses, that included ANOVA’s, ttests, chi square tests, Pearson’s product moment correlation coefficients, and
Spearman's correlation coefficients, revealed results that are discrepant with previous
literature.
Specifically, no statistically significant differences were found on most of the
measures of neuropsychological functioning (Purcell et al., 1997). Tests that produced
statistically significant differences between the two groups were TOL time of single
moves and the ID/ED set shifting task with the healthy comparison participants
outperforming the depressed group. Purcell et al. noted that they found no statistically
significant differences between the medicated and non-medicated participants; however
with an uncontrolled 12:8 ratio, of medicated to non-medicated, their assertion should be
interpreted cautiously.
Purcell et al. (1997) reported findings that support motor speed and attentional set
shifting deficits in depressed individuals. However, they were unable to replicate past
findings of executive function deficits in their population. It should be noted that Purcell
et al.'s depressed participants were all outpatients, except one, and scored in the
moderately depressed range on a measure of depression. Based on this, Purcell et al.
hypothesized that non-hospitalized depressed individuals may have more intact cognitive
abilities than those needing hospitalization for treatment of their depression. Thus, the
authors argued that hospitalized and non-hospitalized depressed individuals may possess
different neurocognitive profiles.
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Another aspect of Purcell et al.’s (1997) work that limits its generalizability is
their definition of “young patients.” They argue that they have provided evidence that
young adults may not necessarily possess the same executive function deficits that middle
aged and elderly individuals do. However, the mean age of the Purcell et al. group was
37.5 years with ages ranging from 18 to 52, an age range that only places some of the
participants into the “young adult” category according to some authors (see Paykel &
Kennedy, 2003). Purcell et al. (1997) note that future research should examine the
depressed young adult in order to determine and understand the relationship between
neuropsychological functioning and depression.
Porter, Gallagher, Thompson, and Young (2003) also investigated young adults
and the potential neurocognitive deficits associated with depression. They asserted that
there have been inconsistent findings in neurocognitive impairment research with
depressed individuals. They attributed these inconsistencies to the wide variety of
participants in various studies in regards to “age, hospitalisation (sic), severity and
subtype of depression, and most importantly, the effect of psychotropic medication”
(Porter et al., p. 214). In order to address such issues, they hypothesized that nonmedicated depressed individuals would perform more poorly than a well-matched healthy
comparison group.
The Montgomery-Asberg Depression Rating Scale (M = 28.9) and the Beck
Depression Inventory (M= 27.9) were used to identify participants for the depressed
group. Individuals for the non-depressed comparison group were required to obtain
scores of less than seven on the Beck Depression Inventory. A total of 44 individuals in
each group (age; M= 32.9, SD = 10.6 for the out-patient depressed group and M= 32.3,
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SD = 11.4 for the control group) participated in the Porter et al. (2003) study. Participants
were matched for age, gender, premorbid IQ (via the National Adult Reading Test), years
of formal education, and season of testing; females were also matched for phase of
menstrual cycle.
All participants completed the Digit Symbol Solution Task, Rey Auditory Verbal
Learning Test, Controlled Oral Word Association Test, ‘exclude letter’ fluency test, and
vigil continuous performance test. Furthermore, the Paired Associates learning, pattern
recognition, spatial recognition, simultaneous/delayed matching to sample, spatial
working memory, and the Tower of London were all completed from the Cambridge
Neuropsychological Test Automated Battery (CANTAB; Porter et al., 2003).
The results of Porter et al.’s (2003) data revealed that most of the depressed
individuals (68%) were experiencing their first episode of depression, had never taken
antidepressant medication (58%; others were medication free for at least 6 weeks prior to
testing), and had never received electroconvulsive therapy (100%). On tests of
neurocognitive functioning, ANOVA’s showed depressed participants performed poorer
than a group of healthy comparison individuals on aspects of verbal and visualspatial
learning and memory as well as sustained attention and executive functioning. (Porter et
al.). By executive functioning, Porter et al. are referring to verbal fluency, spatial working
memory, and planning. Overall, Porter et al. suggested that their work indicates that there
are significant neurocognitive deficits in young adult unipolar depressed out-patient
individuals. It is noteworthy that the most robust findings were in the area of attention
and executive functioning. Porter et al. asserted that while large effect sizes for executive
functions were present, participant performance correlated with level of depression.

66

Porter et al. suggested that the executive functions may be quite sensitive to depressive
symptoms and that even the slightest amount of depressive symptomatology may
substantially affect one’s executive functioning.
Since Porter et al.’s (2003) results cannot be attributed to the effects of
psychotropic or central nervous system active medications their work lends solid support
to the theory of prefrontal cortex dysfunction in depressed individuals. However, while
the mean age of the depressed sample was 32.9 years, the participants’ ages ranged from
19 to 61 years (Porter et al.). This age range has been defined by others as midlife (ages
40 to 60; Paykel & Kennedy, 2003) and later life/elderly (O’Brien & Thomas, 2003).
Therefore, the results of Porter et al.’s (2003) research should be interpreted cautiously as
executive deficits have been reported in middle aged and elderly individuals.
The research studies just discussed have all displayed various neurocognitive
deficits in depressed individuals. However, in the process of doing so, these studies have
not been able to operationally define the executive functions. Although this would appear
an easy task, it is not (Burgess, 2003). The executive functions are the newest, and likely
the least well understood, area of brain functioning research. Due to the infancy of
executive functioning research, there is no shortage of explanations for what they are.
Unfortunately, this has hindered research activities and understanding of the related
phenomena that are the executive functions. As a result most research has been
completed by assessing symptoms of executive dysfunction (e.g., difficulties related to
planning, cognitive flexibility, inhibition, aspects of attention, etc.; Burgess). However,
this is not a complete detriment to this area of study. A great deal of clinical utility has
resulted from such work and has served several of the quotidian needs of clinicians (e.g.,
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a better understanding of how frontal lobe impairment will affect functional ability).
Although work is not complete in this area, great utility can come from this system of
symptom assessment. Symptom identification and assessment may lead to further
theoretical clarity, and-ultimately-an operational definition.
Summary
Information has been presented discussing depression, executive functions, and
research that has investigated the interaction of the two. The previous sections have
established that depression has long been an issue for many people. Estimates suggest
that some 121 million people worldwide suffer from the effects of depression (WHO,
2001). Not only is this of great concern for health care providers, it has also begun to
affect the economy where estimates suggest that depression costs United States
businesses some $33 billion per year due to decreased work productivity and absenteeism
(Quinn, 2000). What is more, less than 25% of these individuals have access to effective
treatment (WHO, n.d.) and over 80% of all depressed individuals will have a second,
more severe, depressive episode later in their life (Barlow & Durand, 1999).
The executive functions have proven to be a difficult set of brain functions to
operationally define (Burgess, 2003; Riccio, 2006). Too often, the definition simply
depends upon who is carrying out the research (Riccio, 2006). Thus, the field has been
left with a series of complex and often incomplete conceptualizations of the executive
functions. Furthermore, the instruments used to assess the executive functions are not
theoretically driven. Most were developed in order to assess functions that are not part of
the executive functions at all. However, it has been found that these “hallmark” measures
of executive functioning are able to detect deficiencies in tasks that are associated with
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certain brain areas (e.g., the frontal lobes; Burgess, 2003). Symptoms have ultimately
been identified by Burgess that have allowed scientists to infer executive dysfunction by
correlation with brain damaged individuals. Thus, there has been a disconnect between
those needing clinical utility from an instrument (i.e., clinicians) and those needing
theoretical backing (i.e., academicians/scholars).
Age and medication status have been common confounds in the literature
regarding the executive functions and depression. Definitions of young adult, middle age,
and late life/elderly individuals have been erratic (e.g., see Channon, 1996; Grant et al.,
2001; Purcell et al., 1997). This is problematic as one cannot generalize to young adults
when one does not know what a young adult is. Furthermore, medication status has not
been addressed as the major variable it is in previous research studies. Several
investigations have analyzed medication status as a post-hoc variable (e.g., see Paradiso
et al., 1997). This is insufficient as antidepressant medications affect brain chemistry and
thus have the potential to affect neurocognitive functioning.
Purpose of Current Study
The purpose of the current study was to assess and compare the level of executive
functioning in a medicated depressed, non-medicated depressed, and non-medicated nondepressed sample. In so doing, the present study assesses executive functions based on
typical executive dysfunction symptoms (e.g., problems with planning, inhibition,
cognitive flexibility, etc.; Alexander and Stuss, 2000; Burgess, 2003, Lezak et al., 2004).
Furthermore, medication status is addressed by separating the depressed participants into
medicated and non-medicated groups. Additionally, participants consisted of individuals
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between the ages of 19 and 40. This age group allows for a purer understanding of the
effects of depression on the executive functions in a younger adult population.
Main Hypotheses
Given the information presented throughout this review, the main hypothesis of
the current study is that differences in performance will be found between the medicated
depressed, non-medicated depressed, and non-medicated non-depressed groups on
measures of executive functioning. More specifically:
la. Differences will be found between the non-medicated non-depressed group
and the depressed groups on The Wisconsin Card Sorting Test.
lb. Differences will be found between the medicated depressed group and the
non-medicated depressed group on The Wisconsin Card Sorting Test.
2a. Differences will be found between the non-medicated non-depressed group
and the depressed groups on the Trail Making Test (Parts A & B).
2b. Differences will be found between the medicated depressed group and the
non-medicated depressed group on the Trail Making Test (Parts A & B).
3a. Differences will be found between the non-medicated non-depressed group
and the depressed groups on the Tower of London, Drexel University (2nd Ed.).
3b. Differences will be found between the medicated depressed group and the
non-medicated depressed group on the Tower of London, Drexel University (2nd
Ed.).
4a. Differences will be found between the non-medicated non-depressed group
and the depressed groups on the Stroop Color and Word Test.
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4b. Differences will be found between the medicated depressed group and the
non-medicated depressed group on the Stroop Color and Word Test.
5a. Differences will be found between the non-medicated non-depressed group
and the depressed groups on the Controlled Oral Word Association test.
5b. Differences will be found between the medicated depressed group and the
non-medicated depressed group on the Controlled Oral Word Association test.
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CHAPTER III
METHOD
Participants
The participants in the current study were divided into three different groups. One
group was a collection of individuals experiencing depression and taking psychotropic
medication (n = 15) while another group included individuals experiencing depression
who were not taking any psychotropic medication (n = 16). Individuals in these two
groups were referred to the principal investigator from various clinical practices located
in Northeastern North Dakota and Northwestern Minnesota. The third group comprised
non-medicated non-depressed individuals (n = 22) enrolled in undergraduate or graduate
courses at a mid-sized university located in the upper Midwestern United States.
Participants were required to meet certain criteria in order to participate in the
current study. All participants were required to have abstained from taking any central
nervous system active medications for at least 28 days and have no history of psychosis
or Schizophrenia. In addition to these basic requirements, there were also group specific
requirements. The medicated depressed participants were required to obtain a score of 17
or higher on the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown. 1996),
meet criteria for Major Depressive Disorder based on the Mood Disorders module of the
Structured Clinical Interview for DSM-IV-I (clinical version; SCID-I; First et al„ 1997),
and be taking either a Selective Serotonin Reuptake Inhibitor (SSRI) or a Monoamine
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Oxidase Inhibitor (MAOI), but no Tricyclic medication due to known cognitive
impairments associated with such medications (Vasko & Guiterrez, 2003). The nonmedicated depressed group was also required to obtain a score of 17 or higher on the
BDI-II, meet criteria for Major Depressive Disorder (MDD) based on the Mood
Disorders module of the SCID-I (First et al.). Additionally, they must also be free from
ingesting any psychotropic medication for at least 28 days prior to testing. The nonmedicated non-depressed group participants were required to have scored a six or lower
on the BDI-II, not meet criteria for MDD based on the Mood Disorders module of the
SCID-I (First et ah), have no history of diagnosed depression, and be free of any
antidepressant medications.
Overall, a total of 53 participants completed the BDI-II (Beck et ah 1996), the
clinical interview assessing depressive symptoms based on modules A (Mood Episodes,
Dysthymic Disorder, Mood Disorder Due to a General Medical Condition, & Substance
Induced Mood Disorder) and D (Mood Disorders) of the SCID-I (clinical version; First et
al, 1997), a measure of ADHD symptoms (Current Symptoms Scale-Self-Report Form;
Barkley & Murphy, 1998), a demographic questionnaire, measures of group equivalence
(Vocabulary subtest of WAIS-III [Wechsler, 1997] & Symptom Checklist-90-Revised
[SCL-90-R; Derogatis, 1994]), and executive functions (Wisconsin Card Sorting Test
[WCST; Heaton, Chelune, Talley, Kay, & Curtiss, 1993], Trail Making Test [TMT A &
B; Reitan, 1996], Tower of London: Drexel Edition [TOLDX; Culbertson & Zillmer,
2005], Stroop Color and Word Test [Stroop; Golden & Freshwater, 2002], & Controlled
Oral Word Association test [COWA; Spreen & Straus, 1998]).
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The participants in the current study (N = 53) resided in the upper Midwestern
United States. Table 1 presents the frequencies and percentages of the participant
demographics found in the present study. The participants in the current study consisted
Table 1. Participant Demographic Information.
Medicated
Depressed

Non-Medicated
Depressed

Non-Medicated
Non-Depressed

All Groups
Together

n (% )

«(% )

«(%)

A (%)

Gender:
Female
Male

13(24.5)
2(3.8)

13(24.5)
3(5.7)

18(34.0)
4(7.5)

44(83.0)
9(17.0)

Ethnicity:
Caucasian/White
African American
Asian American
First Nations Aboriginal
Asian

15(28.3)
0(0)
0(0)
0(0)
0(0)

13(24.5)
2(3.8)
0(0)
0(0)
1(1-9)

20(37.7)
0(0)
0(0)
1(1.9)
0(0)

48(90.6)
2(3.8)
1(1-9)
1(1-9)
1(1-9)

Relationship Status:
Single (Never Married)
Married
Partnered
Divorced
Widowed
Separated
Other (Engaged)

6(11.3)
5(9.4)
0(0)
3(5.7)
0(0)
0(0)
1(1.9)

8(15.1)
6(11.3)
1(1-9)
0(0)
0(0)
0(0)
1(1-9)

12(22.6)
6(11.3)
0(0)
1(1.9)
1(1.9)
1(1.9)
1(1.9)

26(49.1)
17(32.1)
1(1.9)
4(7.5)
1(1-9)
1(1-9)
3(5.7)

Age (In Years):
19-22
23-26
27-30
31-34
35-38
39-40

2(3.8)
2(3.8)
0(0)
6(11.3)
1(1.9)
4(7.5)

6(11.3)
4(7.5)
5(9.4)
0(0)
1(1.9)
0(0)

9(17.0)
4(7.5)
4(7.5)
2(3.8)
2(3.8)
1(1.9)

17(32.1)
10(18.9)
9(17.0)
8(15.1)
4(7.5)
5(9.4)

Yearly Household Income:
$0-$25,000
$25,000-$50,000
$50,000-$75,000
$75,000-$ 100,000
$100,000-5150,000
>$200,000

8(15.1)
4(7.5)
1(1.9)
1(1.9)
0(0)
1(19)

10(18.9)
3(5.7)
2(3.8)
0(0)
1(1.9)
0(0)

11(20.8)
4(7.5)
4(7.5)
3(5.7)
0(0)
0(0)

29(54.7)
11(20.8)
7(13.2)
4(7.5)
1(1.9)
1(1.9)
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Table 1 (cont.). Participant Demographic Information.
Medicated
Depressed

Non-Medicated
Depressed

Non-Medicated
Non-Depressed

All Groups
Together

n(%)

n(%)

n(%)

N (%)

Handedness:
Right
Left
Ambidextrous

14(26.4)
1(1.9)
0(0)

14(26.4)
1(1.9)
1(1.9)

21(39.6)
0(0)
1(1.9)

49(92.5)
2(3.8)
2(3.8)

Years of Education
Completed:
10
12
13
14
15
16
17
18

1(1.9)
4(7.5)
2(3.8)
4(7.5)
1(1.9)
2(3.8)
0(0)
1(1.9)

0(0)
5(9.4)
2(3.8)
7(13.2)
1(1.9)
0(0)
1(1.9)
0(0)

0(0)
4(7.5)
2(3.8)
2(3.8)
8(15.1)
6(11.3)
0(0)
0(0)

1(1.9)
13(24.5)
6(11.3)
13(24.5)
10(18.9)
8(15.1)
1(1.9)
1(1.9)

Previous Diagnosis
of Depression:
Yes
No

3(5.7)
12(22.6)

3(5.7)
13(24.5)

0(0)
22(41.5)

6(11.3)
47(88.7)

If Previous Diagnosis of
Depression, age at
first onset:
9 years
17 years
22 years
23 years
24 years
25 years

0(0)
0(0)
1(1.9)
1(1.9)
1(1.9)
0(0)

1(1.9)
1(1.9)
0(0)
0(0)
0(0)
1(1.9)

0(0)
0(0)
0(0)
0(0)
0(0)
0(0)

1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)

Number of Previous
Depressive Episodes:
One
Two
Twelve
Twenty

1(1.9)
0(0)
1(1.9)
1(1.9)

2(3.8)
1(1.9)
0(0)
0(0)

0(0)
0(0)
0(0)
0(0)

3(5.7)
1(1.9)
1(1.9)
1(1.9)

6(11.3)
9(17.0)

4(7.5)
12(22.6)

0(0)
22(41.5)

10(18.9)
43(81.1)

Currently Engaged in
Psychotherapy:
Yes
No
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Table 1 (cont.). Participant Demographic Information.
Medicated
Depressed

Non-Medicated
Depressed

Non-Medicated
Non-Depressed

All Groups
Together

n(%)

n(%)

n(%)

N (%)

1(1.9)
0(0)
1(1.9)
0(0)
1(1.9)
1(1.9)
0(0)
1(1.9)
1(1.9)

1(1.9)
1(1.9)
0(0)
1(1.9)
0(0)
0(0)
1(1.9)
0(0)
0(0)

0(0)
0(0)
0(0)
0(0)
0(0)
0(0)
0(0)
0(0)
0(0)

2(3.8)
1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)
1(1.9)

Ever Received a Mental
Health Diagnosis:
Yes
No

2(3.8)
13(24.5)

0(0)
16(30.2)

0(0)
22(41.5)

2(3.8)
51(96.2)

If Yes, What Diagnosis:
Obsessive-Compu lsive
Disorder
Depression

1(1.9)
1(1.9)

0(0)
0(0)

0(0)
0(0)

1(1.9)
1(1.9)

For Those Currently Engaged
in Psychotherapy; Number
of Sessions Completed:
Three
Four
Five
Six
Ten
Twelve
Thirteen
Sixteen
Twenty-Seven

of 44 women (83%) and 9 men (17%) who ranged in age from 19 years to 40 years with a
mean age of 27.19 years and a standard deviation of 6.70 years. Of the 53 participants,
90.6% (48) self-identified as Caucasian/White, 3.8% (2) as African American, 1.9% (1)
as First Nations Aboriginal, 1.9% (1) as Asian American, and 1.9% (1) as Asian.
Nearly half of the participants (49.1%, 26) reported that they were ‘Single (never
married),’ while 32.1% (17) reported that they were ‘Married,’ 1.9% (1) ‘Partnered,’
1.9% (1) ‘Separated,’ 7.5% (4) ‘Divorced,’ 1.9% (1) ‘Widowed,’ and 5.7% (3)
‘Engaged.’
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Twenty-nine participants (54.7%) reported that their yearly household income
was between $0 and $25,000, 20.8% (11) between $25,000 and $50,000, 13.2% (7)
between $50,000 and $75,000, 7.5% (4) between $75,000 and $100,000, 1.9% (1)
between $100,000 and $150,000, 1.9% (1) greater than $200,000.
A majority of the participants reported that they were right handed (92.5%, n =
49), while 3.8% (2) endorsed being left handed and 3.8% (2) endorsed being
ambidextrous. In regards to years of education completed, 1.9% (1) of the individuals
reported completing the 10th grade, 24.5% (13) graduated high school (12 years of
education), 11.3% (6) completed 13 years of education, 24.5% (13) completed 14 years
of education, 18.9% (10) completed 15 years of education, 15.1% (8) completed 16 years
of education, 1.9% (1) completed 17 years of education, and 1.9% (1) completed 18 years
of education.
While 88.7% (47) of the participants reported that they had never previously been
diagnosed with depression, 11.3% (6) endorsed that they had. Of these six individuals
who reported a previous diagnosis of depression, 1.9% (1) reported the age of first onset
at 9 years of age, 1.9% (1) reported the age of first onset at age 17, 1.9% (1) reported the
age of first onset at age 22, 1.9% (1) reported the age of first onset at age 23, 1.9% (1)
reported the age of first onset at age 24, and 1.9% (1) reported the age of first onset at age
25. Furthermore, of these six previously diagnosed individuals, 5.7% (3) reported
experiencing at least one previous depressive episode while 1.9% (1) reported
experiencing two, 1.9% (1) reported experiencing twelve, and 1.9% (1) reported
experiencing 20.
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Of the 15 participants in the medicated depressed group, 5 (9.4% of total)
reported taking Prozac, 3 (5.7% of total) Zoloft, 3 (5.7% of total) Paxil, 3 (5.7% of total)
Wellbutrin, 2 (3.8% of total) Effexor, 1 (1.9% of total) Lorazepam, 1 (1.9% of total)
Celexa, and 1 (1.9% of total) Xanax. The sum of these numbers is more than the number
of medicated depressed participants as some participants were taking more than one
medication.
Of the 53 total participants, 18.9% (10) were engaged in psychotherapy at the
time of assessment (medicated depressed = 6, non-medicated depressed = 4). Of these ten
individuals, 3.8% (2) had engaged in three psychotherapy sessions, 1.9% (1) had engaged
in four, 1.9% (1) had engaged in five, 1.9% (1) had engaged in six, 1.9% (1) had engaged
in ten, 1.9% (1) had engaged in 12, 1.9% (1) had engaged in 13, 1.9% (1) had engaged in
16, and 1.9% (1) had engaged in 27 psychotherapy sessions.
Two participants (3.8%) reported previously receiving a mental health diagnosis.
One participant reported receiving a diagnosis of Obsessive-Compulsive Disorder (OCD)
and the other reported a prior diagnosis of depression. Both participants were in one of
the two depressed groups and the participant whom reported a previous history of OCD
reported being symptom free and not in treatment at time of testing.
It should be noted that all participants (100%, N = 53) reported that they had
never received electroconvulsive therapy (ECT), never been diagnosed with ADHD,
never been hospitalized for a psychiatric condition, and never lost consciousness due to a
blow to the head.
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Materials
All participants were asked to complete a demographic questionnaire as well as
various inventories and measures regarding concomitant psychological functioning,
intelligence, depressive symptoms, and executive functions.
Measures o f Group Equivalence
Psychological Functioning. Concomitant psychological functioning was assessed
using the Symptom Checklist 90, Revised (SCL-90-R, Derogatis, 1994). The SCL-90-R
is a 90 item measure that was developed to be a brief self-report that screens for a wide
range of psychological problems and symptoms of psychopathology of psychiatric
inpatients, medical patients, and non-patient individuals in a community for those aged
13 years and older (Derogatis). Derogatis asserted that the SCL-90-R is helpful in
identifying “. . . current, point-in-time, psychological symptom status” (p. 5).
The SCL-90-R consists of nine primary symptom scales and three global indices.
The primary symptom dimensions are: 1) Somatization, 2) Obsessive-Compulsive, 3)
Interpersonal Sensitivity, 4) Depression, 5) Anxiety, 6) Hostility, 7) Phobic Anxiety, 8)
Paranoid Ideation, and 9) Psychoticism. The three global indices include: (a) The Global
Severity Index (GSI), (b) The Positive Symptom Distress Index (PSDI), and (c) The
Positive Symptom Total (PST). The SCL-90-R utilizes a T-score distribution that ranges
from 0-100 (M= 50, SD = 10; Derogatis, 1994).
Four groups were used to establish norms that consisted of adult psychiatric
outpatients (n = 1,002; Males = 425, Females = 577, 32.9% non-White), adult
nonpatients (n = 974; Males = 494, Females = 480, 14.5% non-White), adult psychiatric
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inpatients (n = 423; Males = 158, Females = 265, 44.2% non-White), and adolescent
nonpatients (n = 806; Males = 327, Females = 479, 0.3% non-White; Derogatis, 1994).
Derogatis (1994) reported that the internal consistency coefficients for the nine
primary dimensions were obtained from two separate studies, first of which was research
conducted by Derogatis, Rickels, and Rock (1976). The group reported internal
consistencies ranging from .77 to .90 and test-retest coefficients that ranged from .78 to
.90. Horowitz, Rosenberg, Baer, Ureno, and Villasenor (1988) showed alpha coefficients
that ranged from .79 to .90 with test-retest reliabilities ranging from .68 to .83. However,
in a study by Hafkenscheid (1993), Cronbach alphas ranged from .14 to 1.0, leaving him
to conclude that this instrument would be better described as “. . . a measure of global
distress, i.e. a unidimensional measure” (p.755).
In regards to validity, Schmitz et al. (2000) compared the SCL-90-R to the
Inventory of Interpersonal Problems (IIP-C) and the General Health Questionnaire
(GHQ-12). Their findings showed concurrent validity with Pearson correlations between
the SCL-90-R and the IIP-C at .63. Criterion validity was shown using receiver operating
characteristic analysis (ROC). The area under the curve for the SCL-90-R GSI was 0.917
(SD = 0.049).
Due to the similarity between Attention-Deficit Hyperactivity-Disorder (ADHD)
symptoms and those of executive function deficits, the Current Symptoms Scale-SelfReport Form (Barkley & Murphy, 1998) was used to rule out the presence of ADHD.
This scale is an 18-item questionnaire that asks examinees to answer questions related to
ADHD symptoms on a Likert-type scale where 0 equals “Never or Rarely” and 3 equals
“Very Often.” The scoring method employed in this study, as described by
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Barkley and Murphy, was to identify odd items (those pertaining to inattention) or even
items (those pertaining to hyperactivity-impulsivity) endorsed with a 2 or 3 by the
participant. If six or more items on either set (those pertaining to inattention or
hyperactivity-impulsivity) were endorsed, the participant would have been considered to
possess clinically significant ADHD symptoms and excluded from the current study. No
individual in the current study obtained a score of six or higher on this measure.
Intelligence. General intelligence was assessed through the Wechsler Adult
Intelligence Scale-Third Edition (WAIS-III) Vocabulary subtest. Channon (1996) noted
that this subtest possesses the best correlation with the Verbal IQ (VIQ). Additionally,
Sattler (1992) noted that this subtest is often administered as an estimate of general
intelligence. Hartlage, Alloy, Vasquez, and Dykman (1993) asserted that one's
performance on the vocabulary subtest remains fairly unimpaired by depression. Thus,
the Vocabulary subtest was chosen in order to estimate level of intelligence in the overall
participant sample, which allowed for comparisons to be made between groups.
The Vocabulary subtest of the WAIS-III requires individuals to tell an examiner
what a stimulus word means. It consists of “a series of orally and visually presented
words that the examinee orally defines” (Wechsler, 1997, p. 2). There are 2, 1, and 0
point answers that must be assessed for quality by the examiner with the help of an
administration manual.
The Vocabulary subtest of the WAIS-III has shown reliability coefficient
averages of .93 across a broad range of ages (approximately 16 to 89; No author, 1997).
Measures of test-retest stability on the Vocabulary subtest revealed strong coefficients
that ranged from .89 to .94 (No author). Lastly, inter-rater reliability coefficients were
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also calculated for the Vocabulary subtest which revealed a very high coefficient of .95
(No author). Validity has been shown for the WAIS-III in general and, more specifically,
for the Vocabulary subtest.
Criterion related validity has been found by correlating the WAIS-III with the
WAIS-R (its previous version) and the WISC-III (the children’s version of this test). The
Vocabulary subtest revealed a .90 correlation with the WAIS-R and .83 with the WISCIII indicating strong validity in this area (No author, 1997). Construct validity has been
shown by correlating the subtests of the VIQ with one another as well as the rest of the
subtests from the WAIS-III. It was believed that the VIQ subtests would correlate highest
with one another (No author). Results of the validation effort ultimately revealed that the
Vocabulary subtest correlated the highest with the overall VIQ (.89; No author).
As other measures of intelligence may not have a specific Vocabulary subtest,
validation efforts were made to correlate the overall VIQ Index of the WAIS-III, which
the Vocabulary subtest is part of, with other valid and standard measures in the field. For
example, the VIQ was found to correlate well with The Stanford-Binet Intelligence ScaleFourth Edition Verbal Reasoning score (.72; No author).
Measures o f Independent Variable
Depression. Objective levels of depression were measured by the Beck
Depression Inventory-Second Edition (BDI-II; Beck et al., 1996). The BDI-II is a 21item self-report measure created to assess the severity of depression (based on the DSMIV) in those aged 13 years and older. Each item of the BDI-II is rated on a 4-point scale
that ranges from 0 to 3. Beck et al. reported that normative data was collected from four
different psychiatric outpatient clinics as well as one college-student group. The
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outpatient psychiatric group was comprised of approximately 63% women and 37% men
and was almost entirely European American (91%). The college-student sample was
comprised of 56% women and 44% men and was also predominately European American
(Beck et al.).
Measures of internal consistency revealed coefficient alphas of .92 and .91 for the
outpatients and students respectively (Beck et ah, 1996). Beck et ah also reported that all
21 of the corrected item-total correlations for the BDI-II were significant at the .05 level.
To establish the BDI-II’s stability over time, test-retest correlations were completed and
revealed a correlation of .93 (Beck et ah).
Content, construct, and factorial validity were also assessed by Beck et ah The
content validity of the BDI-II (Beck et ah), as noted earlier, is based on the DSM-IV
criteria for depression. Convergent validity was assessed by comparing the BDI-II to its
predecessor, the BDI-IA. In so doing, Beck et ah reported correlation coefficients of .93
and .84. It is noteworthy that the BDI-II was correlated with the Hamilton Psychiatric
Rating Scale for Depression (HRSD; a popular and often used measure of depression in
research), which revealed a correlation coefficient of .71 (Beck et ah). Discriminant
validity has also been established for the BDI-II by way of correlating it with the
Hamilton Rating Scale for Anxiety (Hamilton, 1959) which revealed a correlation
coefficient of only .47 (Beck et ah, 1996). Beck et ah asserted that due to a .51
correlation coefficient between the HRSD and the Hamilton Rating Scale for Anxiety,
robust discriminant validity was shown. Factorial validity reported by Beck et ah cited
evidence for two factors based on factor analyses, however there was a difference of
almost 7 between the two highest eiganvalues.
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In addition to the BDI-II, the Structured Clinical Interview for DSM-IV Axis I
Disorders (Clinical Version; First et al, 1997), modules A (Mood Episodes, Dysthymic
Disorder, Mood Disorder Due to a General Medical Condition, & Substance Induced
Mood Disorder) and D (Mood Disorders; hereafter referred to as SCID-I) were also used
to categorize individuals into the depressed and non-depressed groups. The SCID-I is a
“semi-structured interview for making the major DSM-IV Axis I diagnoses” (First et al.,
p. 1).
This measure was used to ensure standardization in clinical judgment regarding
participant depression. The SCID-I interview protocol was chosen due to its intent to be
an efficient and user-friendly instrument. The SCID-I has extensive instructions on how
to administer and score responses and further allows for administration of individual
modules for research purposes (First et al.). The SCID-I is a popular and widely used
semi-structured interview in clinical and research settings.
First et al. described the reliability of the SCID-I as being comparable to other
diagnostic instruments. For example, they noted recent studies that have reported kappa
statistics that ranged from .70 to 1.00. Furthermore, First et al. asserted that procedural
validity is desired for a semi-structured interview, yet noted that this can be difficult to
achieve since there is no “gold standard” way that has been established to diagnose
psychiatric disorders. However, initial work is being completed and has begun to build
the procedural validity needed in order to have a sound measure (see Kranzler et al.,
1995; Skodol, Rosnick, Kellman, Oldham, & Hyler, 1988).
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Measures o f Dependent Variable
Executive functioning was assessed by way of the Wisconsin Card Sorting Test
(WCST; Heaton et al., 1993), Trail Making Test, Parts A and B (TMT; Reitan, 1993),
Tower of London, Drexel Edition (TOLDX; Culbertson & Zillmer, 2005), Stroop Color
and Word Test (Golden & Freshwater, 2002), and Controlled Oral Word Association test
(COWA; Spreen & Straus, 1998).
Wisconsin Card Sorting Test. The Wisconsin Card Sorting Test (WCST)

has

been considered the premier test of executive functions for many years” (Malloy, Cohen,
& Jenkins, 1998, p. 584) and is considered to be the most common tool to assess
executive functions (Golden et al., 2000). Various researchers have set numerous
versions of the WCST forth. However, the presently accepted method of administration
and scoring are based on the work of Heaton et al. (1993). In this revised and updated
method, one can complete the WCST either by hand (with a deck of cards) or on a
computer. Both methods require an examinee to match cards to a set of four stimulus
cards (one card with a red triangle, one with two green stars, one with three yellow
crosses, and one with four blue circles) on three parameters, color, form, or number
(Heaton et al.).
Success on the WCST necessitates an individual to determine the correct sorting
principle based on examiner feedback (correct or incorrect) and then maintain said
principle or set while the stimuli changes (Heaton et al.). Two main areas that the WCST
assesses are failure to maintain set and perseveration. A failure to maintain a set occurs
when 5 or more consecutive correct answers are made and an error occurs before the
category (completion of 10 consecutive correct answers) has been established.
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Furthermore, the WCST assesses one’s level of perseveration. This is said to exist when
one is unable to inhibit one’s self from persisting with an older rule and must use the
examiner’s feedback to identify the correct sorting principle (Heaton et al.).
Scores on the WCST are compared to a normative stratified group of nearly 900
individuals from six different samples. Heaton et al. (1993) reported that the normative
group closely approximated the U.S. census data for age for 1995. Inter-rater and intra
rater reliabilities have been investigated for the WCST. Axelrod, Goldman, and Woodard
(1992) reported inter-rater reliability coefficients of .93, .92, and .88 while the samples
consistency was reported as .96, .94, and .91 for Perseverative Responses, Perseverative
Errors, and Nonperseverative errors.
Evidence of concurrent validity for the WCST has been shown. Perrine (1993)
used a Veterans Administration sample to establish discriminate validity between the
WCST and the Halstead Categories Test (HCT). He found that these two measures shared
only 30% of the variance leading him to suggest that they measure separate things. For
example, the WCST was associated with attribute identification whereas the HCT was
associated more with rule learning.
Trail Making Test. The Trail Making Test (TMT) consists of two parts (A & B)
that assesses “visual conceptual abilities, cognitive flexibility, set shifting, sequencing
ability, visual-motor tracking, and visual-spatial functioning” (Golden et al, 2000, p.
171). Part A has 25 encircled numbers in various positions and requires one to connect
the circles by pencil line in correct order as fast as one is able (Spreen & Strauss, 1998).
While Part B employs the same requirements, it differs in that it also utilizes letters as
well as numbers in alternating order. Scoring consists of calculating time in seconds
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taken to complete the measure from beginning to end and comparing the time to a
normative group (Spreen & Strauss).
Research has shown that the two parts of the TMT only correlate at a .49 level,
suggesting that the two assess somewhat different functions (Heilbronner et al., 1991).
Ehrenstein, Heister, and Cohen (as cited in Spreen & Strauss, 1998) showed construct
validity for the TMT by establishing positive correlation coefficients that ranged between
.36 and .93 with an object finding and hidden pattern test.
Other research has shown that the TMT can discriminate between psychiatric
patients and healthy controls. In a study by Warner et al. (1987), it was found that times
for all of the psychiatric patients in the study exceeded the lowest percentile norms of the
healthy controls. Furthermore, Part B is believed to be the more sensitive of the two
measures to general cortical dysfunction and has been utilized a great deal in research
investigating executive functioning (Spreen & Strauss, 1998). This has been a
consistently reliable finding since it was initially believed to be a measure that could
distinguish between brain impaired and non-impaired individuals (Reitan, 1955; Reitan &
Wolfson, 1993; Spreen & Strauss, 1998).
Tower o f London Drexel University: 2ndEdition (TOLDX). The Tower of London
is believed to be an instrument that can “get to the heart of planning disorders” (Lezak et
al., 2004). This test has been heralded as not only an excellent test of frontal lobe
damage, but also of attention and executive functions (Multi-Health Systems, Inc. 2005).
According to Culbertson and Zillmer (2005), the TOLI)X was “designed to assess higherorder problem solving-specifically, executive planning abilities-in children and adults”
(p. 1). They further noted that executive planning impairments are often implicated in
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both acquired and developmental disorders and, thus, may be of great importance to
understanding its etiology and advancing treatment.
The TOLdx consists of two rectangular boards with three pegs on each board
pointing upward from shortest to longest. Examinees are required to move around three
different colored beads that fit onto the previously mentioned pegs. In this task, the
examinee is told to match his/her board to the evaluator’s board. The test begins with the
evaluator asking the examinee to match the bead formation on his/her board to the
evaluator’s in as few moves as possible. After a demonstration problem is completed, the
evaluator informs the examinee of two rules that must be followed. The first rule is that
one can only place as many beads on a peg as the peg was intended to hold (e.g., one peg
is designed to hold one bead, while another can hold two, and the other can hold three).
The second rule is that only one bead can be off of a peg at one time. The evaluator
provides demonstrations of each rule and how it may be violated. Following this, two
practice problems are completed and then the ten test problems of ascending difficulty.
All bead formations are produced on the evaluator’s board and then the examinee is
asked to “now make one like this” on his/her board in as few moves as possible.
The TOLdx provides eight standard scores based on executive planning
performance: Total Moves, Total Correct, Total Rule Violation, Total Time Violation.
Total Initiation Time, Total Execution Time, Total Problem-Solving Time, and Total
Stimulus Bound (only used in populations age 60 years and over).
Normative data were compiled by Culbertson and Zillmer (2005) and represent a
moderate racially diverse sample. Culbertson et al. (2004) reported test-retest reliability
coefficients regarding the temporal stability of the TOLnx obtained from Parkinson’s
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disease patients. The Bivariate correlations revealed that scores were adequately stable
over time for Move Score (r = .80, p < .001); Correct Score (r = .48, p = .007), Time
Violation Score (r = .77,p < .001), Rule Violation Score (r = .37, p < .047), StimulusBound Score (r - .63,p < .001), Initiation Time Score (r = .74,/? < .001), Execution
Time Score (r = .83,/? < .001), and Total Problem Solving Time Score (r = .87,/? < .001).
The validity of the TOLDXhas been assessed through criterion related and construct
related methods and is considered to be a valid measure of executive planning
(Culbertson & Zillmer, 2005).
The Stroop Color and Word Test. The Stroop Color and Word Test (Stroop;
Golden & Freshwater, 2002) was first discussed in professional literature in the late
1800’s (Golden & Freshwater). However, it was not until 1935 that the Stroop began to
take the form of its present state. Its present form has been established through the work
of Charles Golden and is currently felt to test one’s ability to “... sort information from
his or her environment and to selectively react to this information” (2002, p. 2). Golden et
al. (2000) asserted that the Stroop is most frequently used to screen for brain damage,
more specifically frontal lobe damage. The most current form of the Stroop consists of a
three-page form consisting of 5 columns with 20 items in each column. The Word page
consists of the words RED, GREEN, and BLUE printed in black ink. The Color page
consists of XXXX symbols printed in red, green, or blue ink. The Color-Word page
consists of words from the Word page printed in red, green, or blue ink; however, no
words are printed in the color of the word itself (e.g., the word BLUE is never printed in
blue ink; Golden & Freshwater, 2002).
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The current accepted scoring method requires the examinee to complete as many
items as he/she can in 45 seconds (Golden & Freshwater, 2002). All scores are ultimately
converted into standardized /-scores. Original normative data was gathered by Golden
between 1974 and 1977 (Golden & Freshwater). Golden and Freshwater reported that
since the early collection of normative data, updated and expanded norming information
has been collected and implemented in the Stroop manual, which provides adjusted
scores based on one’s age and actual years of education. Reliability of the Stroop has also
been reported. Jensen (1965) reported reliabilities of .88, .79, and .71 for the three
subtests of the Stroop. Furthermore, Golden (1975) found reliabilities of .86, .82, and .73
for the three subtests. It is noteworthy that Raskin, Friedman, and DiMascio (1982)
investigated the Stroop in a sample of depressed individuals and found that there were
significant differences between depressed individuals and healthy controls with the
depressed individuals demonstrating lower scores on the Stroop.
Controlled Oral Word Association. The Controlled Oral Word Association test
(COWA; Spreen & Straus, 1998) evaluates one’s ability to spontaneously produce as
many words as one is able that begin with the letters F, A, and S. Golden et al. (2000)
asserted that one must have adequate mental flexibility and inhibition of verbal output
skills in order to perform successfully on the COWA. If one does not possess mental
flexibility, he/she will likely perseverate and repeat words or produce quite similar words
(Golden et al.). Additionally, if one is unable to inhibit certain responses one may either
produce socially inappropriate words or words that do not fit the category.
While no specific materials are needed, the COWA can be found in some current
neuropsychological batteries (Spreen & Strauss, 1998). Scoring of the COWA consists of
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summing all admissible words from the three letters. Spreen and Strauss asserted that
slang and foreign words that are part of Standard English are acceptable (e.g., faux pas.
lasagna; p. 448). While errors do not necessarily count against an individual in terms of
points, errors waste time and can also be reviewed for insight into potential disorders
(e.g., repetitions and intrusions can indicate potential perseveration and distraction
problems; Spreen & Strauss). Scores are then compared to normative data, which yields
percentile scores. Tombaugh. Kozak, and Rees (as cited in Spreen & Strauss) have
developed acceptable normative data for adults ranging between the ages of 16 and 95 as
well as for specific years of education based on age grouping from a sample of nearly 900
individuals from Ottawa, Ontario, Canada.
Inter-rater reliability estimates have been reported at .70 overall and .70, .60, and
.71 for F, A, and S, respectively (as cited in Spreen & Strauss, 1998). Spreen and
Strauss reported that concurrent validity has been widely established for the COWA
using the letters F, A, and S. Crockett (1977) found that the COWA related to many
abilities that are implicated in executive functions. For example, problem solving,
sequencing, resisting distraction, perseveration, and memory were each related to the
COWA.
Procedure
A number of medical and psychological/psychiatric clinics located in the upper
Midwestern United States were asked to participate in the current study by offering
patients/clients whom reported depressive symptoms a free depression evaluation through
participation in the current research study. Clinicians then referred patients/clients whom
expressed interest in the free depression evaluation to the principal investigator. The

91

principle investigator then contacted these individuals and scheduled evaluation
appointments that ranged in time from 60 minutes (primarily the non-medicated nondepressed participants) to 120 minutes. During the scheduling telephone phone calls,
potential participants were reminded that they were being asked to participate in a
research study and that the free depression evaluation would be completed regardless of
their decision to participate or not participate in the current research study. They were
also informed that while both the participant and the referring source would receive a
letter reporting the findings of the depression evaluation as well as treatment
recommendations, they would not receive any information regarding their performance
on the tests of group equivalence or executive functioning.
Individuals in the non-medicated non-depressed comparison group were recruited
by going into various undergraduate and graduate classes at a mid-sized university in the
upper Midwestern United States and asking for volunteers. This group’s participants were
offered a $5 gift certificate to a local sandwich or coffee shop as compensation for their
participation. It was decided that this group could be given a gift certificate as incentive
to participate as the two depressed groups were receiving a free depression evaluation.
All participants were evaluated in a well lit, climate controlled room with
appropriate testing supplies (e.g., adequately sized table, chairs, etc.). At the beginning of
the testing sessions, all participants were provided with an informed consent statement to
read and sign. All participants were administered the BDI-II (Beck et al., 1996) and the
SCID-I (First et al., 1997) to establish the presence of depressive symptoms in the
depressed groups and the absence of depressive symptoms in the non-depressed group.
Beck et al. (1996) recommend that certain score cutoffs be used to differentiate between
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depressed and non-depressed individuals. They noted that their research has shown that a
cut score of 17 yielded a 93% true-positive rate while only experiencing an 18% false
positive rate for major depression (Beck et al.). Thus, based on Beck et al.’s assertions,
this study employed a cut score of 17 on the BDI-II for inclusion into both of the
depressed groups (medicated & non-medicated). Using the BDI, Channon (1996) secured
a sample of depressed individuals for his research of executive functions and depression.
In his study, a cut score of 5 or below was used as inclusion criteria for the healthy
control group. Based on Beck et al.’s (1996) raw score conversion chart, a score of 5 on
the BDI-A equates to a score of 6 on the BDI-II. Therefore, a cut score of 6 or below was
employed in the current study as inclusion criteria for the non-depressed group.
Following this, each participant completed the demographic questionnaire and the
Current Symptoms Scale—Self-Report Form to rule out ADHD symptoms. To establish
group equivalence, participants then completed the SCL-90-R and the Vocabulary subtest
of the WAIS-III. Participants were then administered the tests of executive function in the
following order, WCST, TMT Part A and B, TOLDX, Stroop, and the COWA. There was
no particular reason for the order of tests.
After the completion of all measures, participants from the depressed groups were
briefed regarding the information obtained from the depression evaluation. Information
was explained and participants were allowed to ask questions regarding their depression
evaluation. After all questions were answered, the participants were thanked for their
time and asked to scribe their name on an envelope in order to send the short report
regarding their depression evaluation. This served to maintain the highest level of
confidentiality as they could address the envelope to wherever they desired and have it be
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in their writing. Non-depressed participants were provided their gift certificate at the end
of testing and also thanked for their participation.
Data Analyses
All analyses were completed using SPSS Version 13.0. During the initial stages of
data analyses, two-tailed bivariate correlations were completed in order to analyze the
numerous variables to ascertain any correlations that would help decipher which later
analyses would be completed. Two noteworthy trends were revealed from this action.
First, the Vocabulary subtest of the WAIS-III (Wechsler, 1997) significantly correlated
with a large proportion of the other variables. Such correlation suggested that Vocabulary
scores be used as a covariate in the later analyses. The second noteworthy trend was that
the sub-scores of each of the executive function measures were intercorrelated (e.g. the
sub-scores of the WCST correlated with each other at a statistically significant level).
Preliminary analyses employed an analysis of variance (ANOVA) on participant age, the
Vocabulary subtest of the WAIS-III (Wechsler), yearly household income, and years of
education completed as well as a multivariate analysis of covariance (MANCOVA), with
age and vocabulary score of WAIS-III serving as covariates, on the SCL-90-R. Based on
this information, it was decided that multivariate analyses of covariance would be
completed for the main analyses.
The main analyses consisted of completing MANCOVAs on the various scores
obtained on the tests of executive functioning with participant age and the Vocabulary
subtest of the WAIS-III as covariates. This served to remove the influence of estimated
level of intelligence and age from the comparison of groups on the factor of performance
on tests of executive functioning. The main area of interest in the current study lies at the
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Post-Hoc Pairwise Comparison level as this allows for identification of specific
differences between the medicated depressed, non-medicated depressed, and nonmedicated non-depressed groups.
A multiple linear regression was also completed as a post-hoc analysis in order to
explore any potential differences that depression and anxiety may have upon executive
function test performance. Using the BDI-II (Beck et al., 1996) and the Anxiety subscale
of the SCL-90-R (Derogatis, 1994), regression analyses were completed in order to
ascertain whether or not anxiety added any predictive ability to how well or poorly one
would perform on tests of executive function over depression (as measured by the BD1-I1
[Beck et al., 1996]) alone.
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CHAPTER IV
RESULTS
The results of the current study are presented in this chapter in three sections. The
first section reports the results of preliminary analyses. The second section reports the
results of the main analyses regarding the main hypotheses of the study and the final
section reports the results of post hoc analyses.
Preliminary Analyses
A correlation matrix was constructed in order to visually analyze any trends in the
data that necessitated certain statistical procedures in the main analyses. High Pearson
correlations (e.g., .65 or higher and -.65 or lower) between variables were identified and
evaluated to determine the necessity of using Multivariate Analyses of Variance
(MANOVA) in the main analyses. Furthermore, the three groups (medicated depressed,
non-medicated depressed, & non-medicated non-depressed) were analyzed in terms of
their group equivalence on the Vocabulary section of the WAIS-III (Wechsler, 1997;
estimated level of intelligence) and the Symptom Checklist-90-Revised (SCL-90-R;
estimated level of psychological well-being).
According to Pagano (2001), “Pearson r is a measure of the extent to which
paired scores occupy the same or opposite positions within their own distributions” (p.
109). A visual search of correlations revealed several significant relationships, both
positive and negative. Several of the 48 variables looked at throughout the following
analyses reached statistical significance and were highly correlated (r > .65 or r < -.65).
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See Table 2 for a full list of correlations between the measures of executive functioning
and Table 3 for correlations between the measures of executive functioning and measures
of affective group equivalence.
Several of the variables were expected to covary to some degree. For example, the
SCL-90-R is a measure of psychological well-being and covers psychological distress on
a variety of continuums. Therefore, Depression, Anxiety, Phobic Anxiety, Interpersonal
Sensitivity, etc., would be expected to covary as one who scores higher on Depression
would presumably score higher on Interpersonal Sensitivity as they share similar
characteristics. Furthermore, the BDI-II (Beck et al., 1996) was expected to covary with
subscales of the SCL-90-R for the same reasons, especially the depression subscale.
Others, however, were expected to have low or no correlations, as this would suggest that
the test was measuring separate constructs as evidenced by a lower correlation
coefficient.
The subscales of the five measures of the executive functions were not expected
to covary with the subscales of the other tests. However, some subscales were expected to
covary with subscales within the same test. For example, analyses revealed several
correlations between the subscales within the Wisconsin Card Sorting Test (WCST;
Heaton et al., 1993).
Higher correlations would be expected between subscales that were affected by
the same event. For example, the Trials Administered subscale correlated highly with the
Total Errors (r = .90), Perseverative Responses (r = .87), Perseverative Errors (r = .87),
Nonperseverative Errors (r = .86), and Failure to Maintain Set (r = .69) subscales. This
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Table 2. Pearson Correlations (r) of Executive Function Measures.
1
1
2
3
4
5
6
7
8
9
10
11
12
13

14
15
16
17
18
19
20
21
22
23

24
25

.51
.86
.87
.87
.86
-.06
-.71
.47
.69
-.20
.27
.50
-.04
-.35
-.29
-.45
-.28
-.34
.34
.06
.30
.30
.21
.06

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

—
.94
.95
.97
-.49
-.89
.72
.44
-.27
.15
.57
-.00
-.19
-.27
-.43
-.27
-.30
.30
.10
.36
.37
.19

—
.99
.84
-.39
-.84
.59
.44
-.36
.21
.46
-.06
-.24
-.29
-.44
-.30
-.25
.22
.10
.27
.29
.14

—
.85
-.41
-.85
.64
.44
-.33
.20
.48
-.05
-.22
-.29
-.43
-.29
-.27
.24
.09
.27
.28
.13

—
-.51
-.87
.73
.41
-.20
.11
.57
.03
-.15
-.25
-.40
-.24
-.30
.33
.10
.40
.41
.23

—
.63
-.68
.35
.23
.17
-.27
-.02
-.22
.06
.08
.04
-.04
.03
-.15
-.22
-.27
-.10

—
-.79
-.42
.21
-.02
-.59
.04
.11
.32
.38
.21
-.27
-.26
-.05
-.32
-.32
-.17

—
.14
.10
-.01
.58
.13
.06
-.22
-.29
-.21
-.28
.23
-.03
.35
.31
.03

—
.05
.24
.36
-.05
-.39
-.35
-.36
-.17
-.43
.45
-.06
.24
.18
.19

—
-.05
.04
.03
.18
.05
-.05
-.12
-.16
.15
-.32
.14
-.03
-.11

—
.31
-.16
-.28
-.29
-.20
-.07
-.14
.11
.26
.13
.23
.19

—
-.16
-.33
-.43
-.49
-.21
-.32
.30
.18
.50
.53
.30

—
.38
.17
.33
.24
-.03
.05
-.11
-.29
-.28
-.36

—
.67
.49
.09
.04
-.08
-.33
-.15
-.28
-.28

—
.48
.01
.33
-.30
-.09
-.15
-.20
-.12

—
.84
.05
-.11
-.16
-.22
-.26
-.10

—
-.13
.08
-.05
-.06
-.04
.08

.10

-.00

-.00

.17

-.06

-.06

.07

.14

.11

.10

.16

.11

.04

-.09

-.09

.04

19

20

21

—
-.88 —
.37 -.23
-.56 .62
-.36 .47
-.15 .27

—
.03
.48
.48

22

23

24

_

.07
.14
.12
.03
.81
.13
-.33
.70
.05
.30
.05
-.09
-.43
-.13
-.18
-.09
-.17
.18
-.05
-.02
-.04
.09
-.05

WCST
3 Total Errors
1 Trials Ad.
4 Persev. Resp.
2 Total Correct 5 Persev. Error

6 Nonpersev. Er.
9 Trials to l sl
12TMTPartA
7 Concept. Level Res. 10 Fail Maintain Set 13TMTPartB
8 Cat. Complete
11 Learn to Learn
14COWA

15 Stroop Word
16 Stroop Color
17 Stroop C-W

-.30

18 Stroop Inter.
TOLDX
19 Tot. Correct

.40

-.13

—
.88 —
.69 .83 —
.25 .21 .05

20 Tot. Move
21Tot.ini.
22 Tot. Execut.

23 Tot. Time
24 Time Violat.
25 Rule Violat.

Table 3. Pearson Correlations (r ) between Measures of Executive Functioning and Measures of
Affective Group Equivalence.
BDI-I1

SCL-90-R Dep
.49
.33
.40
.46
.43
.35
.06
-.32
.23
.42
-.01
.44
.36
-.24
-.44
-.51
-.36
-.14
-.28
.16
.09
.25
.27
.16
.09

W CST Trials Administered
.45
W CST Total Correct
.33
W CST Total Errors
.35
W CST Perseverative Response
.36
W CST Perseverative Error
.35
WCST Nonperseverative Error
.32
W CST Conceptual Level Response .09
W CST Cat. Complete
-.31
W CST Trials to 1st
.25
W CST Fail Maintain Set
.43
W CST Learn to Learn
.09
TM T Part A
.42
TM T Part B
.45
COWA
-.22
Stroop Word
-.41
Stroop Color
-.55
Stroop Color-Word
-.42
Stroop Interference
-.17
TO L dx Total Correct
-.33
TO L dx Total Move
.25
TO LDX Total Initiation
.06
TO L dx Total Execution
.25
TO L dx Total Time
.27
TO LDX Time Violation
.13
TO L dx Rule Violation
.11

SCL-90-R Anx

SCL-90-R GSI

.49
.27
.43
.47
.47
.37
-.03
-.42
.35
.41
-.11
.42
.48
-.26
-.53
-.64
-.34
-.05
-.30
.21
.22
.29
.36
.29
-.10

.55
.35
.46
.48
.48
.41
.03
-.44
.30
.52
-.01
.42
.48
-.25
-.50
-.65
-.37
-.05
-.35
.28
.12
.31
.34
.26
.01

Dep = Depression; Anx = Anxiety; GSI = Global Severity Index

makes conceptual sense, as one would have the opportunity to attempt more trials as one
makes more errors. Additionally, the more errors and trials one attempts, the less likely
one is to maintain a steady action (i.e., maintain a set). Moreover, as this is happening,
one is not going to be completing as many categories due to the fact that the individual
does not comprehend the task. Thus, there was a high inverse correlation between the
Trials Administered subscale and the Categories Completed subscale (r = -.71).
Similarly, there were high correlations between the Total Errors subscale and the
Perseverative Responses (r = .94), Perseverative Errors (r = .95), Nonperseverative
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Errors (r = .97), and Trial to Complete 1st Category (r = .72) subscales. Just the same, an
inverse correlation was revealed between the Total Errors subscale and the Categories
Completed (r = - .89) subscale. In this same vein, high correlations were revealed
between the Perseverative Responses subscale and the Perseverative Errors (r = .99) and
Nonperseverative Errors (r = .84) subscales; as was an inverse correlation between the
Perseverative Responses subscale and Categories Completed (r = -.84) subscale.
Analyses also revealed high correlations between the Perseverative Errors and
Nonperseverative Errors (r = .85) subscales and an inverse relationship between the
Perseverative Errors and Categories Completed (r = -.85) subscales. The
Nonperseverative Errors subscale was inversely related to the Categories Completed (r =
-.87) and Trials to Complete 1st Category (r = -.68) subscales, respectively. Lastly, the
Categories Completed and Trials to Complete First Category were inversely related (r = .79). As one would expect, the more trials it takes to complete the first trial the less likely
it becomes that the individual will complete a higher number of categories.
The Stroop Color and Word test (Golden & Freshwater, 2002) revealed one
expected correlation between the Color-Word and Interference subscales (r = .84). This is
an expected correlation due to the fact that the Interference score is primarily based upon
the Color-Word subscale. The requirement of the Color-Word task is to state the color of
ink the word is printed in, ignoring the word that is spelled out. This is difficult to do, as
it requires one to inhibit reading the word. Thus, the more difficulty one has with the
Color-Word task, the higher one’s Interference score will be.
The TOLdx (Culbertson & Zillmer, 2005) revealed similar correlations. High
positive correlations were found between the Total Execution Time and Total Time
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(,r - .88) and Time Violation (r = .69) subscales. This makes conceptual sense in that the
total time of the task from start to finish is impacted a great deal by the time it takes one
to execute the task. Furthermore, individuals who violate rules are told of their violation
and required to undo the violation and begin from the point at which they violated the
rule. Thus, this takes a good deal of time resulting in increased total times and increased
execution times for anyone who violates a rule.
A relationship was revealed between the TOLux Total Time and Time Violation
(r = .83) subscales. Again, this is conceptually appropriate, as an individual would have
an increased total time if he/she were not completing the tasks in less than 60 seconds
(the amount of time one has to complete the task before one obtains a Time Violation).
Also, the Total Correct and Total Move scores were inversely related (r = -.88) as the two
represent opposite ends of a continuum of success. One would not be able to do well in
terms of Total Correct score if he/she were also obtaining high scores on the Total Moves
subscale as the more moves one makes the less likely it is that the individual will
complete the task in the least amount of moves possible. Therefore, while several
variables correlated highly with others, none appeared to impact the current study in a
way that would render any of the measures obsolete or indicate that any measure was
measuring similar entities.
Four one-way analyses of variance (ANOVAs) were completed in order to
evaluate the relationship between participant age, estimated level of intelligence (i.e., the
raw Vocabulary subtest scores of the WAIS-III), yearly household income, and years of
education completed and group membership. The independent variable in each analysis
was group membership (i.e., medicated depressed, non-medicated depressed, and non-
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medicated non-depressed) while the dependent variable was participant age, Vocabulary
subtest raw scores of the WAIS-III, yearly household income, and years of education
completed. ANOVAs were statistically significant for participant age,
F(2, 50) = 5.5, p = .007, partial if = .18 and Vocabulary subtest raw scores of the WAISIII, F(2, 50) = 6.1, p = .004, partial if = .20 indicating that there are statistically
significant differences between the groups regarding participant age and estimated level
of intelligence. However, these ANOVAs also revealed nonsignificant results for yearly
household income, F(2, 50) = 0.3, p = .761, partial if = .01 and years of education
completed, F(2, 50) = 1.9,/? = .157, partial r|2 = .07.
Follow-up tests were conducted to evaluate pairwise differences among the means
using the Tukey Honestly Significant Differences test (Tukey HSD). In regards to
participant age, statistically significant differences were found between the medicated
depressed (M - 31.6, SD = 6.9) group and both the non-medicated depressed (M= 24.8,
SD = 5.1;/? = .01) and the non-medicated non-depressed (M= 25.9, SD = 6.4; p = .02)
groups. The difference between the non-medicated depressed and non-medicated nondepressed groups failed to reach statistical significance (/? = .85).
Post-hoc analyses of the Vocabulary subtest of the WAIS-III revealed statistically
significant differences between the medicated depressed (M= 39.60, SD = 11.10) and
both the non-medicated depressed (M —40.56, SD = 9.07, p = .02) and non-medicated
non-depressed groups (M= 48.55, SD = 6.31,/? = .01), while there was not a statistically
significant difference between the two depressed groups (/? = .95). Overall, the nonmedicated non-depressed group showed higher levels of intelligence than the other two
groups at a statistically significant level. Based on the information provided by the
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analyses of the participant’s age and the Vocabulary subtest of the WAIS-III, participant
age and the Vocabulary variables were used as covariates in the remaining analyses.
In the second hypothesis of the preliminary analyses, it was hypothesized that the
two depressed groups (medicated depressed & non-medicated depressed) would differ
significantly from the non-medicated non-depressed group on a measure of psychological
well-being as measured by the SCL-90-R. Specifically, differences were expected
between the two depressed groups and the non-medicated non-depressed group on the
depression subscale of the SCL-90-R. Based on the obtained correlations (described
previously) and the observation by Derogatis (1994) that the Global Severity Index (GS1)
“represents the best single indicator of the current level or depth of the disorder, and
should be utilized in most instances where a single summary measure is required” (p. 11),
the GSI was used to assess overall group differences related to overall psychological
well-being.
A one-way univariate analyses of covariance (ANCOVA), with participant age
and WAIS-III Vocabulary subtest scores serving as covariates, was carried out to
determine if significant differences were present on the GSI based on group membership
(depressed or not). Additionally, this analysis was completed in order to lend support to
the hypothesis that the two depressed groups would not differ from one another in terms
of overall psychological well-being as measured by the GSI of the SCL-90-R.
A preliminary analysis evaluating the homogeneity-of-slopes assumption
indicated that the relationship between the covariates (participant age and Vocabulary
score) and the dependent variable (GSI) did not differ significantly as a function of the
independent variable (group membership), F(3, 45), MSE = 0.18,/? = .05, partial if = .16.
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The ANCOVA was significant, F(2, 48), MSE = 0.20, p < .001. The strength of the
relationship between the group membership factor and GSI was very strong as assessed
by a partial if (traditionally a partial if [effect size] of .01 is small, .06 is medium, and .14
is large; Green, Salkind, & Akey, 1999), with the group membership factor accounting
for 43% of the variance on the dependent variable, holding constant the GSI score.
The mean GSI score, adjusting for initial differences, were ordered as expected
across the three groups. Adjusted means resulted in small changes in the three groups
(medicated depressed; M - 1.24, SE= 0.13; non-medicated depressed; M = 0.91, SE =
0.12; & non-medicated non-depressed; M = 0.26, SE= 0.10). Follow-up tests were
conducted to evaluate pairwise differences among these adjusted means. The Holm’s
sequential Bonferroni procedure was used to control for Type I errors across the three
pairwise comparisons. There were significant differences in the adjusted means between
the non-medicated non-depressed group and both depressed groups (medicated
depressed,/! < .001; non-medicated depressed,/? < .001). However, there was not a
statistically significant difference found between the two depressed groups on the GSI (p
= .208).
Based on the correlations previously described, a one-way Multivariate Analysis
of Covariance (MANCOVA), with participant age and WAIS-III Vocabulary subtest
score serving as covariates, was carried out to determine the effect of group membership
on the SCL-90-R subscales. Significant differences were found among the three groups
on the dependent variables of the SCL-90-R, Wilkes’ A = 0.149, F(24, 74) = 4.898,/? <
.001. partial if = .61. The strength of the relationship between group membership and
scores on the SCL-90-R was quite strong (i.e., roughly 60% of the effect is attributable to
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group membership) as assessed by the partial r\2. Table 4 contains raw score means,
standard deviations, estimated marginal means, and standard errors for the dependant
variables and ANCOVA results for the three groups.
Analyses of covariance (ANCOVAs) were conducted on each dependent variable
as follow-up tests to the MANCOVA. A more conservative alpha (.01) was incorporated
in order to control for experimentwise error, thus reducing the chance of Type I error. All
but two (Phobic Anxiety and Hostility) of the dependent variable F statistics were
significant. Table 4 contains the ANCOVA results (F statistics & partial rps) as well as
means, standard deviations, estimated marginal means, and standard errors for all SCL90-R subscales across the three groups (medicated depressed, non-medicated depressed,
non-medicated non-depressed).
Post hoc pairwise analyses to the ANCOVAs were completed for the SCL-90-R
subscales at the .01 level. While the majority of the subscales revealed statistically
significant differences between the two depressed groups and the non-medicated nondepressed group, the Interpersonal Sensitivity (non-medicated depressed, p = .05),
Anxiety (non-medicated depressed, p = .16), Phobic Anxiety (medicated depressed, p =
.02; non-medicated depressed,/? = 1.0), Hostility (medicated depressed,p = .02; nonmedicated depressed,/? = .11), and Paranoid (non-medicated depressed,/? = .13)
subscales failed to reach statistical significance. As hypothesized, there were no
statistically significant differences on the subscales between the medicated depressed
group and the non-medicated depressed group.
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Table 4. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM), Standard Errors (SE), and ANCOVA results for
SCL-90-R.

Medicated
Depressed
n = 15

M

SD

(EMM) (SE)
SCL-90-R
Depression

On

M

SD

(EMM) (SE)

All Groups3
ANCOVA
N = 53

Non-Medicated
Non-Depressed
n = 22

M

SD

F

Partial if

(EMM) (SE)

1.97
0.80
(1.82) (0.18)

1.78
0.88
(1.72) (0.17)

0.18
0.25
(0.32) (0.14)

27.48**

.54

1.05
0.70
(0.90) (0.17)

0.86
1.00
(1.02) (0.16)

0.30
0.24
(0.33) (0.14)

5.71*

.19

Psychoticism

0.60
0.91
(0.89) (0.12)

0.63
0.47
(0.55) (0.10)

0.02
0.05
(0.01) (0.09)

15.29**

.40

Interpersonal Sensitivity

1.64 0.84
(1.60) (0.19)

0.92
0.71
(0.88) (0.18)

0.22
0.50
(0.27) (0.16)

13.33**

.36

Anxiety

1.15
0.81
(1.03) (0.15)

0.72
0.73
(0.65) (0.14)

0.12
0.17
(0.26) (0.13)

6.89*

.22

Obsessive-Compulsive

1.75
0.89
(1.63) (0.18)

1.16
0.71
(1.13) (0.17)

0.40
0.29
(0.39) (0.15)

13.27*

.36

Phobic Anxiety

0.64 0.54
(0.54) (0.10)

0.46
0.23
(0.16) (0.10)

0.02
0.05
(0-14) (0.09)

4.64

.16

Hostility

0.82 0.64
(0.77) (0.143)

0.61
0.63
(0.61) (0.13)

0.19
0.18
(0.22) (O.H)

4.79

.17

Somatization
o

Non-Medicated
Depressed
n = 16

. .

Table 4 (cont.). Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM), Standard Errors (SE), and ANCOVA results for
SCL-90-R.

Medicated
Depressed
n = 15
M

SD

(EMM) (SE)
SCL-90-R
Paranoid Ideation

Non-Medicated
Depressed
n = 16
M

SD

(EMM) (SE)

All Groups3
ANCOVA
N = 53

Non-Medicated
Non-Depressed
n = 22
M

SD

F

P a rtia l if

(EMM) (SE)

1.05
0.8
(1.08) (0.16)

0.70
0.67
(0.61) (0.15)

0.13
0.28
(0.18) (0.13)

8.47*

.26

Global Severity Index

0.62
1.32
(1.24) (0.13)

0.95
0.55
(0.91) (0.12)

0.17
0.21
(0.26) (0.10)

18.21**

.43

Positive Symptom Distress Index

0.58
2.13
(2.03) (0.15)

2.06
0.64
(2.08) (0.14)

1.112 0.37
(1.17) (0.12)

15.17**

.39

54.07 14.96
(52.56) (3.87)

39.81 16.29
(38.13) (3.63)

11.82 11.64
(14.07) (3.14)

28.88**

.55

Positive Symptom Total

'All degrees of freedom = 2, 48, *p < .01, **p < .001.

Main Analyses
The main hypotheses of this study were that differences in performance would be
found between the medicated depressed, non-medicated depressed, and non-medicated
non-depressed groups (independent variables) on five measures of executive functioning
(dependant variables; WCST, TMT A & B, TOLnx, Stroop, & COWA), and primarily at
the group Pairwise Comparison level. The following text reviews the results of those
analyses.
Hypothesis I
To test the first hypothesis that differences would be found between the medicated
depressed, non-medicated depressed, and non-medicated non-depressed groups on the
WCST, a MANCOVA was performed using the eleven subscales of Wisconsin Card
Sorting Test (WCST) as the dependent variables, participant age and WAIS-III
Vocabulary scores as the covariates, and group membership as the independent variables.
The overall MANCOVA was not significant, Wilkes’ A = .54, F( 18, 80) = 1.61, p = .078,
partial rp= .27. However, the strength of the relationship between group membership and
scores on the WCST was quite strong as assessed by the partial if.
Despite the non-significant omnibus test, specific analyses (ANCOVAs) were
performed on each subscale of the WCST (Trials Administered, Total Correct, Total
Errors, Perseverative Responses, Perseverative Errors, Nonperseverative Errors,
Conceptual Level Response, Categories Completed, Trials to Complete 1st Category,
Failure to Maintain Set, & Learning to Learn) as follow-up tests to the MANCOVA.
Each ANCOVA was tested at the .05 level and of the eleven subscales only two revealed
statistically significant differences, the Trials Administered, F(2, 48) = 3.74,p = .031,
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partial rj2= .135 and the Failure to Maintain Set, F(2, 48) = 3.30,p = .045, partial rj2=
. 121.

Post hoc pairwise analyses to the ANCOVAs (with participant age and WAIS-III
Vocabulary scores serving as the covariates) for the Trials Administered and Failure to
Maintain Set subscales of the WCST were performed using a Bonferroni correction with
a .005 significance level in order to control for Type I error. No group comparisons
reached statistical significance. Full ANCOVA results are presented in Table 5
comparing the three groups on the various subscales of the WCST as well as the raw
score means and standard deviations.
Hypothesis II
To test the second hypothesis that differences would be found between the
medicated depressed, non-medicated depressed, and non-medicated non-depressed
groups on the Trail Making Test (TMT) parts A and B (Reitan, 1993), a MANCOVA was
performed using the TMT parts A and B as the dependent variables, participant age and
WAIS-III Vocabulary scores as the covariates, and group membership as the independent
variables. The overall MANCOVA was not significant, Wilkes’ A = .826, F(4, 94) =
2.3514 ,p = .060, partial r|2= .091. The strength of the relationship between group
membership and scores on the TMT was fairly strong as assessed by the partial r|2.
ANCOVAs were also performed as follow-up tests to the MANCOVA. Each
ANCOVA was tested at the .05 level. The ANCOVA for TMT Part B was statistically
significant, F(2, 48) = 4.45, p = .017, partial r|2= .156, while the ANCOVA on TMT Part
A was not, F(2, 48) = 0.75, p = .479, partial rf= .030.
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Table 5. Raw Score Means, Standard Deviations, Estimated Marginal Means, Standard Errors, and ANCOVA results for Wisconsin Card
Sorting Test (WCST).

Medicated
Depressed
n = 15
M

SD

Non-Medicated
Depressed
n = 16
M

SD

Non-Medicated
Non-Depressed
n = 22
M

SD

All Groups3
ANCOVA
N = 53
F

P a rtia l tf

(EMM) (SE)

(EMM) (SE)

(EMM) (SE)

102.67 23.92
(100.13) (5.75)

103.06 24.32
(103.10) (5.39)

82.82 13.44
(84.52) (4.67)

3.740*

0.135

Total Correct

75.33 14.22
(75.06) (2.75)

71.19
9.57
(70.71) (2.76)

67.73
4.62
(68.27) (2.23)

1.680

0.065

Total Errors

27.33 20.50
(25.08) (5.12)

31.88 22.60
(32.39) (4.79)

15.09 11.55
(16.25) (4.16)

3.104

0.115

Perseverative Responses

14.27
9.77
(13.10) (2.64)

16.19 11.63
(16.65) (2.47)

8.05
6.84
(8.51) (2.14)

2.986

0.111

Perseverative Errors

8.89
12.87
(12.01) (2.25)

14.44
9.70
(14.78) (2.11)

7.68
5.45
(8.01) (1.83)

2.854

0.106

Nonperseverative Errors

14.47 12.70
(13.07) (3.10)

17.44 13.95
(17.61) (2.90)

7.41
6.29
(8.24) (2.52)

2.838

0.106

Conceptual Level Response

67.27 16.26
(67.62) (3.26)

63.81 12.13
(63.17) (3.06)

64.86
5.51
(65.10) (2.65)

0.476

0.019

WCST
Trials Administered

Table 5 (cont.). Raw Score Means, Standard Deviations, Estimated Marginal Means, Standard Errors, and ANCOVA results for Wisconsin
Card Sorting Test (WCST).

Medicated
Depressed
n = 15
M

SD

(EMM! (SE1
WCST
Categories Completed

Non-Medicated
Depressed
n = 16
M

SD

(EMM! (SE1

All Groups3
ANCOVA
N = 53

Non-Medicated
Non-Depressed
n = 22
M

SD

F

P a rtia l rf

(EMM! (SE1

4.93
1.94
(5.09) (0.44)

4.69
1.99
(4.69) (0.41)

5.86 0.64
(5.76) (0.36)

1.849

0.072

Trials to Complete 1st Category

25.40 21.72
(26.01) (6.65)

24.19 29.16
(24.01) (6.23)

11.86
2.25
(11.53) (5.40)

1.678

0.065

Failure to Maintain Set

1.40
1.50
(1.35) (0.32)

1.19
1.28
(1.18) (0.30)

0.32
0.48
(0.36) (0.26)

3.303*

0.121

Learning to Learn

0.166 1.78
(0.86) (1.18)

-0.27
3.11
(-0.56) (1.11)

-1.35
5.78
(-1.60) (0.96)

1.193

0.047

A ll degrees of freedom = 2,48 , *p < .05.

Post hoc pairwise analyses to the ANCOVAs (with participant age and the WAISIII Vocabulary scores serving as covariates) for the TMT parts A and B were performed
using the Bonferroni correction with a .025 significance level in order to control for Type
I errors. While significant differences were found between the medicated depressed
(Seconds to completion; M= 71.6; SD = 24.2) and non-medicated non-depressed
(Seconds to completion; M= 44.3; SD = 10.0) groups on TMT part B (p = .017), no other
comparisons reached statistical significance. Full ANCOVA results are presented in
Table 6 comparing the three groups on the various subscales of the TMT parts A and B as
well as the raw score means, standard deviations, estimated marginal means (EMM),
standard error of estimates (SEE), and ANCOVA results.
Table 6. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM), Standard
Error of Estimates (SEE), and ANCOVA results for Trail Making Test, Part A & B.

Group

Trail Making Test3
Part A
Part B

Statistic

Medicated
Depressed
(n = 15)

M
SD

Non-Medicated
Depressed
(n = 16)

M
SD

Non-Medicated
Non-Depressed
(n = 22)

M
SD

All Groups3
ANCOVA
(N = 53)

F
df
P a rtia l rf

EMM
SEE

EMM
SEE

EMM
SEE

27.80
7.21
25.57
2.04

71.60
24.20
66.40
5.04

25.06
9.26
25.74
1.92

56.88
22.29
58.59
4.72

21.86
6.69
22.90
1.66

44.323
9.97
46.62
4.10

0.748
2,48
0.030

aAll degrees of freedom = 2, 48 , *p < .05.

112

4.445*
2,48
0.156

Hypothesis III
To test the third hypothesis that differences would be found between the
medicated depressed, non-medicated depressed, and non-medicated non-depressed
groups on the Tower of London: Drexel Edition (TOL1)X; Culbertson & Zillmer, 2005), a
MANCOVA was performed using the five subscales of TOLDXas the dependent
variables, participant age and WAIS-III Vocabulary scores as the covariates, and group
membership as the independent variables. The overall MANCOVA was not significant,
Wilkes’ A = .813, F(10, 88) = .960, p - .483, partial r|2= .098. The effect of group
membership on scores of the TOLDXwas fairly strong as assessed by the partial if.
ANCOVAs, with participant age and the WAIS-III Vocabulary scores serving as
covariates, were performed on each subscale of the TOLDX(Total Correct, Total Move
Score, Total Time, Time Violation, & Rule Violation) as follow-up tests to the
MANCOVA. Each ANCOVA was tested at the .05 level. Of the five subscales tested,
none revealed statistically significant differences. Full ANCOVA results are presented in
Table 7 comparing the three groups on the five subscales of the TOLDXas well as the raw
score means and standard deviations.
Table 7. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM), Standard
Error of Estimates (SEE), and ANCOVA results for Tower of London-Drexel University Test
(TOLdx).

Group

Medicated
Depressed
(n = 15)

Statistic

M
SD

EMM
SEE

Total
Correct

Total
Move
Score

Total
Time
(sec.)

3.87
2.95
3.96
0.67

34.00
20.92
33.64
4.90

315.27
139.78
301.68
29.43
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Total
Rule
Violation
Time
Violation
1.07
1.44
0.93
0.30

0.27
0.60
0.20
0.15

Table 7 cont. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM),
Standard Error of Estimates (SEE), and ANCOVA results for Tower of London-Drexel
University Test (TOLDX).

Group

Statistic

Total
Move
Score

Total
Time
(sec.)

5.06
2.62
5.55
0.62

26.38
19.52
23.68
4.59

266.69
106.54
268.14
27.57

0.50
0.82
0.50
0.28

0.38
0.62
0.42
0.14

22.73
13.82
24.94
3.98

242.23
68.50
250.44
23.91

0.60
0.85
0.68
0.24

0.23
0.43
0.25
0.12

0.551
2, 48
0.02

0.623
2,48
0.03

Non-Medicated
Depressed
(n = 16)

M
SD

Non-Medicated
Non-Depressed
(n = 22)

M
SD

EMM
SEE

5.77
2.02
5.36
0.54

All Groups3
ANCOVA
(N = 53)

F
df
P a rtia l rf

1.728
2, 48
0.07

EMM
SEE

Total
Rule
Violation
Time
Violation

Total
Correct

1.237
2, 48
0.05

0.836
2, 48
0.03

Hypothesis IV
To test the fourth hypothesis that differences would be found between the
medicated depressed, non-medicated depressed, and non-medicated non-depressed
groups on the Stroop Color and Word Test (Golden & Freshwater, 2002), a MANCOVA
was performed using the four subscores of the Stroop as the dependent variables,
participant age and WAIS-III Vocabulary scores as the covariates, and group membership
as the independent variables. The overall MANCOVA was significant, Wilkes’ A = .645,
F(8 , 90) = 2.76, p = .009, partial i f = .197. The strength of the relationship between group
membership and scores on the Stroop was quite strong as assessed by the partial if.
Analyses of covariance (ANCOVA) were performed on each subscale of the
Stroop (Word, Color, Color-Word, & Interference) as follow-up tests to the MANCOVA.
Each ANCOVA was tested at the .05 level and all four of the analyses revealed
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statistically significant results; Word raw scores, F(2, 48) = 3.23,p = .048, partial rp =
.119; Color raw score, F(2, 48) = 5.72, p

=

.006, partial y)2= .192; Color-Word raw score,

F(2, 48) = 6.72, p = .003, partial if = .219; and Interference raw score, F(2, 48) = 4.06, p
= .024, partial if = .145, respectively.
Post hoc pairwise analyses to the ANCOVAs (with the participant age and WAISIII Vocabulary scores serving as covariates) for the four Stroop subscales were performed
using the Bonferroni correction with a .013 significance level in order to control for Type
I errors. Significant differences were found on the Color raw score subscale between the
non-medicated non-depressed group (M= 82.05, SD = 11.34) and the medicated
depressed group (M= 67.47, SD = 9.83; p = .005) and the Color-Word raw score
subscale between the non-medicated non-depressed group (M= 52.10, SD = 13.66) and
the non-medicated depressed group (M= 40.63, SD = 10.38; p = .004). No other group
comparisons reached statistical significance. Full ANCOVA results are presented in
Table 8 comparing the three groups on the subscores of the Stroop as well as the raw
score means and standard deviations.
Table 8. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM),
Standard Error of Estimates (SEE), and ANCOVA results for Stroop Color-Word Test.
Group
Medicated
Depressed
(n = 15)

Non-Medicated
Depressed
(n = 16)

Statistic

Word

Color

Color-Word

M
SD
EMM
SEE

90.07
13.92
91.82
3.93

67.47
9.83
68.62
2.84

39.93
8.04
14.34
3.12

3.13
8.30
3.66
2.93

M
SD
EMM
SEE

100.94
14.08
100.82
3.69

75.63
8.09
75.22
2.66

40.63
10.38
38.82
2.92

-2.25
9.74
-3.54
2.74
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Interference

Table 8 (cont.). Raw Score Means, Standard Deviations, Estimated Marginal Means
(EMM), Standard Error o f Estimates (SEE), and ANCOVA results for Stroop ColorWord Test.

Statistic

Word

Color

Color-Word

Interference

Non-Medicated
Non-Depressed
(n = 22)

M
SD
EMM
SEE

106.36
13.79
105.25
3.20

82.05
11.34
81.55
2.31

52.10
13.66
52.45
2.53

6.36
12.10
6.94
2.38

All Groups3
ANCOVA

F
df
Partial rf

Group

cn
II
£

3.23*
2, 48
0.12

5.72*
2, 48
0.19

6.72*
2, 48
0.22

4.06*
2, 48
0.15

*p < .05

Hypothesis V
To test the fifth hypothesis that differences would be found between the
medicated depressed, non-medicated depressed, and non-medicated non-depressed
groups on the Controlled Oral Word Association test (COWA; Spreen & Straus, 1998), a
one-way analysis of covariance (ANCOVA) was performed using the COWA as the
dependent variable, participant age and WAIS-III Vocabulary scores as the covariates,
and group membership as the independent variables. The ANCOVA was not significant,
F(2, 48) = .443, MSE = 109.36, p = .645, partial p2=.018. The effect of group
membership on one’s COWA score was strong as assessed by the partial if. Full
ANCOVA results are presented in Table 9 comparing the three groups on the COWA as
well as the raw score means and standard deviations.
Post Hoc Analyses
While the core of the present study was to examine if depression affects
individuals’ executive functions, several multiple linear regressions were also completed
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Table 9. Raw Score Means, Standard Deviations, Estimated Marginal Means (EMM),
Standard Error of Estimates (SEE), and ANCOVA results for Controlled Oral Word
Association test.

Group

Statistic

COWA tsec.l

Medicated
Depressed
(n = 15)

M
SD
EMM
SEE

33.27
10.07
34.33
2.94

Non-Medicated
Depressed
(n = 16)

M
SD
EMM
SEE

36.38
11.86
37.73
2.75

Non-Medicated
Non-Depressed
(n = 22)

M
SD
EMM
SEE

39.36
10.28
37.65
2.39

All Groups3
ANCOVA
(N = 53)

F
df
Partial rf

0.44
2, 48
0.02

in order to gain a better understanding of whether or not anxiety, as measured by the
SCL-90-R Anxiety dimension, added any predictive ability to the executive function
measures. A set of stepwise regression analyses were conducted on the combined groups
to evaluate whether raw scores on the second independent variable, the Anxiety
dimension of the SCL-90-R, predicted performance on the measures of executive
functioning above and beyond that of the BD1-II.
Indeed, the Anxiety dimension accounted for a statistically significant proportion
of the variance after controlling for the effects of the BDI-II score on the following
measures of executive function: WCST Total Errors (AR2= .066, p = .049), WCST
Perseverative Responses (AR2 = 0.93, p = .018), WCST Perseverative Errors (AR2 = .099,
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p = .015), WCST Categories Completed (A/?2 = .080, p = .033), WCST Learning to Learn
(AR2 = .077, p = .045), Stroop Word (AR2= .109, p = .009), and the Stroop Color (AR2 =
.113,/? = .003). Such results indicate that anxiety scores on the SCL-90-R, in several
cases, accounted for significant amounts of variance in EF above and beyond that of
scores on the BDI-II. Table 10 presents the data from the regression analyses.
Table 10. Regression Coefficients of the Statistically Significant Executive Function
Measures with the BDI-II (Step 1) and SCL-90-R (Step 2) as Independent Variables.
Criterion

R2

AR2

AF

dfs

P

WCST
Trials Administered
Total Correct
Total Errors
Perseverative Responses
Perseverative Errors
Nonperseverative Errors
Conceptual Level Response
Categories Completed
Trials to Complete 1st Category
Failure to Maintain Set
Learning to Learn

.506
.109
.187
.224
.225
.142
.030
.173
.123
.201
.086

.056
.001
.066
.093
.099
.039
.023
.080
.061
.017
.077

3.78
0.07
4.06
5.97
6.41
2.30
1.18
4.83
3.46
1.04
4.22

1,50
1,50
1,50
1,50
1, 50
1,50
1,50
1,50
1,50
1,50
1, 50

.057
.794
.049*
.018*
.015*
.136
.283
.033*
.069
.313
.045*

Trail Making Test
Part A
Part B

.201
.247

.027
.052

1.66
3.44

1, 50
1, 50

.203
.070

Tower of LondonDX
Total Correct
Total Moves
Total Time
Time Violation
Rule Violation

.117
.063
.127
.084
.084

.005
.001
.056
.067
.073

0.29
0.03
3.18
3.65
3.97

1,50
1,50
1,50
1,50
1,50

.592
.854
.081
.062
.052
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Table 10 (cont.). Regression Coefficients of the Statistically Significant Executive
Function Measures with the BDI-II (Step 1) and SCL-90-R (Step 2) as Independent
Variables.
Criterion

AR2

R2

AF

dfs

P

Controlled Oral Word

.070

.021

1.11

1, 50

.298

Stroop
Word
Color
Color-Word
Interference

.277
.413
.176
.047

.107
.113
.001
.017

7.42
9.66
0.04
0.88

1,50
1,50
1,50
1,50

.009*
.003*
.840
.352

* = Statistically Significant

Of particular note is the regression analysis on the dependent variable of WCST
Learning to Learn and the independent variable, the BDI-II. This was not significant;
however, the second step using the Anxiety dimension of the SCL-90-R was statistically
significant, R2 change = .077, F(l, 50) = 4.224,/? = .045. This suggests that while
depression, as scored on the BDI-II, does not predict scores on the WCST Learning to
Learn subscale at a statistically significant level, Anxiety, as scored on the SCL-90-R,
does. This is noteworthy as the Anxiety dimension of the SCL-90-R is only able to
account for variance that has been left over from depression, as measured by the BDI-II.
Thus, this data suggests that anxiety has more predictive ability regarding the WCST
Learning to Learn subscale than depression.
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CHAPTER V
DISCUSSION
Depression is a psychological condition that afflicts approximately 121 million
people worldwide (WHO, 2001) and has been estimated to cost employers over $33
billion dollars a year due to missed work and decreased productivity (Quinn, 2000). The
deleterious effects of depression are typically not limited to one painful experience.
Barlow and Durand (1999) have reported that as many as 80% of depressed individuals
experience additional, and often more severe, depressive episodes later on in their lives.
While several areas of science have investigated the etiology of depression, WHO
(2001) asserted that there is a combination of biological, genetic, and psychological
underpinnings at the core of depression. The effects of depression on various aspects of
human functioning have traditionally been a major area of research. The brain and effects
depression has upon brain functioning have also been major areas of interest to scientific
investigation. More specifically, the frontal lobes, the area of the brain believed to house
higher-order regulatory and supervisory functions in human beings (Zillmer et al., 2001),
have recently seen increased interest. However, the effects of psychotropic medications
and differences in various age ranges have left this area of investigation with many
questions unanswered.
Thus, the purpose of the current study was to assess young adult individuals on
measures of executive functioning in a depressed and non-depressed sample.
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Furthermore, medication status was addressed by separating the depressed group into two
separate groups, medicated and non-medicated. Additionally, participants were required
to be between the ages of 19 and 40. These restrictions allowed for a purer understanding
of the effects of depression on the executive functions of depressed young adults. The
following discusses the present study’s findings.
Preliminary Analyses
The preliminary analyses revealed that there were statistically significant
differences between the three groups in regards to intelligence, as measured by the
Vocabulary subtest of the WAIS-III (Wechsler, 1997). Furthermore, there were
statistically significant age differences between the three groups. This suggests that the
three groups differed enough in terms of age and estimated intelligence that these
variables were used as covariates in the present study. This statistical procedure allows
one to compare groups on a variable of interest by simultaneously controlling for the
effect of a confounding variable. In this case, it allowed for the examination of executive
functioning, while simultaneously controlling for age and estimated intelligence
differences between the three groups.
The preliminary analyses also revealed that there were statistically significant
group differences on the Global Severity Index (GSI) of the SCL-90-R, which was used
to evaluate overall psychological well-being. As hypothesized, there were statistically
significant differences between the non-medicated non-depressed group and the two
depressed groups suggesting that the individuals in the non-medicated non-depressed
group possessed better overall psychological well-being than the two depressed groups.
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Furthermore, the GSI revealed no statistically significant differences between the two
depressed groups.
The analyses revealed no statistically significant differences between the two
depressed groups on any of the SCL-90-R subscales even beyond the GSI. There were
some subscales that failed to reveal statistically significant differences between the nondepressed and the depressed groups. For example, the non-medicated non-depressed
group and the non-medicated depressed group failed to reveal statistically significant
differences on the Interpersonal Sensitivity, Anxiety, and Paranoid subscales and neither
of the depressed groups differed from the non-medicated non-depressed group on the
Phobic Anxiety and Hostility subscales at a statistically significant level.
That there were no statistically significant differences between the two depressed
groups suggests that they are similar in their level of psychological distress. However,
this does not indicate or suggest that there depressive symptomatology is similar. While
there are similarities between depressive symptoms, there are different ways in which one
can meet criteria for the clinical diagnosis. For example, one may be suicidal and another
individual may not be; yet both can still obtain similar scores on measures of depressive
symptomatology.
Main Hypotheses
The main hypotheses of the current study were that medicated depressed, nonmedicated depressed, and non-medicated non-depressed participants would perform
differently on tests of executive functioning at a statistically significant level.
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Hypothesis I
Hypothesis I stated that statistically significant differences would be found
between the medicated depressed, non-medicated depressed, and non-medicated nondepressed groups on the Wisconsin Card Sorting Test (WCST). The overall omnibus test
was not significant. These findings are contrary to much of the research literature in this
area (Channon, 1996; Grant et al., 2001; & Merriam et al., 1999). Although the omnibus
test indicated that that there were no statistically significant differences between the three
groups on their overall WCST performance, there were statistically significant
differences on two subscales, Trials Administered and Failure to Maintain Set.
The Trials Administered score is simply the total number of cards used in the
administration of the WCST. Little research has been completed investigating the Trials
Administered scale’s effect upon the overall WCST. However, conceptually, an increased
number of trials administered score is likely to affect other scale scores (e.g., Total
Number Correct, Total Number of Errors, etc.). The other subscale that revealed
statistically significant differences between groups was the Failure to Maintain Set
subscale. A failure to maintain a set is achieved on the WCST (Heaton et al., 1993) when
one “makes five or more consecutive correct matches but then makes an error before
successfully completing the category” (p. 12). Therefore, while there may appear to be
some understanding involved of the task, errors made suggest that the examinee was
accidentally sorting the cards correctly based on an inaccurate understanding of the
sorting principle.
Although overall group differences were found on these two subscales (Trials
Administered and Failure to Maintain Set), no specific group differences reached
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statistical significance. This suggests that group differences are present when all groups
are considered together, but not when individual groups are compared with one another.

The WCST manual offers no information on how one should interpret the Trials
Administered subscale or if one should at all. One study that reported data from the Trials
Administered scale (Fey, 1951) found statistically significant differences between young
adult schizophrenics and healthy controls. Another (Channon, 1996) found statistically
significant differences between dysphoric and non-dysphoric participants on the Trials
Administered subscale. However, neither study discussed the implications of the finding,
thus, providing little insight into the meaning of Trials Administered performance.
Furthermore, that the pairwise comparisons failed to reveal statistically significant
individual group differences, the current study is unable to interpret the effects of
depression on Trials Administered performance.
The current finding that statistically significant overall group differences were
also found on the Failure to Maintain Set subscale is contrary to some previous research
(Merriam et al., 1999). However, this finding is congruent with others (e.g., Channon,
1996). As with the Trials Administered subscale, no individual group differences reached
statistical significance in regards to the Failure to Maintain Set subscale. Although the
Failure to Maintain Set subscale measures one’s ability to shift and maintain a set as well
as one’s ability to make use of feedback (Heaton et al., 1993), the current data do not
allow for a discussion of which group is more affected in this area than another. Due to
the lack of pairwise follow-up significance between any of the three groups, it can only
be speculated as to which group outperformed the others. As such speculation is
unacceptable in scientific research the need for further research to shed light into such a
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topic is obvious. Even if further studies reveal similar results, trends would be able to be
identified.

Hypothesis II
Hypothesis II stated that statistically significant differences would be found
between the medicated depressed, non-medicated depressed, and non-medicated nondepressed groups on the Trail Making Test (TMT) parts A and B (Reitan, 1993). Tests of
between-subjects effects revealed statistically significant group differences on the TMT
Part B, but not Part A. Follow-up pairwise comparisons on TMT Part B revealed that the
non-medicated non-depressed group outperformed the medicated depressed group at a
statistically significant level while no statistically significant differences were found
between the two depressed groups nor the non-medicated non-depressed and nonmedicated depressed groups.
The TMT (Parts A & B) are considered to be “tests of speed for attention, mental
flexibility, and of visual search and motor function” (Spreen & Strauss, 1998).
Heilbronner et al. (1991) reported that parts A and B might measure different functions,
which highlights the importance of understanding what Part B is believed to actually
measure. The primary difference between Parts A and B is that there are numbers and
letters that one must alternate between while completing Part B. On TMT Part B, in
particular, one must analyze the stimulus material and then integrate the numbers and
letters into a single sequence (Reitan & Wolfson, 1993). Additionally, Part B requires
more visual perceptual processing, psychomotor ability, and mental flexibility (Golden et
al., 2000; Woodruff, Mendoza, Dickson, Blanchard, & Christenberry, 1995). Anderson
(1994) noted that Part B assesses number and letter recognition, visual scanning,
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cognitive flexibility, visual-spatial functioning, and visuomotor coordination. Moreover,
as noted previously, Part B is considered to be “one of the best general indicators of
cerebral dysfunction” (Thomas, 2000, p. 171).
The current findings are consistent with the results reported by others such as
Paradiso et al. (1997) and Reitan and Wolfson (1993). However, the present data are
contrary to others who have found no such differences on overall TMT performance (e.g.,
Grant et al., 2001; Landro et al., 2001). Of particular interest is the current finding that
the medicated depressed group obtained higher average times to complete Part B than the
non-medicated non-depressed group. The fact that no differences were found between the
non-medicated depressed and the non-medicated non-depressed groups might initially
suggest that medication status may affect performance on this measure. However, the
lack of statistically significant differences between the two depressed groups cast doubt
on such an assertion.
Although medication status cannot completely account for the difference between
groups in the current study, important information can be gleaned from these results. As
noted previously, Part B assesses several important areas of executive functioning that
are necessary for adequate daily functioning (e.g., number and letter recognition, visual
scanning, and cognitive flexibility [Anderson, 1994]). Thus, the current data suggest that
depressed individuals taking antidepressant medications may very well experience
greater difficulties in regards to the aforementioned areas than others.
Hypothesis III
Hypothesis III stated that statistically significant differences would be found
between the medicated depressed, non-medicated depressed, and non-medicated non-

126

depressed groups on the Tower of London, Drexel University: 2nd Edition (TOLDX;
Culbertson & Zillmer, 2005). The overall omnibus test was not statistically significant
indicating that participants in the three groups did not perform differently on these
measures.
The TOLdx was designed to assess ones high-order problem solving abilities
(Culbertson & Zillmer, 2005), such as “abstraction, reasoning, judgment, analysis ...”
(Lezak et al., 2004, p. 30) and ability to synthesize information (Lezak et al.). More
specifically, the TOLDXwas developed in order to assess executive planning abilities. As
no statistically significant differences were found between any of the three groups of
participants, the current data suggests that neither depression nor medication status
affects planning abilities as measured by the TOLDX.
The current findings correspond with those of Grant et al. (2001), Porter et al.
(2003), and Purcell et al. (1997). Porter et al. (2003) and Purcell et al. (1997) both failed
to find statistically significant differences on the Tower of London planning task
comparing depressed younger adults against healthy comparisons. Although there are
subtle differences between the original Tower of London task (see Shallice, 1982) and the
edition used in the current study (TOLDX), one’s ability to plan and carry out a task is
assessed by both.
Additionally, the work of Grant et al. (2001) utilized a different measure of
planning (the Stockings of Cambridge) that was based on the original Tower of London
test. Grant et al. found statistically significant group differences on one subscale of the
Stockings of Cambridge in the area of Initial Thinking Time relative to a certain number
of moves. However the TOLDXdoes not assess this and thus does not allow for direct
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comparison. Nonetheless, the overall lack of evidence supporting the effect depression or
medication status on one’s ability to plan is growing as evidenced by this and other
studies (Grant et al., 2001, Porter et al., 2003; Purcell et al., 1997) and may be an area of
executive functioning that is spared from depression and/or antidepressant medication
effects.
Hypothesis IV
Hypothesis IV stated that statistically significant differences would be found
between the medicated depressed, non-medicated depressed, and non-medicated nondepressed groups on the Stroop Color and Word test (Stroop; Golden & Freshwater,
2002). The overall omnibus test was statistically significant indicating that participants in
the three groups performed differently on these measures at a statistically significant
level. Furthermore, subsequent analyses revealed that each subtest of the Stroop also
revealed statistically significant differences between the three groups. More specifically,
the non-medicated non-depressed group outperformed the medicated depressed group at a
statistically significant level on the Color subscale of the Stroop. Additionally, the nonmedicated non-depressed group outperformed the non-medicated depressed group on the
Color-Word subscale. Interestingly, no differences reached statistical significance on the
remaining two subscales of the Stroop (Word or Interference) at the group pairwise level.
One particularly confusing finding is the pairwise comparisons of the Color-Word
subscale. As previously noted, the non-medicated non-depressed group outperformed the
non-medicated depressed group at a statistically significant level, but not the medicated
depressed group. This is noteworthy since the difference between mean scores on this
subscale between the two depressed groups was only 0.7. However, this may be the result
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o f the one participant difference between the two depressed groups (medicated depressed,
n = 15; non-medicated depressed , n = 16).

Several different issues that are relevant to the current study can affect Color
subscale scores. For example, psychiatric patients may have low scores because of
emotional rather than cognitive reactions to the colors. Alternatively, these effects are
also hypothesized to be the result of low effort and or low motivation (Golden &
Freshwater, 2002).
The current study’s findings are in line with the idea named above to some
degree-that is-the non-medicated non-depressed group may have performed better than
the medicated depressed group based on the aforementioned emotional influences or due
to low effort. However, this would not account for the lack of statistical significance
between the non-medicated non-depressed group and the non-medicated depressed group.
Such findings suggest a medication component to the effects. However, these findings
also contrast Paradiso et al. (1997) who found no such differences between their groups.
Low Color scores on the Stroop (Golden & Freshwater, 2002), in the absence of
color-blindness, are sometimes seen in the presence of psychiatric conditions (e.g.,
depression) as the colors may arouse emotional reactions rather than cognitive ones.
However, Golden and Freshwater noted that such scores are also seen as a result of low
effort rather than any impairment in cognitive functioning. As just detailed, the
importance of statistically significant differences between the non-medicated nondepressed group and only one of the depressed groups (medicated depressed), suggests
that emotionality is not necessarily the reason for the lack of performance in the
medicated depressed group as the non-medicated depressed group’s scores did not differ
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from the non-medicated non-depressed group's scores at a statistically significant level.
Thus, it appears, based on the current findings that medication status may account for
difficulties encountered on the Stroop Color subscale.
There were also statistically significant differences found between the nonmedicated non-depressed group and the non-medicated depressed group on the ColorWord subscale, but no statistically significant differences between the two depressed
groups or the non-medicated non-depressed and medicated depressed groups. The ColorWord subscale is often said to reveal pre-frontal lobe brain pathology (in which case the
dominant word naming cannot be inhibited) through low scores (Golden & Freshwater,
2002). However, a major caveat is needed in that emotional turmoil, again, has been
implicated in obtaining low scores on this subscale.
While it was easier to identify likely primary involvement of either medication
status or depression status in the previously described Color subscale, this current finding
does not lend itself to such simple interpretation. The fact that the non-medicated nondepressed group outperformed the non-medicated depressed group at a statistically
significant level initially suggests that medication effects were at play. However, that the
medicated depressed group was not found to differ from the non-medicated nondepressed group at a statistically significant level takes such a hypothesis away and
leaves one struggling to understand what may be at the root of such a difference.
Furthermore, the lack of a statistically significant difference between the two depressed
groups further complicates this finding. This reveals an interesting difference that must
be investigated further as the quasi-experimental nature of the current study limits the
ability to speculate what is at the root of such a finding. Although, the unequal number of
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participants in each of the depressed groups may have affected the statistical analyses
enough to result in one group achieving statistically significant differences while the
other depressed group revealed none.
The Interference subscale of the Stroop can identify individuals with frontal lobe
dysfunction when viewed in the context of certain scoring patterns with other Stroop
subscales (Golden et al., 2000). Low Interference scores can also suggest problems with
cognitive flexibility and one’s ability to respond to job demands (Golden et al.). On this
scale, no statistically significant individual group differences were found suggesting that
although groups were affected by depression in regards to the construct measured by the
Interference subscale, individual groups cannot be contrasted to reveal which groups
outperformed others.
Paradiso et al. (1997) reported statistically significant differences between
depressed individuals and non-depressed individuals on neurocognitive tests, including
some executive functioning measures. The current study is consistent with Paradiso et
al.’s finding that depressed participants showed weaker performances than non-depressed
participants. With the Stroop test commonly used as a measure of frontal lobe
dysfunction (Golden et al., 2000), these findings, in combination with findings from
Paradiso et al. (1997), suggest that depression affects the area of the frontal lobes and
one’s ability to suppress automatic word-reading response, separate word- and color
naming stimuli, shift perceptual set to conform with changing demands, and attention that
are assessed by the Stroop Color-Word test (Anderson, 1994).
In day-to-day functioning this may affect an individual’s ability to inhibit an
action or thought when confronted with multiple stimuli. Furthermore, as task demands
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change, one will likely show difficulties adjusting to the changes adequately. For
example, work difficulties could present themselves if one works in an area where tasks
are dynamic and one must evaluate situations and adjust accordingly.
Hypothesis V
Hypothesis V stated that statistically significant differences would be found
between the medicated depressed, non-medicated depressed, and non-medicated nondepressed groups on the Controlled Oral Word Association test (COWA; Spreen &
Strauss, 1998). The overall omnibus test was not statistically significant indicating that
participants in the three groups did not perform differently on this measure at a
statistically significant level.
While various studies have reported statistically significant differences between
depressed participants and non-depressed participants (Landro et al., 2001; Porter et ah,
2003), the current study adds to the research described by those such as Grant et al (2001)
contradicting such assertions. Grant et al. found no differences between a sample of
depressed participants and a healthy comparison group. The COWA assesses an
individual’s word fluency, speech, and verbal comprehension. It is also known to be
sensitive to dysfunction in the left frontal lobe of the brain where lesions tend to
negatively impact oral word fluency (Anderson, 1994).
According to Lezak et al. (2004), the COWA requires generation of words, which
has proven to be sensitive to brain dysfunction associated with the frontal lobes
(regardless of hemisphere). As frontal lobe lesions have repeatedly revealed decreased
verbal fluency scores, the lack of such support evidenced by the current study and Grant
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et al. (2001) indicates that verbal fluency and word production are unhampered by
depression and/or medication status.
Summary of Hypotheses
A major trend that was revealed through the current analyses is that the nonmedicated non-depressed group outperformed both depressed groups in all aspects of
tests of executive functioning. Not all differences reached statistical significance, but
several did. The two most impressive differences occurred on the TMT Part B and the
Stroop Color and Color-Word tests.
As noted previously, the TMT Part B is considered one of the most sensitive
measures to any type of cerebral disruption (Reitan & Wolfson, 1993). This measure also
serves to highlight what are believed to be more specific frontal lobe functions such as
effortful attention, mental flexibility, visual scanning, fine motor control, and alphanumerical recognition (Reitan & Wolfson). This measure does not count errors against an
examinee. However, more errors lead to higher overall times and thus do count against
the individual in this capacity.
The Stroop Color and Color-Word subscales also revealed pronounced
differences between the groups. While the non-medicated non-depressed group
outperformed the medicated depressed group and the non-medicated depressed group at a
statistically significant level, it was on two different subscales. The Color subscale
appears to implicate medication use as the non-medicated depressed group did not
perform differently from the non-medicated non-depressed group at a statistically
significant level. However, the Color-Word subscale only revealed statistically
significant differences between the non-medicated non-depressed group and the non-
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medicated depressed group. This finding is complicated, as neither medication status nor
depression status is readily identifiable as the reason for the affected performance on this
subscale.
The Stroop and the TMT Part B have revealed areas of differential functioning
between non-medicated non-depressed and medicated and non-medicated depressed
individuals (e.g., planning, distractibility, lack of insight, poor decision-making,
perseveration, impulsivity, and an inability to inhibit responses; Burgess, 2003). Both
measures utilize these aspects of executive functioning, and typically not in isolation.
This highlights Ricco’s (2006) assertion that the study of the executive functions is
complicated by the lack of being able to assess a function (e.g., inhibition) in isolation.
That is, to complete a measure, one typically visually scans a page and then inhibits the
automatic desire to impulsively react. Inhibiting such impulses, potentially limits
incorrect responses. This small example highlights the fact that several areas of executive
functioning are used simultaneously when completing certain tasks. Thus, while science
can implicate areas of dysfunction, localizing such dysfunction to specific brain areas or
isolated executive functions have been elusive.
The Color and Color-Word subscales of the Stroop and TMT Part B have been
identified as problematic areas of functioning for individuals with depression (either
medication free or those taking medication) in the current study as well as previous
research (Paradiso et al., 1997; Reitan & Wolfson, 1993; Ridout et al., 2007). However,
such findings have also been contradicted in previous studies where no such differences
have been displayed (e.g., Grant et al., 2001; Landro et al., 2001). Furthermore, the
♦
overall results of the present study have also failed to show deficiencies in depressed
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individuals that have typically been a consistent finding in previous research (e.g.,
WCST, COWA; Grant et al., 2001; Landro et ah, 2001; Porter et ah, 2003).
The main overall consistent finding in the current study is one of inconsistency in
performance on tests of executive functions. This inconsistency is in line with previous
research (see; Channon, 1996; Channon & Green, 1999; Grant et ah, 2001; Landro et ah,
2001; Merriam et ah, 1999; Paradiso et ah, 1997; Porter et ah, 2003; Purcell et ah, 1997).
An important question of whether these differences represent a static or dynamic
disruption in cerebral and frontal lobe dysfunction cannot be answered by the current
study. However, the present data are trending in a direction that suggests dysfunction is
present in depressed individuals with a slight emphasis toward medication effects, as
demonstrated by the TMT Part B and the Color subscale of the Stroop. Such findings
have valuable implications in that research is now accumulating that reveals a trend
toward certain executive function deficits in depressed individuals and that medication
status affects functioning as well (Channon, 1996; Channon & Green, 1999; Grant et ah,
2001; Landro et ah, 2001; Merriam et ah, 1999; Paradiso et ah, 1997; Porter et ah, 2003,
Purcell et ah, 1997).
The present study has not been able to definitively implicate depression,
medication status, or one particular area of executive functioning that is at the root of the
broad research findings in this area of study. However, clearer understanding of the
interaction between depression and executive functioning has resulted.
The present study has revealed deficits in executive function domains. Although
not specific, a generalization of areas that may provide difficulties to depressed
individuals has been an accomplishment of the present study. Depression and medication
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status appear to deleteriously affect certain areas of executive functioning (e.g., planning,
distractibility, lack of insight, poor decision-making, mental flexibility, perseveration,
inability to make use of feedback, impulsivity, and an inability to inhibit responses) while
sparing others (e.g., planning, higher order problem solving, mental flexibility, and
inhibition).
Researchers have detailed the difficulties of studying the executive functions
(Burgess, 1997; Riccio, 2006). The present study found deficient performances in certain
areas of executive functions (e.g., planning and mental flexibility), yet found no such
deficiencies on other measures of the same faculty. Riccio (2006) asserted that this is
where studies of executive functioning suggest that there may be other areas of the brain
and/or associations that are not yet identified or understood. Future research will be
needed in order to fully flesh out such inconsistencies.
Post Hoc Analyses
The post hoc regression analyses revealed several interesting findings. Most
importantly was that Anxiety, as measured by the SCL-90-R Anxiety dimension,
accounted for a statistically significant amount of the variance on several subscales of the
WCST and the Stroop after taking out the variance accounting for depression as
measured by the BDI-II.
Anxiety accounted for a statistically significant amount of the variance on the
WCST’s Total Errors, Perseverative Responses, Perseverative Errors, and Learning to
Learn subscales. Heaton et al. (1993) instructed that an error occurs when one’s response
does not match “the correct sorting principle in effect at the time the response is made”
(pp. 7-8). Therefore, the total score subscale does not provide a great deal of information
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in that one still does not know what type of errors were made (e.g., perseverative versus
nonperseverative). However, this finding suggests that one who scores high on a measure
of anxiety may make more errors on complex problem solving tasks such as the WCST.
The finding that individuals who obtained higher scores on an anxiety measure
also made more perseverative responses and perseverative errors on the WCST suggests
that anxiety may be a condition that affects ones ability to shift sets and inhibit one’s
actions. This is an interesting finding and worthy of further research in order to deduce
the affects of anxiety on this executive function domain. Similarly, the Categories
Completed subscale was also better predicted by scores on a measure of anxiety. This
subscale simply informs one to how many categories (color, form, or number) an
individual has completed over the course of the test. This finding suggests that ones level
of anxiety affects how many categories one will complete on the WCST. Thus, these
findings are significant for clinical situations (e.g., anxious individuals may have greater
difficulty moving from one situation to the next and may very well be ruminating over
past situations rather than moving on and dealing with situations as they happen) and
deserve further investigation to better decipher their impact.
The Learning to Learn subscale of the WCST is another interesting finding in that
this score “reflects the client’s average change in conceptual efficiency across the
consecutive categories” (Heaton et al., 1993, p. 13). Therefore, a positive score indicates
improved efficiency of learning across the categories, while a negative score suggests no
learning or slower learning. Overall, this means that higher scores on an anxiety measure
predict lower efficiency in learning across the consecutive categories on the WCST
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(Heaton et al.). Again, this finding deserves further attention as scientists work to better
differentiate between the effects of anxiety and depression.

In regards to the Stroop, higher scores on a measure of anxiety predicted lower
scores on the Word and the Color subscales. The Word subscale is presumed to be a
measure of basic reading speed and may reflect motor-speech problems, poorly
developed reading skills, and/or poor dominance for reading skills as is the case in many
learning disabled individuals (Golden et al., 2000, Golden & Freshwater, 2002). Golden
and Freshwater (2002) noted that lower scores on the Word subscale, and resulting
difficulties (as just described), are suggestive of disorders of the posterior left
hemisphere. The word reading score is not indicative of an executive functioning skill,
yet in the myriad interconnections within the brain, this finding is important in the overall
effort to better understand psychiatric disorders and their effects upon neurocognitive
performance.
Low color scores on the Stroop, in the absence of color-blindness, are sometimes
seen in the presence of psychiatric conditions (e.g., depression or anxiety). Thus, this
findings is somewhat anticipated. However, the fact that anxiety accounted for a
statistically significant amount of the variance after depression is interesting. Why
symptoms of anxiety would affect an individual’s ability to name a word or the color of
ink printed on a page is currently unknown and not easily understood. With lower Word
scores suggestive of posterior left hemisphere dysfunction, it complicates the earlier
finding of all three experimental groups performing differently at a statistically
significant level on all four Stroop subscales. This study viewed the overall Stroop as a
test of frontal lobe functioning (executive functioning). Such a finding highlights Riccio’s
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(1996) assertion that while the executive functions may be viewed as being related to the
frontal lobes, associations running throughout the brain are likely impaired in areas other
than strictly the frontal lobes.
Numerous studies have investigated anxiety’s affect on various aspects of
cognitive functioning (see Derakshan & Eysenck, 1998; Dutke & Stober, 2001; Eysenck,
1979, 1985; Kusche, Cook, & Greenberg, 1993). Dutke and Stober (2001) investigated
the effects of test anxiety on working memory and cognitive performance. They noted
that anxious individuals worry and grow concerned about irrelevant things rather than
focusing on a task. Highly anxious individuals tend to self-evaluate, which occupies
aspects of one’s working memory capacity (Dutke & Stober). “In easy tasks, the
remaining memory capacity may suffice to fulfill task requirements. In complex tasks,
however, it may not” (pp. 382-383). As a result of this, highly anxious individuals tend to
show deficits in task performance.
Similarly, Kusche et al. (1993) investigated the neuropsychological effects of
anxiety in school-aged children. In their study, anxious participants had lower levels of
academic achievement, yet obtained superior scores on nonverbal tasks over verbal tasks.
Additionally, anxious participants obtained lower scores on analogies and threedimensional block designs implicating right-temporal parietal dysfunction. On measures
associated with the executive functions, anxious participants exhibited poorer
performances on the TMT Part B, which is consistent with the current study.
Overall, Kusche et al. (1993) asserted that the anxious school-aged participants in
their study possessed cognitive processing deficits. Interestingly, they pointed out that
most of these children were “good” kids and thus go unnoticed by their parents and/or
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teachers because they do not exhibit behavioral problems. Findings such as the current
study and these just described indicate that there is a need for further research in the area
of anxiety and its affect on cognitive functioning. Furthermore, an emphasis on the
executive functions may add more specific information to an area that appears to be both
an issue for younger school-aged children as well as adults. These “good” kids will grow
up and if their cognitive deficits have gone unnoticed by their parents and teachers, they
will undoubtedly have difficulties throughout their adolescence, young adulthood,
and-potentially-adult years.
Clinical Implications
Depression. The current study has added another layer of understanding and data
to the expanding research base investigating the effects of depression upon younger adult
executive functioning. While some measures and subscales revealed statistically
significant differences between the medicated depressed, non-medicated depressed, and
non-medicated non-depressed groups, others uncovered no such evidence. This is
critically important for those whose clinical practice focuses not only on
neuropsychological assessment, but also those whose primary clinical work is with
individuals experiencing affective disorders encompassing depression.
The research literature discussing depression and executive functions appears to
be limited to assessment of deficits. A recent literature search of PsycINFO yielded no
articles that discussed counseling/psychotherapy with individuals experiencing
executive/cerebral/cognitive dysfunction and depression. Thus, at the present time,
psychotherapists are without direction as research is indicating that depression and
medication status are affecting certain aspects of executive functioning in their clients,
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yet no research is presently available to them to assist in treatment. Recommendations
made in the following text are therefore speculative at best and will serve to engender
future research in the area of executive dysfunction, depression, and psychotherapy
outcomes.
In an individual’s daily life there are countless times when one uses aspects of
executive functions. Which route will be chosen in order to avoid traffic, changing lanes
while driving on an interstate or expressway, and deciding what to say and what not to
say to a friend or colleague are all examples of day-to-day tasks that involve the
executive functions. Take, for example, the last situation described. If one’s boss is being
unreasonable and an individual is depressed and displaying executive functions deficits,
there is a strong chance that executive dysfunction symptoms will hinder not only
interpersonal communications with colleagues, but also job performance (Quinn, 2000).
This example is multilayered as the symptoms of depression and the symptoms of
executive dysfunction are identified. The low mood (e.g., feeling sad and/or empty
inside), finding no interest or pleasure in one’s activities, weight fluctuations, difficulty
sleeping, fatigue, feelings of worthlessness, and-potentially-thoughts of death and/or
suicide (DSM-IV-TR, 2000) deleteriously affect an individual without argument.
Additionally, if one also experiences cognitive processing difficulties such as planning,
distractibility, lack of insight, poor decision-making, apathy, perseveration, impulsivity,
Know-Do dissociations, poor abstract thinking, and an inability to inhibit responses, the
difficulties experienced simply as a result of the depression may be amplified and
exacerbated and will likely profoundly add to the depressed individual’s difficulties.
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Those whose clinical practice focuses on psychotherapeutic interventions with
depressed individuals will need to consider such dysfunctions (on the part of their clients)
in the context of their clinical work. Based on the results of the current study, individual
clients may present with difficulties related to a lack of ability to shift and maintain a set
or make use of feedback (from WCST Failure to Maintain Set; Heaton et al., 1993),
problems with slow cognitive processing speed, visual scanning deficits, decreased
motivation/effort, and decreased psychomotor deficits (TMT Part B), as well as reading,
motivation, and inhibition (Stroop Color-Word test). Normalizing these issues for the
individual experiencing depression may grant clients some measure of relief.
Additionally, psychotherapeutic interventions should be evaluated in the context
of how they are to be carried out. For example, in the context of the present study, a
depressed individual who is experiencing difficulties with his/her ability to shift thoughts
and/or pay attention may benefit from interventions that help assuage the impact of such
a deficit. This information is important in that some deficits may present as brain damage,
only to have been attributable to the individuals’ affective state. A psychotherapist
without knowledge of the effects of depression upon the executive functions could send
his/her client for medical or neuropsychological evaluation and begin a lengthy and
expensive process of ruling out non-affectively related symptom clusters only to, in the
end, work on alleviating depressive symptoms and assisting the client to adapt more
productively to his/her situation.
Depressed individuals experiencing executive functioning deficits who are
engaged in psychotherapy will not likely respond well to an inflexible unidimensional
approach. Due to the client’s own inflexibility, they may appear as refractory and
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interventions will likely need to be symptom specific. As with most psychotherapeutic
interventions, what may work for one, may not work for another (see Wampold, 2001),
thus necessitating a flexible, yet highly structured, approach.
Moreover, those whose clinical work emphasizes neuropsychological evaluation
need to keep in mind the growing evidence that those experiencing depression may have
deficits in areas of executive functioning. Therefore, patients presenting with a history of
depression should alert the clinical neuropsychologist to deficits that will likely be
revealed upon examination. Only then can proper diagnosis and treatment planning
occur.
Another clinical implication resulting from the current study is in regards to
medication status. Some measures of executive functioning revealed statistically
significant differences between medicated depressed and non-medicated depressed
individuals. Although many of the measures and subscales failed to reach statistical
significance, data trends indicated that the non-medicated depressed individuals
consistently performed better than medicated depressed individuals.
This is cause for attention as antidepressant medications continue to be the
standard of treatment for depression (Hollon et al., 1993), thus a large percentage of
depressed individuals takes some type of antidepressant medication. Antidepressant
medications play a larger role in executive functioning than many believe (Vasko &
Gutierrez, 2003). Some may argue that this is not a result of the medication, but an issue
of depressive severity (i.e., more severely depressed individuals take antidepressants and
thus score lower on tests of executive functioning due to increased depressive
symptoms). Yet, the current study failed to reveal statistically significant differences

143

between the two depressed groups (medicated depressed and non-medicated depressed)
based on BDI-II (Beck et al., 1996) scores and thus casts doubt upon a severity argument.
Although the current study cannot specifically implicate medication status as a sole cause
of decreased performance, the data can serve as a launch pad pointing out the clear
necessity of further research into the question of how exactly antidepressant medications
do and do not affect cognitive functioning, and more specifically, the executive functions.
Anxiety. The post-hoc analyses results regarding anxiety and executive
functioning also have implications for clinical work. While the link between depression
and anxiety is well known (Hunt, Slade, Andrews, 2004; also see Lenze et al., 2001),
these two disorders have been studied separately in the literature in the context of
neurocognitive functioning. Several studies investigating anxiety’s affect upon
neurocognitive functioning have displayed significant deficits (Dutke & Stober, 2001;
Eysenck, Payne, & Derakshan, 2005; Kusche et al., 1993).
As was the case with depression, those whose clinical practice focuses on
psychotherapy with individuals experiencing the symptom constellation associated with
the construct of anxiety will need to consider the executive function deficits that appear
to coexist with anxiety. Based on the results of the present study, individuals may present
to psychotherapy with difficulties related to ones ability to shift sets, inhibit actions, and
efficiently understand concepts in the presence of changing situations (Heaton et al.,
1993). As previously noted, an anxious individual may have greater difficulty moving
from one situation to the next due to his/her ruminating over past events instead of
dealing with situations as they occur. This is important for psychotherapists to remember
as they apply their chosen theoretical orientation to a client’s treatment. Just as in
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working with depressed individuals, normalizing such difficulties may provide a measure
of relief to clients presenting to psychotherapy with symptoms o f anxiety.

Anxious individuals experiencing executive functioning deficits who are
attempting to assuage the deleterious experiences associated with anxiety may benefit
from structured psychotherapy emphasizing the decrease of ruminative thoughts. Barlow
and Durand (1999) described how challenging such behaviors and dealing with fear
provoking stimuli “head on” and in the moment have proven to be beneficial.
As well, those whose clinical work focuses on neuropsychological evaluation
need to understand the effects of anxiety upon cognitive functioning in those
experiencing anxiety. As previously detailed regarding depression, a history or current
diagnosis of anxiety (or symptoms consistent with anxiety during the testing session)
should be considered “red flags” and alert the clinical neuropsychologist to deficits that
are consistent in individuals experiencing anxiety. This will serve to facilitate proper and
accurate diagnosis as well as assist in treatment planning.
Overall, the current study, as well as previous literature in the area of anxiety and
cognitive functioning, highlights the need for further research that may identify specific
areas of cognitive deficits as well as potential interventions that could help assuage and
ameliorate such effects.
Limitations of the Current Study
The limitations of the current study are noted here and discussed in an attempt to
aid future research in avoiding such limitations. The first, and primary, limitation of the
current study is in regards to the quasi-experimental design implemented. The hallmark
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of a quasi-experimental design is the lack of random assignment of participants to
experimental groups (Cook & Campbell, 1979; Heppner et al., 1999).
The lack of random assignment of participants to groups represents a threat to
internal validity, as one is not able to identify fully causal reasons for changes among
and/or between groups (Dunn, 2005). For example, are the differences in the current
study between the non-medicated depressed group and the medicated depressed group
due to medication effects? Or, do these two groups represent selection effects that
predisposed one group to perform differently on tests of executive functioning? That is,
are there differences in those that are more willing to take antidepressant medications and
those who prefer to treat their depression without pharmacological agents? Such
questions cannot be answered using a quasi-experimental design due to the lack of
random assignment of participants to groups (Cook & Campbell, 1979; Dunn. 2005;
Heppner et ah, 1999). Such a limitation restricts how much one is able to generalize in
regards to the current findings and represents a need for further, more controlled,
laboratory experiments.
However, having pointed out this limitation, Heppner et ah (1999) noted the
usefulness of quasi-experimental designs in contemporary applied clinical research. As a
result of the intent of the current study, random assignment of participants was not an
option. However, as recommended by Heppner et ah, a sound attempt was made to
understand the basis on which the groups were formed and the applied setting from which
they came in order to better understand the somewhat naturally occurring groups that
were used (i.e., medicated depressed, non-medicated depressed, & non-medicated nondepressed). Such efforts assisted in the understanding of these groups that resulted in

146

better controlling of preexisting issues (e.g., using estimated IQ as a covariate). While
this is not the preferred manner in which to reveal cause and effect relationships in
psychological research, such a design has allowed for understanding and interpretation at
a clinical level which is an important component of the struggle to take laboratory
research to applied settings (Heppner et al.).
A second and equally important limitation is related to the total number of
participants in the current study. Although great amounts of time and effort were made to
obtain a higher number of participants for the two depressed groups, the non-medicated
non-depressed (healthy comparison) group was the only group that reached the desired
group size (n = 22). Obtaining desired participant numbers for the two depressed groups
proved challenging. Despite utilizing several facilities as recruiting sites, the two
depressed group numbers fell short and thus limits the generalizability of the current data.
A replication study that obtains the desired number of participants based on a power
analysis would eliminate this limitation as well as add to the research literature in this
area of study.
In this same vein, the ratio of men to women in the current study is not as
reflective of the prevalence rates of the DSM-IV-TR (2000) as was desired. The DSMIV-TR reported prevalence rates of MDD in community samples as between 10% and
25% for women and between 5% and 12% for men, or roughly a ratio of 2:1. The current
study’s sample had a ratio of nearly 5 women to every 1 man. Although this ratio equates
to the high estimate for women and low estimate for men, a 2:1 ratio was desired and
believed to be a better representation of the disorder’s occurrence. A replication study
investigating only males or only females would be beneficial to the overall understanding
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of the current research topic as well as provide greatly needed information regarding any
potential gender differences.

Additionally, the racial and ethnic make-up of the current study’s sample is
another limitation. Given the region where the research study was carried out, the
generalizations of the data must be restricted to similar individuals. Upper Midwestern
Caucasians were the largest single group of individuals who participated (over 90% of
the sample). Such a homogenous sample presents a major difficulty in the
generalizability of the study’s results to ethnically and racially diverse populations.
Research utilizing a more diverse sample would be beneficial.
Recommendations for Future Research
The current research has added to the burgeoning literature base investigating the
effects of depression on executive functioning. However, several questions have been
created as a result. For example, previous research (e.g., Channon & Green, 1999; Landro
et al., 2001; Paradiso et al., 1997), as well as the present study, has attempted to manage
the group sampling in such a way that group differences could explain executive
functioning deficits found in different populations. Future investigations should attempt
to entirely control medication status through experimental design in order to fully
understand if and how medication status influences executive functioning. Such control
would resolve the problems associated with a quasi-experimental design (i.e., random
assignment of participants to groups) and enable one to more easily identify a causal
relationship between medication status and any cognitive functioning deficits that may be
found.
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Moreover, in an attempt to better explain the inconsistent findings of research
looking into depression and the executive functions (e.g., Landro et al., 2001; Paradiso et
al., 1997), research that further reduced the age range and limited the degree of
depressive symptoms experienced by potential research participants would add needed
clarity. This would serve to focus the information gained to a better-defined group of
individuals (based on a smaller age range and narrower scope of depression). As smaller
groups become better understood, such findings could be brought together to better
explain the inconsistent findings of research looking into depression and the executive
functions.
Another suggestion for future research is in regards to the instruments used to
assess executive functions. There is no dearth of measures and instruments available to
study the executive functions. However, this makes it difficult to compare research
findings across several studies (e.g., Grant et al., 2001; Landro et al., 2001; Purcell et al.,
1997). A meta-analytic review may be quite helpful in this regard and would surely
enable a more standardized, reliable, and valid battery of measures to assess executive
functioning in order to carry out the aforementioned research. Consequently, instrument
development and validation is a vital component of any research line in this area.
Lastly, future research implementing neuroimaging and biofeedback could greatly
advance the understanding of what is exactly happening on a neurochemical and
neurophysiological level. Although neuroimaging is not perfect and cannot fully reveal
all happenings of the brain, attempts could be made to identify and localize areas of the
brain that become activated while depressed individuals are attempting tasks associated
with tests of executive functioning (Rogers et al., 2004). Moreover,
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electroencephalograms and other biofeedback measures could add data to the overall
understanding o f depression and the executive functions.

Regarding anxiety, future research should address the shared variance that is well
known in the psychological community between depression and anxiety. Completing
laboratory research with individuals experiencing anxiety and not depression will allow
for a purer understanding of the effects anxiety has upon cognitive functioning and, more
specifically, the executive functions. Although research such as Dutke and Stober (2001)
have pronounced that cognitive deficits among anxious individuals are well established,
delineating specific differences between the effects of anxiety versus depression are
needed.
Furthermore, behavioral interventions focused on both the deleterious effects of
anxiety symptoms as well as decreased cognitive functioning are needed. While
psychotherapeutic work with anxious individuals is well established and researched (see
Barlow & Durand, 1999), the effects of cognitive dysfunction and whether or not such
deficits remain upon anxiety symptom remittance are less well known.
Lastly, anxiolytic medications are typically sedative hypnotics and are known to
affect cognitive capacities (DiMicco & Gutierrez, 2003). While cognitive deficits are
expected with such medications, it would be helpful to fully understand the severity and
specific domains affected. Such information would undoubtedly aid clinicians in their
work to increase treatment compliance. Such efforts would also likely improve the
overall educational needs and desires of the mental health care consumer of the 21st
century.
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Conclusion

The current study attempted to further the research literature base that has
revealed equivocal findings regarding the effect of depression upon younger adult
individuals’ executive functions. A major intent of the current study was to utilize a
methodology that would increase understanding of psychotropic medication effects upon
executive functioning as well as compare executive functioning of depressed individuals
against non-depressed individuals.
The results of the current study have added information to the research base in
various areas. However, several findings will ultimately fuel future research. The results
of the current study lends support to the hypothesis that there are differences in executive
functioning between medicated depressed, non-medicated depressed, and non-medicated
non-depressed individuals in different areas related to executive functioning. This is
especially true in regards to one’s ability to shift and maintain a set or make use of
feedback (from WCST Failure to Maintain Set; Heaton et al., 1993), problems with slow
cognitive processing speed, visual scanning deficits, decreased motivation/effort, and
decreased psychomotor deficits (TMT Part B), as well as reading, motivation, and
inhibition (Stroop Color Word test) where non-medicated non-depressed participants
outperformed participants in the two depressed groups. Furthermore, there was a trend
toward the non-medicated depressed group also outperforming the medicated depressed
group. However, definitive answers have not resulted from the current study. Such
answers will have to come from future research (as detailed previously).
Burgess (2003) recently noted the executive functions are likely the newest area
of neuropsychological investigation. Thus, this and other such investigations are clearly
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in their infancy; much more will be learned as more research is carried out. The aim of
the current study was to add a foundational piece to the burgeoning base of literature
attempting to explain the effects of depression on executive functioning. Clearly,
disorders such as depression (and potentially anxiety) interact with our executive
functions, and evidence from this study suggests that it does so differently depending on
the presence or absence of antidepressant medication. Future research must build on these
findings in order to advance our understanding of executive functioning in depressed
younger adults.
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APPENDICES

Appendix A

Informed Consent Depressed Groups
My name is Michael Ransom; I am a Counseling Psychology doctoral student under the advisement of
Kara B. Wettersten, Ph.D. in the Department o f Counseling at the University o f North Dakota. 1 am
conducting a research study looking at cognitive functioning in depressed and non-depressed individuals.
You are invited to participate in this research study which will require you to meet with a research team
member and complete a demographic questionnaire and some tasks assessing depression and cognitive
functioning (e.g., attention, planning, memory, etc.) which will take approximately 1 and one-half hours to
complete. Your participation in this study is completely voluntary and anonymous and your confidentiality
is extremely important. Therefore, while the results o f this study may be published, neither your name nor
any other identifiable information will be used. Furthermore, upon completed data collection, the
anonymous data will be stored in a secure location. All data obtained will be retained for at least three years
following the completion o f this study and kept in a secure location where only Michael Ransom, Dr.
Wettersten, and 1RB auditing personnel will have access to it.
There is a possibility that you may experience some psychological discomfort in completing these
measures. Should you have any concerns regarding your performance or any other aspect o f this research
study, you are encouraged to let the principle investigator know so your questions can be answered or
provided with an appropriate referral. If you should choose to withdraw your participation from this
research study please inform the individual administering the assessments to you (i.e., Michael Ransom,
M.A.). Furthermore, there will be no penalty or repercussions should you choose not to participate or
choose to withdraw from the research study. While there is no financial or monetary compensation
provided for participation in this study, the benefits o f you participation include an opportunity to
participate in the advancement o f scientific and clinical knowledge regarding the diagnosis and treatment of
clinical depression. Additionally, there is no cost to you to participate in the present study or receive the
free depression evaluation. However, if you choose to seek any treatment based on the findings o f the free
depression evaluation, the cost will be your sole responsibility. There is a possibility that you may be
excused from the research study if you are taking certain medications or have a medical diagnosis that may
impact your test taking abilities. However, if this is the case, the depression evaluation will still be
completed free o f charge.
It is required by law that I must obtain assistance for individuals who are imminently suicidal. If you are in
immediate danger or harming yourself or others, 1 will contact the referral source or other emergency
personnel.
If you have any questions or concerns regarding this research study, please contact m yself at
michael.ransom@und.edu or Dr. Wettersten at kara wettersten@und.edu. both o f whom are at the
University o f North Dakota, Department o f Counseling (701-777-2729). If you have any other questions or
concerns, please call Research Development and Compliance at (701) 777-4279.
Thank you very much for your time and help in this research project,
Michael Ransom, M.A.
I have read and understand that above information regarding this research study. I also have been given a
chance to ask any questions. A copy o f this form has been provided to me for my records. By signing
below, I agree to participate and understand that I may stop my participation at any time without
repercussion for doing so.
Name (please print)

Date

Signature
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Informed Consent Non-Depressed Group
My name is Michael Ransom; I am a Counseling Psychology doctoral student under the advisement of
Kara B. Wettersten, Ph.D. in the Department o f Counseling at the University o f North Dakota. I am
conducting a research study looking at cognitive functioning in depressed and non-depressed individuals.
You are invited to participate in this research study which will require you to meet with a research team
member and complete a demographic questionnaire and some tasks assessing depression and cognitive
functioning (e.g., attention, planning, memory, etc.) which will take approximately 1 and one-half hours to
complete. Your participation in this study is completely voluntary and anonymous and your confidentiality
is extremely important. Therefore, while the results o f this study may be published, neither your name nor
any other identifiable information will be used. Furthermore, upon completed data collection, the
anonymous data will be stored in a secure location. All data obtained will be retained for at least three years
following the completion o f this study and kept in a secure location where only Michael Ransom, Dr.
Wettersten, and IRB auditing personnel will have access to it.
There is a possibility that you may experience some psychological discomfort in completing these
measures. Should you have any concerns regarding your performance or any other aspect o f this research
study, you are encouraged to let the principle investigator know so your questions can be answered or
provided with an appropriate referral. If you should choose to withdraw your participation from this
research study please inform the individual administering the assessments to you (i.e., Michael Ransom,
M.A.). Furthermore, there will be no penalty or repercussions should you choose not to participate or
choose to withdraw from the research study. Your participation will help in the advancement o f scientific
and clinical knowledge regarding the diagnosis and treatment o f clinical depression and be rewarded with a
$5 gift card to a local eating establishment or discount store. Additionally, there is no cost to you to
participate in the present study or receive the free depression evaluation. However, if you choose to seek
any treatment based on the findings o f the free depression evaluation, the cost will be your sole
responsibility. There is a possibility that you may be excused from the research study if you are taking
certain medications or have a medical diagnosis that may impact your test taking abilities. However, if this
is the case, the depression evaluation will still be completed free o f charge.
It is required by law that I must obtain assistance for individuals who are imminently suicidal. If you are in
immediate danger or harming yourself or others, I will contact the referral source or other emergency
personnel.
If you have any questions or concerns regarding this research study, please contact m yself at
michael.ransom@und.edu or Dr. Wettersten at kara wettersten@und.edu. both o f whom are at the
University o f North Dakota, Department o f Counseling (701-777-2729). If you have any other questions or
concerns, please call Research Development and Compliance at (701) 777-4279.
Thank you very much for your time and help in this research project,
Michael Ransom, M.A.

I have read and understand that above information regarding this research study. I also have been given a
chance to ask any questions. A copy o f this form has been provided to me for my records. By signing
below, I agree to participate and understand that I may stop my participation at any time without
repercussion for doing so.

Name (please print)

Date

Signature
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Appendix B

Demographic Questionnaire

1. Age (please specify):

2. Sex (circle one):

Female

Male

3. Race/Ethnicity (please specify):

4. Relationship Status (check one):
Single (never married) _
Married ___
Partnered ___
Divorced ___
Widowed ___
Remarried___
Separated ___
Other (please specify): _
5. Yearly household income (check one):
$0 to $25,000
____
$25,000 to $50,000 ____
$50,000 to $75,000 ____
$75,000 to $100,000 ____
$100,000 to $150,000____
$150,000 to $200,000____
Greater than $200,000____
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Appendix C
Interview Questions
1. Are you:

Right Handed ____
Left Handed ____
Ambidextrous ____

2. How many years of education have you completed:___________
3. Have you ever been diagnosed with depression (check one):
Y es____
If yes, age of first onset:_____
Number of total depressive episodes:_____

N o ____
(If no, skip to question 8)

If individual is currently receiving counseling, how many sessions have been
completed:______
Have you ever received Electroconvulsive Therapy (ECT):
Yes
No
4. Have you ever been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD,
also known as ADD) (check one):
Y e s____
If yes, age of diagnosis:_____

N o ____

5. Have you ever received a formal mental health diagnosis:
Y es____
N o ____
If yes, what (please list):___________________

6. Have you ever been hospitalized for a psychiatric condition:
Y es____
N o ____
If yes, how many times:____________
7. Have you ever sustained an injury that resulted in a loss of consciousness (knocked out):
Yes
No
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